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levam um pouco de nós 
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ABSTRACT 
Paraquat (1,1´-dimethyl-4,4´-bipyridylium dichloride; PQ) is an effective and widely used 
herbicide that has a proven safety record when appropriately applied to eliminate weeds. 
Over the last decades there have been numerous fatalities and for that reason PQ is 
considered one of the most toxic poisons involved in suicide attempts. The therapies 
currently used have failed to successfully ameliorate the burden regarding PQ poisoning. 
During the last years, our research group has been a reference to the scientific community 
in the field of PQ toxicity and development of antidotes. Sodium salicylate (NaSAL) and 
lysine acetylsalicylate (LAS) have been shown to have a multifactorial protection 
mechanism against PQ-induced toxicity, due to its ability to modulate inflammatory 
signaling systems, to prevent oxidative stress and to its capacity to complex with PQ. 
Although salicylates have conferred full survival when administered 2h after PQ 
intoxication in rats, in clinical practice sometimes patients might be admitted when lethal 
doses of PQ were already uptaken by pulmonary cells. An alternative approach to 
lowering PQ toxicity is to modify the PQ formulation. The formulation has faced some 
changes since its introduction such as the addition of a blue dye, a stenching agent, an 
emetic and an alginate. However, the existing formulations of PQ in the market are still 
highly toxic. The present thesis aimed to develop a safer PQ formulation with the 
incorporation of LAS as the antidote and preserving the herbicide effectiveness. To 
accomplish these aims the thesis is structured in three studies in order to evaluate i) the 
safety of the formulation to Wistar rats and maintenance of herbicidal activity; (ii) the 
safety of the formulation to the microalga Chlorella vulgaris, and (iii) the acute toxicity and 
mechanisms of toxicity, of the formulation in comparison with PQ. 
For this purpose, the toxicity of the mixture of Gramoxone® (commercial formulation 
containing 20% PQ) and LAS in Wistar male rats and the herbicidal efficacy against grass 
lawn (50% of Poa pratensis and 50% of Festuca arundinacea) were evaluated. The 
survival rate of the PQ group was only 40%, while LAS provided effective protection, with 
full survival observed in the groups that received 125 mg/kg of PQ ion and 316 mg/kg of 
LAS.  Moreover, the LD50 of the PQ+LAS formulation is higher than the LD50 of 
Gramoxone® (34.86 mg/kg vs. 187.5 mg/kg, respectively). Outstandingly, both 
formulations of PQ, either in the absence or in the presence of LAS, provided the same 
herbicidal activity against the tested herbal species. 
In order to clarify the mechanisms involved in the protective effect of LAS, the formulation 
was administered to male Wistar rats by gavage, and sacrificed after 24 and 48h to 
evaluate the histological and biochemical biomarkers. LAS treatment caused a significant 
 xviii 
reduction in PQ-induced lipid peroxidation, oxidative stress, and activation of nuclear 
factor kappa B (NF-κB) in lung. Also the PQ elimination was higher in the PQ+LAS group 
and was accompanied by the restoration of the normal values of urinary creatinine, 
proteins, and N-acetyl-β-glucosaminidase (NAG).  
A considerable amount of the herbicides applied in crop fields enters into freshwater 
aquatic ecosystems leading to environmental contamination, potentially harming the 
aquatic organisms. Accordingly, it was also relevant to assess the safety of this new 
formulation to primary producers such as the microalga Chlorella vulgaris. PQ significantly 
inhibited C. vulgaris growth, an effect that was also significantly prevented by LAS at the 
proportion used in the formulation [1:2 (mol/mol)], while the highest protection was 
achieved at the proportion of 1:8. 
In conclusion, the present thesis successfully achieved the goals proposed by developing 
a formulation of PQ that demonstrated to be: (i) safer to Wistar rats, (ii) equally effective 
against weeds and, (iii) less toxic to microalgae.   
 
Keywords: paraquat, herbicide, antidote, lysine acetylsalicylate, algae, Chlorella vulgaris
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RESUMO 
O paraquato (dicloreto de 1,1´-dimetil-4,4´-bipiridilo, PQ) é um herbicida eficaz e 
amplamente utilizado que tem um histórico de segurança comprovado quando aplicado 
de forma adequada para eliminar as ervas daninhas. Ao longo das últimas décadas, o PQ 
tem causado inúmeras fatalidades e, por essa razão, é considerado um dos compostos 
mais tóxicos usados em tentativas de suicídio. As terapias usadas atualmente têm sido 
ineficazes na redução das fatalidades resultantes do envenenamento com PQ. Durante 
os últimos anos, o nosso grupo de investigação tem sido uma referência para a 
comunidade científica em relação ao estudo da toxicidade do PQ e desenvolvimento de 
antídotos para o tratamento das intoxicações. O salicilato de sódio (NaSAL) e o 
acetilsalicilato de lisina (LAS) possuem um mecanismo de proteção multifatorial contra a 
toxicidade induzida pelo PQ, devido à sua capacidade anti-inflamatória, capacidade 
antioxidante e à sua capacidade de complexar com o PQ. Embora os salicilatos sejam 
capazes de conferir uma sobrevivência de 100% quando administrados 2h após a 
intoxicação com PQ em ratos, na prática clínica quando os pacientes são admitidos, a 
concentração pulmonar atingida pode já ser letal. O desenvolvimento de formulações 
com menor toxicidade poderá constituir uma alternativa eficaz para as intoxicações 
voluntárias com PQ. Desde que foi introduzida no mercado, a formulação de PQ tem 
sofrido alterações ao longo dos anos, tais como, a adição de um corante azul, um agente 
modificador de odor, um emético e um alginato. No entanto, as formulações de PQ 
existentes no mercado são ainda altamente tóxicas. A presente tese teve como objetivo 
desenvolver uma formulação PQ mais segura com a incorporação de LAS como antídoto, 
preservando a atividade herbicida. Para atingir estes objetivos a tese está estruturada em 
três estudos, com a finalidade de avaliar i) a segurança da formulação em ratos Wistar e 
a manutenção da atividade herbicida, (ii) a segurança da formulação para a microalga 
Chlorella vulgaris, e (iii) a toxicidade aguda e mecanismos de toxicidade da formulação, 
em comparação com o PQ. 
Para esta finalidade, foi avaliada a toxicidade da mistura de Gramoxone® (formulação 
comercial contendo 20% de PQ) com LAS em ratos machos Wistar e a atividade 
herbicida foi testada em relva constituída por 50 % de Poa pratensis e 50 % de Festuca 
arundinacea. A taxa de sobrevivência do grupo PQ foi de apenas 40 %, enquanto no 
grupo que recebeu 125 mg/kg de PQ e 316 mg/kg de LAS foi de 100%. Além disso, o 
LD50 da formulação PQ + LAS é maior do que o LD50 do Gramoxone ® (34,86 mg/kg vs. 
187,5 mg/kg, respetivamente). Incrivelmente, ambas as formulações de PQ, quer na 
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ausência ou quer na presença de LAS, possuem a mesma atividade herbicida contra as 
espécies testadas. 
Com o objetivo de esclarecer os mecanismos envolvidos no efeito protetor do LAS, a 
formulação foi administrada a ratos Wistar machos por via oral, e estes foram sacrificados 
após 24 e 48h para avaliar as alterações de biomarcadores histológicos e bioquímicos. O 
tratamento com LAS causou uma redução significativa nos marcadores de peroxidação 
lipídica, de stress oxidativo e na ativação do fator nuclear kappa B (NF-kB) induzida pelo 
PQ no pulmão. Além disso, a eliminação de PQ foi maior no grupo PQ + LAS, a qual foi 
acompanhada pelo restabelecimento dos valores normais urinários de creatinina, 
proteínas e N-acetyl-β-glucosaminidase (NAG).  
Devido ao risco de contaminação dos ecossistemas aquáticos aquando da aplicação dos 
herbicidas na agricultura, foi também objetivo desta tese avaliar a segurança desta nova 
formulação para os produtores primários, como a microalga Chlorella vulgaris. O PQ 
inibiu significativamente o crescimento C. vulgaris, um efeito que também foi prevenido 
significativamente pelo LAS, tanto na proporção utilizada na formulação [1:2 (mol/mol)], 
como na proporção de 1:8, onde foi atingida a proteção máxima. 
Em conclusão, a presente tese atingiu com êxito os objetivos propostos através do 
desenvolvimento de uma formulação de PQ que demonstrou ser: (i) mais segura para 
ratos Wistar, (ii) igualmente eficaz contra as ervas daninhas, e (iii) menos tóxica para as 
microalgas. 
 
Palavras-chave: herbicida, paraquato, antídoto, acetilsalicilato de lisina, algas, Chlorella 
vulgaris. 
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 In Chapter I, a general introduction of the state of art of the key topics within the thesis is 
presented.  Once PQ has been studied since 1962, there is a huge number of publications 
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Chapter III 
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Chapter V 
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Paraquat (1,1′-dimethyl-4,4′-bipyridylium dichloride; PQ) is the leading herbicide of the 
chemical family of bipyridylium quaternary ammonium herbicides. PQ was introduced in 
the market in 1962 by the Imperial Chemical Industries and since its introduction it has 
been used all over the world in more than 130 countries, although nowadays it is only 
registered and sold in 90 countries. In the past decade, the use of PQ has been 
controversial as it appears to be, in one hand, a cheap option for farmers to control weeds 
and, in another hand, extremely toxic to humans. For this reason, PQ has been banned 
from the European Union in 2007 and recently other countries have been restricting its 
use or applying a phase-out procedure. The fatalities due to PQ poisoning continue to be 
a heavy burden worldwide with a rate of fatalities between 30-80% (Bertolote et al., 2006; 
Lee et al., 2009b). The majority of the cases are suicide attempts followed by accidental 
poisonings and rarely by occupational exposure. The higher incidence of PQ poisonings 
occurs mainly in Asiatic countries such as Sri-Lanka (Eddleston et al., 2005; Senarathna 
et al., 2012), Indonesia, Malaysia, South Korea and China (Yin et al., 2013).  China is 
currently the largest producer and consumer of PQ with an annual production of nearly 
80,000 tons (Yin et al., 2013). However, the Chinese government is also following the 
same trend of other Asiatic countries by restricting the registration of new products 
containing PQ and demanding the complete withdraw of the herbicide from Chinese 
market until 2016. The obvious reasons are the extreme toxicity and lack of effective 
treatment measures. Despite the human poisonings, pesticide industry pressure and 
farmers demand for PQ are the reasons why this herbicide is still in the market in 
countries with severe regulatory systems such as USA, Canada, Australia, Japan, and 
New Zealand.  
PQ presents exceptional agricultural properties with a very competitive price. PQ is a fast-
acting, non-selective, contact herbicide which means that only the green part of the plants 
receiving the herbicide is affected. PQ is used in several varieties of crops including 
cereals, peanuts and cotton in North America; rice in China; coffee in Brazil; and oil palm 
in Malaysia. Furthermore, due to the nature of PQ residues in soils, the major part (some 
99.99%) of PQ application that reaches the soil within the typical Good Agricultural 
Practice is strongly adsorbed to soils of a wide variety of textures (Bromilow, 2004). More 
relevant to environmental conditions is its rapid photodegradation on surfaces exposed to 
light, photolysis in aqueous solution, and biodegradation by soil microorganisms to non-
toxic metabolites and ultimately to carbon dioxide (Roberts et al., 2002). PQ deactivation 
allows the sow of the crops almost immediately into treated soil without risk of 
phytotoxicity (Bromilow, 2004). This last property is particularly important as it limits 
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movement by leaching or in surface run-off, therefore restraining the ecotoxicological 
effects of PQ.  
As a desiccating agent, PQ inhibits photosynthesis by intercepting the electron flow from 
photosystem I and shunting the electron transport chain. By accepting one electron, PQ is 
reduced to the PQ monocation free radical (PQ•+), which is rapidly reoxidised by O2 to 
PQ2+, initiating a series of reactions leading to production of superoxide anion (O2•−) with 
subsequent cell membrane disruption and plant death. The mechanism of PQ 
phytotoxicity is transversal to other organisms, vegetal or mammalian. Despite the 
evidences of the poor environmental persistency profile, concerns regarding the 
environmental fate of PQ are still an important issue. A review of the literature has shown 
that continued use of PQ under Good Agricultural Practice conditions will have no 
detrimental effects on either crops or soil-dwelling flora and fauna (Roberts et al., 2002). 
However, even small amounts of herbicide reaching the aquatic environment can still be 
toxic. PQ affects the growth of different microalgae species from phytoplankton, which are 
the primary producers responsible for the maintenance of the equilibrium of the aquatic 
ecosystems, production of oxygen and organic substances, and therefore adverse effects 
of pollutants on these organisms may have reflexes in higher trophic levels (Carr et al., 
1986; Ibrahim, 1990; Ma et al., 2004; Ma et al., 2006; Ma et al., 2002; Saenz et al., 1997). 
The major burden concerning PQ use is undoubtedly its extreme mammalian toxicity. 
There are no widely accepted guidelines on treatment of patients with PQ self-poisoning 
and the treatment varies from supportive care alone to various combinations of 
immunosuppressors, antioxidant therapy, haemoperfusion and haemodialysis (Dinis-
Oliveira et al., 2008b). However, the overall mortality remains >50% in centers routinely 
practicing such intensive measures. PQ poisoning results in toxicity in most organs but the 
toxicity is particularly severe in the lung (Smith and Heath, 1975). PQ pulmonary 
concentrations can be 6 to 10 times higher than those in the plasma, and the compound is 
retained in the lung even when blood levels start to decrease. Early experiments 
demonstrated that the accumulation of PQ into rat lung slices occurred against a 
concentration gradient (Rose et al., 1974). PQ structural similarities to the endogenous 
polyamines, putrescine and cadaverine led to the discovery of the putative lung 
transporter involved in PQ translocation, the polyamine uptake system. Therefore, PQ is 
mistakenly accumulated into the lung, especially in the alveolar type I and II pneumocytes 
and in the Clara cells, through this transport pathway (Smith, 1987).  
Acute PQ poisonings are mostly due to ingestion of the concentrated liquid herbicide 
formulations and the severity of intoxication depends on the quantity of PQ ingested. The 
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symptomatology of PQ poisonings can be divided into three different presentations: 
asymptomatic or mild toxicity (<7.5 mL of 20% (m/v) concentrate), moderate to severe 
(7.5–15 mL of 20% (m/v) concentrate) and severe acute fulminant toxicity (>15 mL of 20% 
(m/v) concentrate). The moderate to severe poisoning culminates in pulmonary fibrosis, 
which progresses after a few days to a few weeks. There are three distinct phases in the 
progression of severe toxicity: (i) first phase: nausea, vomiting, gastrointestinal 
irritation/corrosion, and characteristic lesions on the tongue; (ii) second phase: acute 
proximal tubular necrosis, renal failure, and hepatocelluar necrosis; (iii) third phase: 
delayed pulmonary fibrosis leading to a rapid development of refractory hypoxemia, 
resulting in death. Patients surviving the early clinical stages generally show a period of 
improvement. However, in most cases this is merely the prelude to the late onset, which 
involves damage almost exclusively to the lungs. The lung pathophysiology of PQ is 
characterized by an early destructive phase (1-3 days) with extended alveolitis, pulmonary 
edema, and infiltration of inflammatory cells, followed by a final proliferative phase (where 
fibroblasts proliferate, collagen is deposited, and pulmonary fibrosis occurs). 
The molecular mechanisms of PQ-induced toxicity in peripheral organs in humans are 
well understood. It is generally accepted that the primary reaction in the mechanism of PQ 
toxicity is associated with its capacity to undergo redox-cycling and subsequent 
generation of reactive oxygen species (ROS). PQ is metabolized by several intracellular 
enzyme systems [NADPH-cytochrome P450 reductase, xanthine oxidase, NADH-
ubiquinone oxidoreductase and nitric oxide synthase (NOS) to the PQ•+ and reoxidized to 
PQ2+, leading to the generation of O2•−].  This then sets in the well-known cascade leading 
to the production of other ROS, mainly hydrogen peroxide (H2O2) by dismutation of O2•−, 
and hydroxyl radical (HO.), through the Fenton or the Haber-Weiss reactions, with 
consequent cellular deleterious effects (Smith, 1987). The oxidative stress triggers and 
impairs several pathways which are involved in PQ deleterious effects. PQ induces a 
decrease in the ratio of reduced and oxidized nicotinamide adenine dinucleotide 
phosphate (NADPH/NADP+), leading to inhibition of oxidized glutathione (GSSG) 
reduction to reduced glutathione (GSH) and therefore to detoxification of H2O2 by 
glutathione peroxidase; and inhibition of the pentose-phosphate shunt (Keeling and Smith, 
1982). Consequently, there is a decrease in the intracellular antioxidant defenses as a 
result of the continue oxidation of GSH to GSSG and formation of protein mixed disulfides 
(Keeling et al., 1982). Electrophilic free radicals are capable of abstracting allylic hydrogen 
atoms from membrane-associated polyunsaturated fatty acids, resulting in alterations of 
membrane structure and ultimately, lipid peroxidation (LPO). In vivo studies have shown 
that PQ can cause lung protein oxidation assessed by carbonyl groups formation (Dinis-
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Oliveira et al., 2006a; Dinis-Oliveira et al., 2006c), and DNA oxidation and fragmentation 
(Dinis-Oliveira et al., 2007a; Dusinska et al., 1998). PQ causes lung apoptosis by 
cytochrome c release, increase of caspase-3 and -8 activity, decrease of caspase-1 
activity, and increase of p53 and activator protein-1 (AP-1) expression, resulting in DNA 
fragmentation (Dinis-Oliveira et al., 2007a). Indeed, PQ has been shown to cause 
mitochondrial damage (Czerniczyniec et al., 2011; Czerniczyniec et al., 2013) by inhibiting 
the complexes I and III, although this concept is not consensual between authors 
(Castello et al., 2007; Cocheme and Murphy, 2008).  Release of cytochrome c and 
activation of caspase-9 was shown to be associated to the induction of Bcl-2 family 
members such as Bak, Bid, BNip3, and NOXA (Fei and Ethell, 2008; Fei et al., 2008). 
More recently, it was suggested that PQ-induced alveolar epithelial cell apoptosis is 
mediated through the NF-E2-related factor 2 (Nrf-2)-regulated mitochondrial dysfunction 
and endoplasmic reticulum stress (Chen et al., 2012). Moreover, Niso-Santano et al. 
investigated the role of the transcription factor Nrf2, a master regulator of cytoprotective 
genes, and its target thioredoxin (Trx), which binds and inhibits apoptosis signal-regulating 
kinase 1 (ASK1). PQ induced a dose-dependent decrease in Trx levels correlated with a 
major increase in phosphorylated ASK1, suggesting that Nrf2/Trx is crucial in PQ-induced 
apoptosis (Niso-Santano et al., 2011; Niso-Santano et al., 2010).  
PQ-induced ROS also activate important inflammatory signalling pathways involving the 
nuclear factor kappa B (NF-κB) and AP-1 (Dinis-Oliveira et al., 2007a; Dinis-Oliveira et al., 
2007b). The NF-κB family of transcription factors has an essential role in inflammation and 
innate immunity. NF-κB exists as homo- or heterodimers and are retained inactive in the 
cytoplasm of most cells, bound to the inhibitory proteins, IκBs (Hoesel and Schmid, 2013). 
The proinflammatory cytokines (tumor necrosis factor [TNF-α], interleukin 1 beta [IL-1β]) 
and oxidative stress activate IκB kinase β (IKKβ) leading to the degradation of the NF-kB 
complexes thus preventing the translocation to the nucleus and transcription of the target 
genes (Rahman and Fazal, 2011). The expression of proinflammatory genes such as 
Intercellular Adhesion Molecule 1 (ICAM-1) by this mechanism mediates adhesion and 
transendothelial migration of leukocytes. A characteristic feature of PQ toxicity is the 
massive pulmonary infiltration of leukocytes, particularly neutrophils. Then, local activation 
of rapidly responding resident cells, primarily macrophages, also release several 
proinflammatory cytokines, including TNF-α, IL-1β, and chemokines such as IL-8 and 
macrophage inflammatory protein 2α (Fan et al., 2001). Alveolar macrophages secrete 
fibrogenic factors such as transforming growth factor (TGF)-β (Assoian et al., 1987) and 
gene expression of TGF-β is enhanced in the lungs after PQ exposure (Ishida et al., 
2006). Activated macrophages in inflamed lungs in response to PQ exposure also 
INTRODUCTION 
 
7 
synthesize increased amounts of several other cytokines, including interleukin 1 alpha (IL-
1α), IL-1β, platelet-derived growth factor, TGF-α, insulin like growth factor, TNF-α that 
mediate an enhanced fibroproliferative response . 
Although PQ liability is more significant regarding accidental or deliberate ingestion, there 
is a growing apprehension concerning the prolonged effects of occupational exposure to 
PQ. The herbicide is slightly toxic by the dermal route since absorption through intact skin 
is minimal (0.03 µg/cm2 over 24 h), and has low inhalation toxicity , as PQ has no 
appreciable vapor pressure and the aerosolized particles are larger than 5 mm and, 
therefore, non-respirable (Environmental Protection Agency, 1997). Whether occupational 
PQ exposure is associated with adverse respiratory health effects among farmers is still 
controversial (Cha et al., 2012; Dalvie et al., 1999; Senanayake et al., 1993). Furthermore, 
the few occupational studies performed have shown that even after a dermal or inhalation 
exposure during application, urine levels were either undetectable (Chester et al., 1993; 
Van Wendel de Joode et al., 1996) or below the  limit of quantification before-, during- and 
after-PQ spray days (Lee et al., 2009a).  
Besides the respiratory adverse effects, the current spotlight of research is the putative 
involvement of PQ in the etiology of Parkinson’s Disease (PD) (Dinis-Oliveira et al., 
2006b; Kamel, 2013; Tanner et al., 2011). The in vivo and in vitro experimental data have 
shown that PQ is able to reproduce some of the features of PD such as specific cell loss 
on substantia nigra pars compacta (SNpc), and accumulation and increased aggregation 
of α-synuclein in dopaminergic neurons of substantia nigra (SN), but does not induce clear 
motor deficits (Cicchetti et al., 2009). The mechanisms of PQ-induced neurotoxicity are 
not fully comprehended yet, but several pathways have been proposed: (i) induction of 
oxidative stress, (ii) microglia activation, (iii) mitochondrial dysfunction, (iv) apoptosis, (v) 
autophagy and inhibition of the ubiquitin- proteasome system, and (v) induction of 
synucleinopathy and tauopathy. On the other hand, despite some studies found an 
association between PQ and increased risk for PD, the Human data may be misleading 
since the epidemiological studies currently available have a number of limitations. In 
addition, survivors of PQ poisoning have never presented parkinson signs during either 
the acute phase or the recovery period (Brent and Schaeffer, 2011). This emerging issue 
is extensively discussed in the Chapter II of this thesis. 
Taking into consideration of the above mentioned rationale, it is no surprise that research 
of new antidotes and new formulations of PQ is still arousing international interest. In fact, 
the treatment of PQ intoxications has been directed towards: (i) preventing the generation 
of ROS, namely by the effective control of iron distribution by desferrioxamine, (ii) 
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scavenging ROS though the maintenance of effective levels of antioxidants, such as  
vitamin E and N-acetylcysteine, (iii) repairing the oxidative lesions, particularly the 
maintenance of effective levels of glutathione by administrating N-acetylcysteine,  (iv) 
reducing inflammation by dexamethasone, methylprednisolone and cyclophosphamide, 
and (v) induction of glycoprotein-P by dexamethasone (Dinis-Oliveira et al., 2006a; Dinis-
Oliveira et al., 2006c; Mitsopoulos and Suntres, 2011; Suntres, 2002; Suntres and Shek, 
1995; Yeh et al., 2006). Other experimental pioneer antidotes include inhibitors of the 
angiotensin-converting enzyme (Ghazi-Khansari and Mohammadi-Bardbori, 2007; Ghazi-
Khansari et al., 2007), mechanic ventilation with nitric oxide (.NO), propofol (Ariyama et 
al., 2000), edaravone (Zhi et al., 2011), inhibitors of quinone Oxidoreductase 2 (Janda et 
al., 2013), chitosan oligosaccharide (Yoon et al., 2011), naringin (Chen et al., 2013), 
bosentan (Zhang et al., 2013), and rapamycin (Lorenzen et al., 2010). However, neither of 
the proposed treatments conferred full survival after a LD50 dose was administered nor 
the schedule of administrations was consistent since some of the compounds were used 
prior to PQ poisoning (Chen et al., 2013; Mitsopoulos and Suntres, 2011; Yoon et al., 
2011).  
So far, only salicylates, sodium salicylate (NaSAL) (soluble form of salicylic acid) and 
lysine acetylsalicylate (LAS) were able to grant 100% survival to rats intoxicated with PQ 
(Dinis-Oliveira et al., 2009; Dinis-Oliveira et al., 2007a; Dinis-Oliveira et al., 2007b). 
NaSAL (200 mg/kg) decreased the PQ-induced lung toxicity through an effective inhibition 
of pro-inflammatory factors such as NF-κB, scavenging of ROS, inhibition of 
myeloperoxidase (MPO) activity, inhibition of platelet aggregation and apoptosis (Dinis-
Oliveira et al., 2007a; Dinis-Oliveira et al., 2007b). LAS is the water-soluble form of 
acetylsalicylic acid (ASA) available in hospitals for parenteral administration, and therefore 
the subsequent studies were performed with this drug and also led to a successful 
outcome (Dinis-Oliveira et al., 2009). ASA is one of the most commonly used drugs 
worldwide with emerging novel clinical uses, well beyond the classical mechanism of non-
steroidal anti-inflammatory drugs action: inhibition of prostanoids formation, which is 
achieved by inhibition of cyclooxygenase (COX). Since ASA is markedly de-acetylated to 
salicylate (ionic form, SAL), it could be assumed that the pharmacological effects of ASA 
are mainly mediated by its metabolite, given that both drugs exhibit similar anti-
inflammatory activities in vivo. Nevertheless, SAL is a weak COX inhibitor due to the lack 
of the acetyl group but both drugs are strong inhibitors of NF-κB and AP-1 (Kopp and 
Ghosh, 1994; Whittle et al., 1980). Even though both salicylates have overlapping 
activities, ASA has other unique properties such as the induction of ferritin, lipoxins, NO, 
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heme oxygenase 1 (HO-1), and inhibition of NAD(P)H oxidase activity. On the other hand, 
SAL strongly scavenges HO. and chelate transition metals (Baltazar et al., 2011).  
Despite the promising results, over the last few years there has been increasing pressure 
from government and regulatory authorities to develop formulations which have less 
impact on the environment and are safer for both applicators, manufacturers or people 
that accidentally or intentionally ingest those products. PQ producers also followed this 
trend to modify the formulation in order to reduce its toxicity. Firstly, a blue dye, a 
stenching agent and an emetic were added to the liquid concentrate in the late 1970s 
(Sabapathy, 1995). Gramoxone INTEON® is the most recent PQ formulation specifically 
developed to decrease toxicity through a reduction in the amount of PQ absorbed from the 
gastrointestinal tract following ingestion (Heylings et al., 2007). In order to achieve that 
goal, the new formulation included three novel components: (i) an alginate that 
immediately gels when entering the acidic environment of the stomach; (ii) an increase in 
the amount of emetic to induce vomiting more quickly; (ii) and an osmotic purgative 
(magnesium sulphate) to speed its elimination from the small intestine, the main site of its 
absorption. The survey realized after the introduction of INTEON® in Sri Lanka 
demonstrated that self-poisoning with this herbicide was associated with a significantly 
reduction of the mortality rate compared to the standard formulation (from 27.1 to 36.7%: 
p<0.002) (Wilks et al., 2008). However, years later a further assessment showed that this 
effect was not significant. The authors believe that this may be partly due to the large 
number of patients in whom PQ concentrations were too low for analytical confirmation of 
the formulation (Wilks et al., 2011). 
The present work intends to implement a first principle of poisoning prevention: to change 
the formulation of the marketed product in an attempt to reduce human toxicity. If PQ use 
is to continue, and it seems that it will in many countries for the foreseeable future, then 
the answer must be to include an antidote to the formulation, as LAS, use more dilute PQ 
preparations as the primary product for agricultural use or make it more difficult to assess. 
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Abstract: The pharmacological action of salicylates has been historically related to their ability to inhibit cyclooxygenases, thereby 
blocking the synthesis of prostaglandins and thromboxane A2. On the other hand, several studies have suggested that salicylates have a 
multitude of cyclooxygenase-independent actions specially related with their antioxidant properties, which might contribute to the overall 
salutary effects of these compounds. Although salicylates are well-known antioxidants through their ability to scavenge hydroxyl radical, 
their antioxidant mechanisms of action have not been fully compiled and characterized. In this context, several mechanisms of action 
have been suggested, namely i) scavenging of hydroxyl radical and chelation of transition metals; ii) upregulation of nitric oxide; iii) in-
creased synthesis of lipoxins; iv) inhibition of neutrophil oxidative burst; v) inhibition of NF-B  and AP-1 protein kinases; and vii) in-
hibiton of lectin-like oxidized LDL receptor-1. The newly discovered acetyl salicylic acid-triggered lipoxins probably play a key role in 
the maintenance of the oxidative stress balance. Furthermore, salicylates have shown to protect low-density lipoprotein from oxidation 
and elicit an inhibitory effect on the expression of lectin-like receptors on endothelial cells. This review aims to provide an overview of 
the various proposed antioxidant mechanisms of salicylates. 
Keywords: Salicylates, oxidative stress, antioxidant mechanisms. 
1. INTRODUCTION 
Willow bark and other salicylate-containing plants have been 
used for pain relief, fever and chronic inflammatory diseases such 
as arthritis and rheumatism since ancient times. As pharmaceutical 
drugs, salicylates were first introduced as analgesic antirheumatic 
drugs in 1876. Despite its unquestionable beneficial effects in in-
flammatory disorders, salicylic acid (SA) (the first salicylate to be 
used therapeutically) elicited an unpleasant sweet taste and was 
often associated with stomach ulcers accompanied by nausea and 
vomiting. These adverse effects were partially attenuated with the 
synthesis of the SA derivative, acetylsalicylic acid (ASA). Acetyl-
salicylic acid, commercially known as Aspirin®, is the acetylated 
form of SA, with improved gastric tolerability and similar anti-
inflammatory activity [1]. Indeed, ASA, at the turn of its 112th an-
niversary, is one of the most commonly used drugs worldwide with 
emerging novel clinical uses, well beyond the classical mechanism 
of non-steroidal anti-inflammatory drugs (NSAID) action: inhibi-
tion of prostanoids formation, which is achieved by inhibition of 
cyclooxygenase (COX) (also referred as prostaglandin H synthase) 
[2-3]. After oral administration of an analgesic dose (1g single 
dose) of ASA, 50% is immediately hydrolyzed (de-acetylated) to 
SA, to some extent pre-systemically in the gastrointestinal mucosa 
and the remaining 50% is hydrolyzed within 15 minutes after gas-
tric and intestinal absorption [1] (Fig. 1). The plasma half-life of SA 
is dose-dependent and ranges from 2 to 30 hours [4]. The metabo-
lism of SA occurs mainly in liver, through glycine conjugation to 
salicyluric acid, by enzymatic hydroxylation to 2,5-dihydroxy-
benzoic acid (gentisic acid) and by glucuronidation to produce ei-
ther salicyluric acid phenolic-, salicyl phenolic- or salicyl acyl-
glucuronide (Fig. 1) [5]. 
Since ASA is markedly de-acetylated to SA, it could be as-
sumed that the pharmacological effects of ASA are mainly medi-
ated by its metabolite, given that both drugs exhibit similar anti-  
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inflammatory activities in vivo [6]. Nevertheless, SA has been 
found to be a relatively weak inhibitor of COX activity in vitro,
despite being an effective inhibitor of prostanoids formation at the 
place of inflammation in vivo [6]. Presently, there is no agreement 
about the extent of the contribution of SA to ASA´s anti-
inflammatory effects [7]. 
The inhibiton of COX activity is responsible for the historical 
clinical applications of salicylates as analgesic/antipyretic and anti-
inflammatory agents [1]. Nowadays, ASA is still commonly used to 
treat pain and febrile disorders but its use as anti-inflammatory drug 
is mainly restricted to particular inflammatory diseases, such as 
Kawasaki disease [1]. COX-1 is expressed in platelets where it 
stimulates the synthesis and release of thromboxane A2 (TXA2)
resulting in platelet aggregation and vascular smooth muscle con-
traction [8-9]. Thus, the ASA property of inhibiting COX-1 activity 
is strategically used as an antithrombotic feature to prevent acute 
occlusive vascular events including ischemic stroke derived from 
platelet aggregation [10]. Thus, low-dose therapy is worldwide 
recommended for the primary and secondary prevention of myo-
cardial infarction and for the treatment of unstable angina, non-ST-
segment myocardial infarction, and acute coronary syndrome [10]. 
Also, numerous studies suggest that ASA has a protective effect on 
vasculature in several models of pathological conditions, including 
hypertension [11], hyperglycemia [12] and hyperlipidemia [13].  
Recent studies have suggested further cyclooxygenase-
independent mechanisms of action of salicylates that might explain 
their pleiotropic functions [14]. Accumulating epidemiologic data 
demonstrated that ASA prevents the development of colon rectal 
cancer, and decreases the risk for Alzheimer´s disease and athero-
sclerosis [14-15]. The etiology of these diseases has been associated 
with oxidative stress, which is a condition that results from the 
imbalance between the generation of reactive pro-oxidant species 
[reactive oxygen species (ROS) or reactive nitrogen species (RNS)] 
and the antioxidant defenses, in favor of the former, potentially 
leading to oxidative-related damage [16]. Noteworthy, low or mod-
erate production of ROS and RNS play a physiological role in sev-
eral redox-responsive signaling pathways, for example in defense 
against environmental pathogens, regulation of vascular tone by 
nitric oxide (NO), regulation of cell adhesion, and apoptosis [17]. 
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Nevertheless, when these reactive species are sustainably produced 
in overwhelming amounts, may initiate a wide range of pro-oxidant 
reactions that result in damage of cellular macromolecules, includ-
ing lipid peroxidation, protein nitration and oxidation, as well as 
DNA damage [17]. These events are known to be involved in the 
aging process [17] and in the pathogenesis of many degenerative 
diseases such as cancer [18-19], atherosclerosis [20] , arthritis [21], 
diabetes [22] and the neurodegenerative disorders Alzheimer’ [23] 
and Parkinson´s diseases [24]. 
In the past few decades, a considerable and consistent amount 
of evidence has demonstrated that ASA and SA have antioxidant 
properties [11, 13, 25-26], though the mechanisms underlying these 
effects remain unclear. Firstly, it has been reported that salicylates 
comprise free radical-scavenging and iron chelation properties [27]. 
ASA was shown protects endothelial cells from oxidative stress 
mediated by hydrogen peroxide (H2O2) [28] and reduces vascular 
superoxide (O2·) production in both normotensive and hypertensive 
rats [11]. In a clinical study with normolipidaemic volunteers taking 
300 mg of ASA, daily for two weeks it was shown that isolated 
low density lipoprotein (LDL) from these patients were more pro-
tected from oxidative modifications induced by ultraviolet C irra-
diation after the treatment [29]. In the several attempts to clarify the 
mechanisms responsible for the observed ASA-induced cytoprotec-
tion, it was noted that this drug had the ability to induce the expres-
sion of ferritin and hemeoxygenase-1 (HO-1), as well as to increase 
endothelial NO formation [30-33]. The discovery of new lipid me-
diators, the ASA-triggered lipoxins or 15-epi-lipoxin A4 (ATL) [34] 
enlightened the molecular basis of additional antioxidant mecha-
nisms suggested for ASA [35-36]. Indeed, ATL have shown the 
ability to increase NO synthesis through endothelial nitric oxide 
synthase [37], induce HO-1 expression [35] and inhibit peroxyni-
trite (ONOO) formation [38] as observed for ASA. Moreover, 
ASA downregulates transcription factors such as nuclear factor 
kappa B (NF-B) and activator protein 1 (AP-1), as well as the 
expression of lectin-like receptors (LOX-1) and several kinases that 
directly modulate signaling pathways linked to the immune and 
oxidative stress response [15, 39-40]. In addition, compelling evi-
dence has shown that the vasoprotective effects of ASA might go 
beyond prostaglandin synthesis and be mainly due to its hypolipi-
daemic potential [41], inhibition of LDL oxidation [42] and im-
provement of endothelium function [43] mediated by ASA antioxi-
dant properties.  
Taken together, these data support the hypothesis that ASA 
possesses antioxidant activity by scavenging of hydroxyl radical 
and chelation of transition metals, stimulation of NO synthesis, 
increased expression of lipoxins, inhibition of neutrophil oxidative 
burst, inhibition of NF-B, AP-1 and protein kinases, and inhibiton 
of lectin-like oxidized LDL receptor-1. The aim of this review is to 
elucidate these various mechanisms of action by which salicylates 
exert their antioxidant activity.  
1. CYCLOOXYGENASE-DEPENDENT ACTIONS 
The classically attributed mechanism of action of NSAIDS con-
sists on the inhibition of prostaglandin H synthase’s COX activity, 
blocking the biosynthesis of prostaglandins [3, 8]. There are at least 
two distinct isoforms of this enzyme, designated COX-1 and COX-
2 [44]. COX-1 is considered to be the constitutive isoform, ex-
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Fig. (1). Acetylsalicylic acid (ASA) metabolism pathways and relative concentrations of each metabolite following to salicylic acid clearance. ASA is rapid 
hydrolyzed to salicylic acid (SA) as the primary metabolite. The dominant metabolic pathway is conjugation with glycine to salicyluric acid (SUA). SA can 
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pressed in most tissues where it plays a key role in platelet aggrega-
tion and gastric protection [44]. It is widely assumed that ASA 
causes an irreversible inhibition of COX-1 activity by acetylation of 
a critical serine (Ser-530) in the substrate channel of the COX-1 
enzyme, limiting the access of arachidonic acid (the substrate) to 
the catalytic active site [3, 45]. The other isoform, COX-2, is in-
duced during inflammation, wound healing, and neoplasia and is 
responsible for the synthesis of the majority of prostaglandins [44]. 
Nevertheless, this concept is evolving since its known that COX-2 
is expressed constitutively in several tissues including brain [46], 
kidney [47] and arterial endothelial cells under steady-state shear 
stress [48]. ASA is a nonselective inhibitor of COX activity, al-
though it seems to possess a higher affinity for COX-1 [7]. This 
ability is responsible for its recognized anti-platelet properties since 
COX-1 is constitutively expressed in platelets where it stimulates 
the synthesis and release of TXA2 [8-9]. Furthermore, platelets are 
not capable of regenerating COX-1 since they lack the biochemical 
machinery necessary to its synthesis. Therefore, inhibition of the 
TXA2 is maintained during platelets life-time (7 to 10 days) [49]. 
Moreover, ASA triggers the synthesis of a unique class of eicosa-
noids by acetylation of COX-2 and 5-lipoxygenase (5-LO), which 
may additionally contribute to the therapeutic impact of this drug 
(Fig. 2) [34-36, 50] (Fig. 4).
1.1. Increased Expression of Lipoxins 
As described above, inhibition of prostaglandins and TXA2
formation by ASA is achieved through irreversible inhibition of 
COX-1 by acetylation [3]. Nevertheless, acetylation of vascular 
COX-2 by ASA does not lead to inhibition of the enzyme, but 
rather switches the catalytic activity for conversion of arachidonic 
acid to intermediates of prostaglandines and TXA2 into the produc-
tion of 15R-hydroxyeicosatetraenoic acid (15R-HETE) [34]. 15R-
HETE is released from endothelial and epithelial cells and is con-
verted by leukocyte 5-LO to 15(R)-epi-lipoxin A4 also referred as 
ASA-triggered lipoxin (ATL) (Fig. 2) [34]. 
Lipoxins (LXs), produced by leukocytes during cell-cell inter-
actions, are a distinctive class of endogenous lipid mediators with 
strong anti-inflammatory activity [51]. Inhibition of neutrophils’ 
recruitment, and decrease in chemokine production by native 
lipoxin A4 (LXA4), and its analogues, is mediated by the activation 
of the G protein-coupled lipoxin A4 receptor (ALXR) [52]. LXA4 is 
capable of attenuating the chemotaxis, adhesion and transmigration 
of neutrophils and this ability to block endothelial cell-leukocyte 
interactions can be seen as a protective mechanism against reactive 
oxidants produced by activated leukocytes [53]. Furthermore, LXA4
inhibits O2· formation, selectively stimulates monocytes and 
macrophages in a nonphlogistic fashion leading to the phagocytosis 
of apoptotic polymorphonuclear cells (PMN) by monocyte-derived 
macrophages and blocks tumor necrosis factor alpha (TNF-) ac-
tions [53-55].  
ASA-triggered lipoxins and the endogenous LXA4 have similar 
biological activities as both downregulate the neutrophils-mediated 
tissue damage [50]. Thus, ATL may account for the additional ef-
fects of ASA not related to the inhibition of the cyclooxygenase 
system, namely the antioxidant activity [36, 52, 56-57].  
Recent studies have shown that the stable ASA-triggered 
lipoxin A4 analog (15-epi-16-(para-fluoro)-phenoxy-lipoxin A4)
(ATL-1) potently promotes HO-1 de novo synthesis in a concentra-
tion and time-dependent manner (Fig. 2) [35]. Also, in this study it 
was confirmed the involvement of ALXR since an antagonist of 
this receptor blocked the ATL stimulation effect on HO-1 expres-
sion. Moreover, HO-1 induced by ATL significantly inhibited the 
TNF--induced expression of the adhesion molecules, endothelial 
adhesion molecule 1 (E-selectin) and vascular cell adhesion mole-
cule-1 (VCAM-1). This phenomenon was corroborated by the fact 
that a HO-1 inhibitor, tin-protoporphyrin (SnPP), reversed the 
LXA4-induced inhibition of VCAM [35]. HO-1 is also a down-
stream target of NO [30, 32]. Thus, the induction of HO-1 expres-
sion by ATL-1 might also be mediated via eNOS and NO [37]. Of 
note, ATL-1 increases plasma NO with subsequent inhibition of 
leukocyte trafficking via eNOS and inducible nitric oxide synthase 
(iNOS), illustrated by experiments with knockout mice for these 
enzymes [37].  
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In a model of stroke-prone spontaneously hypertensive rats 
(SHRSP), chronic treatment with ASA improved eNOS expression 
and NOS activity in the arteries of salt-loaded SHRSP, in associa-
tion with a significantly increase of ATL levels [58]. As other stud-
ies demonstrated [34, 37], neither SA nor indomethacin improved 
NO release or triggered ATL synthesis in salt-loaded SHRSP [58]. 
Collectively, it seems that ASA triggers the synthesis of ATL, 
which contributes to increase NO synthesis and the consequent 
expression of the antioxidant protein HO-1, hence inhibiting leuko-
cyte-endothelium interactions during acute inflammation. These 
observations provide evidence that there is an antioxidant syner-
gism between two pathways, the lipoxins and the HO-1,NO being 
the linking element [59]. 
The stable ASA-triggered lipoxin analog abolishes NAD(P)H 
oxidase-dependent ROS generation in a concentration and time-
dependent manner in endothelial cells and requires ALXR signaling 
(Fig. 2) [36]. Endothelial NAD(P)H oxidases are important sources 
of reactive oxygen species. It is assumed that the sustained activa-
tion of these enzymes results in a variety of intracellular signaling 
events that may lead to a dysfunction of the endothelium, prolifera-
tion of vascular smooth muscle cells, expression of pro-
inflammatory and pro-apoptotic genes and remodeling of the ex-
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tracellular matrix [60]. The prototypical NAD(P)H oxidase is the 
isoform found in neutrophils, which is constituted by four major 
subunits: plasma membrane cytochrome b558, comprising gp91phox
and p22phox, and two cytosolic components p47 phox and p67phox [60]. 
The pathophysiological increase in NAD(P)H oxidase activity and 
expression can be triggered by a number of growth factors (e.g. 
transforming growth factor and platelet-derived growth factor), 
cytokines (e.g. TNF- and IL-1), laminar shear stress, hyperinsu-
linemia, hyperglycemia, and G protein-coupled receptor agonists 
(e.g. serotonin, thrombin, endothelin and angiotensin II) [61]. De-
spite Wu and colleagues [11] have suggested a novel antioxidant 
pathway of ASA by inhibiting NAD(P)H oxidase, which was cor-
roborated by other authors [62], the underlying molecular mecha-
nism was not elucidated. In human endothelial cells exposed to high 
glucose concentrations, Dragomir and co-workers [62] demon-
strated that ASA-induced reduction of protein kinase C activation is 
a key event for NAD(P)H oxidase activation [63]. As mentioned 
above, ASA-triggered lipoxin analog abolishes NAD(P)H oxidase-
dependent ROS generation through ALXR signaling. Furthermore, 
ATL-1 inhibits the p47phox phosphorylation and subsequent translo-
cation and stable binding to p22phox on the endothelial cells mem-
brane. This is a key event that precedes NAD(P)H oxidase activa-
tion and ATL-1 seems to interfere on the enzyme assembly, proba-
bly because it modulates the p47phox phosphorylation status [36, 
60].  
Angiotensin II (Ang II) is a strong inducer of NAD(P)H oxidase 
and therefore stimulates a number of biological responses via re-
dox-sensitive mechanisms, including the pro-inflammatory tran-
scription factor NF-B [61]. ATL-1 significantly inhibits Ang II-
induced NF-B activation and consequently this effect will reduce 
the synthesis of pro-inflammatory cytokines, chemokines and in-
ducible enzymes [36]. Similarly, lipopolysaccharide (LPS) chal-
lenged PMN and mononuclear leukocytes evoke nuclear accumula-
tion of NF-B/p65 and AP-1/c-fos [38]. However, when these cells 
are incubated with LXA4/ATL analogs, the mobilization of these 
transcription factors to the nucleus is inhibited as well [38]. In the 
same experimental model, LXA4/ATL analogs markedly attenuated 
ONOO formation, IL-8-mRNA expression and IL-8 release possi-
bly via inactivation of NF-B and AP-1 [38]. Peroxynitrite is 
formed in the reaction of NO with O2· and is predominantly re-
leased by inflammatory cells during several inflammatory patholo-
gies. Peroxynitrite is highly reactive towards all classes of bio-
molecules including nucleic acids, lipids and proteins. It has been 
suggested that ONOO is involved in cell signaling pathways that 
modulate leukocyte trafficking through induction of cytokines such 
as IL-6 and TNF- and up-regulation of surface expression of 
CD11b/CD18 and consequently increase in PMN adhesion to endo-
thelial cells [64-65]. ATL-1-mediated inhibition of NAD(P)H ulti-
mately reduces O2·, which eventually can decrease ONOO by 
withdrawing O2· from the site of reaction with NO [36]. Further-
more, this hypothesis may be an additional explanation for the 
observed increase of NO evoked by ASA and 15-epi-lipoxins [37, 
66]. 
Chiang and colleagues [50], reported that daily treatment with 
low dose (81 mg) of ASA triggers the formation of ATL in healthy 
individuals in vivo. The detectable amount of lipoxins generated is 
sufficient to evoke the anti-inflammatory actions [34] and up-
regulation of antioxidant mediators such as NO and HO-1 [35, 37]. 
Therefore, local production of ATL may also account for the gen-
eral pharmacological actions of ASA.  
1.2. Inhibition of Neutrophil Chemotaxis 
As mentioned above, salicylates are potent inhibitors of platelet 
aggregation. Platelets function has been exclusively associated to 
the maintenance of hemostasis and platelet-derived growth factors 
[67]. However, several lines of evidence support the important role 
of platelets in inflammation [67-68]. During the inflammatory proc-
ess, platelets undergo chemotaxis, release proinflammatory cytoki-
nes and adhesive proteins, and recruit neutrophils [69]. Indeed, a 
significant role of platelets in the inflammatory process is their 
ability to promote neutrophils rolling, leading to its firm adhesion to 
the endothelium with further diapedesis [69]. Chronic inflammation 
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mediated through platelets also leads to oxidative injury of the 
endothelium and the inflamed tissue, hence there is a linkage 
among platelets and inflammation, thrombosis, and atherogenesis 
[67]. Thus, the antiplatelet beneficial effects of ASA, preventing 
atherothrombotic events (e.g. arterial thrombosis), acute myocardial 
infarction and cerebrovascular diseases, might be further due to its 
inhibition of the proinflammatory cascade and oxidative stress [10] 
(Fig. 4). 
2. SCAVENGING OF HYDROXYL RADICAL AND CHELA-
TION OF TRANSITION METALS  
Among ROS, hydroxyl radical (HO.) is the most reactive radi-
cal known, as it can nonspecifically oxidize all classes of biological 
macromolecules including lipids [70-71], proteins, and nucleic 
acids [72]. The in vivo antioxidant efficacy of HO. scavengers will 
depend on the rate constant for reaction with HO., their metal-
binding capacity, the geometry of the metal complex formed as 
well as the availability of transition metals in solution directly cor-
related to the physiological levels of phosphate and bicarbonate 
[73]. The HO. generation is site-specific, frequently at sites of in-
flammation, for example in the inflamed rheumatoid joint where the 
pH is acidic [74]. At this acidic environment, SA has two effective 
binding sites, referred as a bidentate chelation site [75]. The transi-
tion metals, Fe(III) and Cu(II) bind to these sites forming the Fe(III) 
and Cu(II)-salicylate complexes (Fig. 3) [75]. Thus, chelation of 
transition metals at the sites of inflammation decreases the probabil-
ity of HO. generation through the Fenton reaction (Equation 1) [27, 
76].  
H2O2 + FeII(L)n = FeIII(L)n + HO- + HO.           (1) 
Besides its chelation properties, it is also well known that ASA 
and mainly its SA metabolite strongly scavenge HO. [77]. The ma-
jor evidence for this activity is the ability of ASA and SA to un-
dergo aromatic hydroxylation by reacting with HO. (Fig. 3) [27, 
78]. Accordingly, the application of SA as a chemical trap for HO.
represents a simple and convenient technique to study the in vivo 
and in vitro production of free radicals [77, 79]. The major hy-
droxylation metabolites resulting from HO. attack on SA, under 
physiological conditions, are 2,5-dihydroxybenzoic acid (2,5-
DHBA; gentisic acid), 2,3-dihydroxybenzoic acid (2,3-DHBA) and, 
to a smaller extent, the catechol, 1,2-dihydroxybenzene (Fig. 2).
Other minor products include 2,4- and 2,6-DHBA [80]. Both iso-
mers, 2,5-DHBA and 2,3-DHBA, can be measured as markers of 
HO. formation by high-performance liquid chromatography with 
electrochemical detection [77, 81]. 1,2-dihydroxybenzene and 2,3-
DHBA have not been reported as products of enzymatic metabo-
lism by cytochrome P450 in contrast to 2,5-DHBA. Thus, 2,3-
DHBA is considered a specific marker of in vivo HO. production 
[82] and it has been used, for instance, to study postischemic oxida-
tive injury in isolated tissues [83-84]. In addition, 2,3-DHBA is a 
potent iron chelator (Fig. 3) [85] and, as it was referred before, iron 
is required for HO. generation via Fenton reaction. 
Importantly, when used for the treatment of inflammatory proc-
esses, ASA and its metabolite SA originate sufficiently high con-
centrations at sites of inflammation [86]. Thus these drugs are con-
sidered better in vivo HO. scavengers than other several well estab-
lished antioxidants (e.g. ascorbate, GSH and cysteine) not only 
because of the site-specific location, iron-binding ability but also 
due to the high reaction rate of HO. with ASA (3.61010 M-1 sec-1)
and SA (6-10109 M-1 sec-1) [25]. 
3. SUPEROXIDE DISMUTATION 
Jay and co-workers [87] demonstrated that the salicylate-iron 
complex has superoxide dismutase (SOD) activity, confirmed by 
the inhibition of the reduction of nitroblue tetrazolium at pH 7.8 in 
a xanthine-xanthine oxidase system (Fig. 4). In these experiments it 
was shown that iron and the salicylate-iron complex have also xan-
thine oxidase inhibitory properties [87], which represents another 
antioxidant mechanism for salicylates. On the other hand, the 
authors also observed that during the dismutation reaction, the for-
mation of H2O2 and simultaneously the reduction of Fe(III) of the 
complex to Fe(II), may occur, leading to the generation of HO. [87].  
4. NITRIC OXIDE-DEPENDENT ACTIONS 
Nitric oxide is involved in numerous biological processes in-
cluding inflammation, neurotransmission, gene regulation and 
vasodilation [88]. However, NO is also one of the proposed cyto-
toxic species produced by the immune surveillance system. At 
physiological concentrations, NO has also been shown to protect 
endothelial cells [89], fibroblasts [90], hepatocytes [91], and car-
diomyocytes [92] from cytotoxicity produced by oxidative stress. 
NO is a potent terminator of radical chain propagation reactions
during lipid peroxidation, as observed in model lipid systems [93], 
low density lipoprotein oxidation [94] and in cell cultures [91, 95]. 
On the other hand, at high concentrations or when it reacts with 
O2·, forming the highly reactive ONOO, it can responsible for 
cellular damage [88]. 
In the past few years, compelling evidence suggests that ASA 
increases NO formation and this pathway contributes to the preven-
tion of endothelial injury in cardiovascular diseases [66]. It was 
demonstrated that the increase of NO synthesis is mediated through 
a stimulatory effect of ASA on eNOS since the inhibitor of NO 
synthase, L-NG-monomethyl arginine (L-NAME), and the NO 
scavenger, PTIO, were shown to completely abolish cytoprotection 
by ASA [32] (Fig. 4). Furthermore, ASA was shown to induce an 
immediate concentration-dependent NO release from porcine coro-
nary artery, with a half maximal effective concentration of 50 nM, 
by a calcium-independent mechanism [66]. The concentration re-
quired to enhance NO release is within the range of concentrations 
achieved during low-dose regimens [96]. ASA may enhance accu-
mulation of endothelial soluble guanylyl cyclase (cGMP) levels 
through a direct effect on eNOS and in a NO-dependent manner as 
both elevations of NO and cGMP were attenuated by L-NAME [32, 
66]. Additionally, this effect appears to be due to a direct acetyla-
tion of eNOS. Given the rapid onset of its action on the enzyme 
activity, a genomic action of ASA seems unlikely, though ASA 
may also indirectly induce the expression of eNOS through the 
increased production of lipoxins (Fig. 2). Other NSAIDs including 
SA, failed to enhance NO generation in endothelial cells, which 
demonstrates that the acetyl group in ASA is a structural require-
ment for NOS activation [32]. In addition, ASA analogs containing 
an acetyl group were capable of mimicking activation of isolated 
eNOS and the extent of NO release was strongly correlated with the 
acetylation potency of these compounds [66]. Currently, the mo-
lecular level at which eNOS acetylation occurs is not clear. Taubert 
and colleagues [66] have shown that ASA increases citrulline for-
mation from L-arginine, and therefore it seems possible that ASA 
modulates eNOS post-transcriptionally by affecting its substrate 
accessibility, cofactors (e.g. NADPH or tetrahydrobiopterin) or 
protein-protein interactions [97]. It is noteworthy that NO and NO 
donors produced a very similar profile of endothelial protection 
evoked by ASA [98].  
5. INDUCTION OF HEME OXYGENASE-1  
HO-1 is an inducible isoenzyme responsible for the rate-
controlling step of heme catabolism [99]. The highest HO-1 activity 
is found in the spleen, testes, and brain [100]. HO-1 is induced by a 
range of oxidative stress stimuli such as transition metals, LPS, 
hyperoxia, ischemia, NO, UV light and strongly by its heme sub-
strate. These stimuli lead to the induction of HO-1 in tissues such as 
the heart, vasculature, liver and kidney, where under normal condi-
tions, the enzyme has a lower activity [100].  
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Grosser and coworkers [33], proposed that the antioxidant pro-
file of ASA is attributable to its ability to stimulate the expression 
and enzymatic activity of HO-1 in endothelial cells. In that study, 
the HO-1 induction and the endothelial protection was achieved at 
micromolar concentrations of ASA, which are within the plasma or 
tissue levels attained after oral therapy for cardiovascular diseases. 
Therefore, it could be assumed that HO-1 plays an important role in 
endothelial cells against oxidative stress injury in view of the fact 
that, in the presence of the HO-1 inhibitor tin-protoporphyrin 
(SnPP), the cellular protection afforded by ASA was abolished. 
Grosser and Schroder [32] demonstrated that the induction of HO-1 
by ASA was NO-dependent since the inhibitor of NO synthase, L-
NAME, abolished ASA-induced HO-1 activation. These findings 
are in agreement with prior studies supporting that NO is a down-
stream mediator of HO-1 [30] and that ASA elicits NO release from 
vascular endothelium at therapeutic concentrations [66] (Fig. 2).
Remarkably, these effects are specific to ASA and not induced by 
other NSAIDs such as diclofenac, indomethacin, or SA or by selec-
tive COX-2 inhibitors [31, 33]. On the other hand, NO and NO 
donors have been reported as inducers of HO-1 trough cGMP-
dependent pathways [30]. Besides enhancing the expression of HO-
1 at the mRNA level, NO was reported to increase the protein ex-
pression, the catalytic action and to prolong the half-life of HO-1 
mRNA [101-102].  
The activation of HO-1 gene is considered an adaptive mecha-
nism of cell survival since it has been described that overexpression 
of HO-1 provides cytoprotection in a variety of cell culture and 
animal models [103]. The HO-1 system is physiologically signifi-
cant because it catalyzes the oxidation of the pro-oxidant heme to 
biologically active catabolites as (i) iron, a gene regulator; (ii) bili-
rubin, an antioxidant; and (iii) carbon monoxide (CO), a heme 
ligand [100].  
The HO-1 product biliverdin is rapidly converted to bilirubin by 
biliverdin reductase. At micromolar concentrations, bilirubin exhib-
its a strong antioxidant activity by scavenging peroxyl radicals 
[104-105]. In accordance, in a model of H2O2-mediated toxicity to 
endothelial cells [33], it was shown that exogenous bilirubin, at 
physiological plasma levels, increased cellular resistance to oxida-
tive damage. Other studies also demonstrated that bilirubin protects 
neuronal cells from oxidative stress [106]. Furthermore, HO-1, in 
cultured endothelial cells, inhibits the ability of proinflammatory 
cytokines such as TNF- or interleukin-1- (IL-1-) to induce the 
expression of adhesion molecules, as the inter-cellular adhesion 
molecule-1 (ICAM-1), VCAM-1, and E-selectin, bilirubin being a 
key factor for this action [107]. Consequently, serum bilirubin has 
been considered a novel coronary heart disease risk marker with a 
strong inverse association [108]. Thus, the ASA induction of HO-1 
and further increase in bilirrubin production may also contribute to 
explain the antioxidant and beneficial cardiovascular effects of this 
drug.  
Heme oxygenase-derived CO exerts anti-apoptotic, anti-
inflammatory, anti-platelet and vasodilation effects [109]. The other 
HO-1 metabolite, iron, leads to de novo synthesis of ferritin protein, 
an antioxidant mediator [110] (see below). Nonetheless, it is note-
Fig. (4). Schematic overview of the potential antioxidant pathways of salicylates. Activation or induction (); inhibition ( ); AP-1, activator protein 1; 
ALT, acetylsalicylic acid-triggered lipoxins; Bax, bcl-2–associated X protein; CO, carbon monoxide; COX, cyclooxygenase; C/EBP , CAAT enhancer bind-
ing protein beta; eNOS, endothelial nitric oxide synthase; E-selectin, endothelial adhesion molecule 1; Fe(II), ferrous ion; HO., hydroxyl radical; HO-1, heme 
oxygenase 1; ICAM-1, inter-cellular adhesion molecule 1; IL, interleukin; iNOS, inducible nitric oxide synthase; LOX-1, lectin-like oxidized low-density 
lipoprotein receptor 1; MAPK, mitogen-activated protein kinase; MMP, matrix metalloproteinase; NADPH oxidase, reduced nicotinamide adenine dinucleo-
tide phosphate oxidase; NF-B, nuclear factor kappa B; NO, nitric oxide; O2·, superoxide radical; ONOO, peroxynitrite; oxLDL, oxidized low density lipo-
protein; SA, salicylic acid; SOD, superoxide dismutase; TNF-, tumor necrosis factor alpha; TXA2, thromboxane A2; VCAM-1, vascular cell adhesion mole-
cule 1. 
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worthy that free iron is a catalyst of Fenton reaction leading to gen-
eration of HO. [111]. Thus, the induction of HO-1 may be one of 
the mechanisms underlying the observed induction of ferritin syn-
thesis through ASA [31].  
HO-1 is considered a promising target for the treatment of car-
diovascular diseases, including atherosclerosis, and neurodegenera-
tive processes such as Alzheimer and Parkinson’s disease, because 
it can trigger a unique combination of protective actions on tissue 
and smooth muscle-relaxing effects. Thus it is conceivable that the 
antioxidant activity and antiatherogenic properties of ASA are at 
least partially attributable to the increase of HO-1 expression and 
ensuing formation of bilirubin and CO (Fig. 2). 
6. INDUCTION OF FERRITIN SYNTHESIS 
Iron is an essential physiological metal and it is a required 
component of several enzymes (e.g. ribonucleotide reductase, xan-
thine oxidase, catalase, cytochrome P450) and oxygen binding 
molecules such as hemoglobin and myoglobin [112]. Despite its 
biological benefits, free iron might also have deleterious effects due 
to its ability of catalyzing the oxygen-dependent radical formation 
via Fenton reaction. Indeed, compelling evidences suggest that 
excess free iron is a risk factor for developing several types of can-
cer [113-115] and coronary diseases [116], raises the incidence of 
myocardial infarction [117] and promotes atherosclerosis [118-
119]. 
Ferritin is a high molecular mass (450 kDa), multimeric protein 
constituted by 24 polypeptide chains of two types (Heavy or H 
chain, and Light or L chain), which form a cavity with a high ca-
pacity for storing iron (4,500 mol of iron/mol of ferritin) [120]. 
Ferritin plays a key role in iron metabolism since, additionally to its 
storage, is able to sequester free cytosolic iron, the highly toxic 
Fe(II) and transform it into the non- toxic Fe(III) as an inorganic 
complex [121]. Thus, ferritin removes the free metal ions from the 
site of radical formation and therefore prevents the oxidative stress 
cascade leading to tissue damage.  
It is well established that ferritin synthesis is induced in re-
sponse to an elevation of free iron serum concentrations through 
post-transcriptional mechanisms and increase in ferritin mRNA 
[122]. Furthermore, several findings support that oxidative stress 
stimulus applied to different types of cultured cells enhances ferritin 
synthesis, hence decreasing the accumulation of ROS [110, 121, 
123-125]. As mentioned above, the increase in ferritin synthesis can 
be mediated by HO-1 as an adaptive response to oxidative stress 
[126]. Oberle and co-workers [31], showed, for the first time, that 
ASA (30-300 M) increases ferritin synthesis in endothelial cells in 
a dose and time dependent manner. The stimulatory effect of ASA 
was limited to the translation level, given that ferritin mRNA syn-
thesis was unaltered. In the same study [31], other NSAIDs such as 
SA, diclofenac, and indomethacin failed to up-regulate ferritin, 
which suggests that the acetyl group is a structural requirement to 
inactivate the ferritin repressor protein from the ferritin mRNA, 
allowing the translation of the protein. 
Although ferritin expression was shown to increase in in vitro 
studies using endothelial cells exposed to ASA [31, 127], other 
authors reported contradictory results after treatment with ASA in 
humans. In an US elderly population [128] the use of ASA was 
associated with significantly lower serum ferritin levels, consistent 
with Milman and colleagues findings in a Danish population [129]. 
Fleming [128] hypothesized that this effect could be a consequence 
of lower body iron stores resulting from increased occult blood loss, 
an adverse effect of ASA. A further observation described an in-
verse association between ASA intake and serum ferritin which was 
more marked in the subgroup of diseased elderly subjects with un-
derlying infection, liver disease or inflammation. Ferritin was de-
scribed as an acute phase inflammatory protein, inducible by inter-
leukin-1-beta (IL-1-) and tumor necrosis alpha (TNF-) [130]. The 
inhibition of cytokine-mediated synthesis and secretion of ferritin 
from the liver is a possible mechanism to explain the observed ef-
fects of continuous ASA intake leading to the assumption that fer-
ritin levels in these cases are unlikely to be related to iron stores. 
Although the existence of some conflicting results in humans, it can 
be hypothesized that ASA induction of ferritin in endothelial cells 
plays a direct vasoprotective effect and this mechanism is likely to 
attenuate the activation of both injury and pathophysiological sig-
naling pathways associated with the development of vascular dis-
ease.  
7. INHIBITION OF MYELOPEROXIDASE 
Oxidative burst results from the release of oxidative species 
such as O2· and H2O2 by neutrophils and monocytes in response to 
bacteria or fungi infection [131]. Myeloperoxidase (MPO), abun-
dantly expressed in neutrophils, is an enzyme that participates in 
innate immune response due to its ability to generate strong chlo-
rinating oxidants such as hypochlorous acid from H2O2 produced by 
neutrophils [132]. Furthermore, it oxidizes tyrosine to tyrosyl radi-
cal using H2O2 as an oxidizing agent [131]. Hermann and col-
leagues demonstrated that SA acts as a catalyst of lipid oxidation in 
LDL in the presence of MPO due to its ability to form phenoxyl 
radicals [133]. Conversely, the main metabolite of SA, gentisic 
acid, not only inhibited the MPO system but also counteracted the 
tyrosyl radical-promoted LDL oxidation [133] (Fig. 4). It is note-
worthy that gentisic acid has the ability to overcome the salicylate-
stimulated LDL oxidation at salicylate/gentisic acid ratios found in 
plasma of patients under ASA treatment [133]. Thus, it seems that 
the overall beneficial effect of ASA therapy on the prevention of 
cardiovascular risk might be partially mediated by the antioxidant 
effect of gentisic acid on LDL lipid oxidation caused by phenoxyl 
radicals [133]. 
8. OTHER PROMISING PHARMACOLOGIC MECHA-
NISMS 
The clinical use of ASA in inflammatory diseases requires 
doses exceeding those usually needed to inhibit COX (1-2mM) 
[14]. Moreover, SA, even in high doses, is a weak inhibitor of COX 
but an effective anti-inflammatory agent which suggests that at least 
at high doses, ASA and SA effects are COX-independent [6]. Fur-
thermore, ASA and SA have been shown to block NF-B-mediated 
gene expression at suprapharmacological concentrations [40] (Fig. 
4). Also, these molecules inhibit COX-2 and iNOS protein expres-
sion through blocking the binding of CAAT/enhancer binding pro-
tein  (C/EBP) [134-136] (Fig. 4). More recently, a possible 
mechanism by which both ASA and SA may reduce vascular oxida-
tive stress has been suggested. These salicylates inhibited the ex-
pression of LOX-1 that was induced by oxidized low-density lipo-
protein (oxLDL) in endothelial cells [15]. These recent studies pro-
vide new insight into novel pharmacological actions of ASA and 
SA, which implicate the transcription factors C/EBP and NF-B, 
as well as the receptor LOX-1, as potential targets for therapy of 
inflammation and oxidative stress-mediated tissue injury. 
8.1. Inhibition of NF-B, AP-1 and Protein Kinases 
Nuclear factor kappa B is a pivotal transcription factor involved 
in the innate immune response, inflammation, apoptosis and stress 
responses. The dimeric Rel/NF-B family of transcriptional factors 
regulates the expression of proinflammatory genes encoding vari-
ous cytokines (e.g., IL-1, IL-2), chemokines (e.g., IL-8, monocyte 
chemotactic protein 1), enzymes (e.g., iNOS, COX-2), adhesion 
molecules (e.g., ICAM-1, VCAM-1) and immunoreceptors that 
mediate the innate immune response [137] (Fig. 4). The mammalian 
NF-B transcription factor family consists of five cellular proteins: 
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Rel (c-Rel), RelA (p65), RelB, NF-B1 (p50 and its precursor 
p105) and NF-B2 (p52 and its precursor p100) [138]. NF-B ex-
ists as homo- or heterodimers and are retained inactive in the cyto-
plasm of most cells, bound to the inhibitory proteins, IBs [139]. 
Nuclear factor kappa B is activated in response to various stimuli 
such as TNF-, IL-1 and pathogen associated molecular patterns 
which, through different receptors, including tumor necrosis factor 
receptor (TNFR) and Toll-like receptor (TLR)-interleukin-1 (IL-1) 
receptor (IL-1R) superfamily, activates the IB kinase complex 
(IKK) [140]. This complex is composed by a heterodimer of two 
catalytic subunits, IKK and IKK that are linked to a regulatory 
subunit, IKK or NEMO [141]. There are two distinct pathways 
that lead to NF-B activation and thereby its translocation from the 
cytoplasm to the nucleus [140]. The classical or canonical signaling 
pathway begins with the activation of IKK via an IKK-dependent 
manner that catalyzes the phosphorylation of IBs, polyubiquitina-
tion and proteasome-mediated degradation [140]. The released 
dimer, p50-p65, binds to DNA and activates gene transcription. The 
new signaling pathway, known as the non canonical pathway is 
independent of IKK and is strictly dependent on NF-B inducing 
kinase (NIK) phosphorylation that activates IKK homodimers 
with the consequent nuclear translocation of p52-RelB dimer [140].  
Kopp and Ghosh were the first to describe that SA and ASA 
impair the activation of NF-B. In LPS-stimulated cells, ASA and 
SA blocked the LPS-induced phosphorylation and proteolysis of 
IB, which suggests that the inhibition of NF-B was mediated 
through the inactivation of the classical signaling pathway [40]. 
Noteworthy, the concentrations used of 2-20 mM for ASA and 2-5 
mM for SA, were near the range of the plasmatic concentrations (1-
2mM) attained during anti-inflammatory therapy [39-40]. Even 
though concentrations of 10-20 mM might be considered su-
prapharmacological, such high concentrations could be found in 
patient´s plasma under treatment of chronic inflammatory diseases 
such as arthritis [142]. Succeeding studies confirmed that both ASA 
and SA inhibit NF-B activation by avoiding phosphorylation and 
subsequent dissociation of IB [143]. The mechanism underlying 
the inhibition of the IKK complex activity in vivo and in vitro is due 
to the ability of salicylates to compete with ATP and directly bind-
ing to the subunit IKK, therefore preventing the degradation of 
IB [144]. In addition, salicylates are able to suppress downstream 
targets of NF-B as shown by the decrease of the TNF--induced 
mRNA levels of the adhesion molecules VCAM-1 and ICAM-1 
[143].  
Our research group has been exploring the NF-B inhibitory ef-
fect of salicylates as an antidote for paraquat poisonings. It was 
clearly shown that SA (200 mg/Kg i.p.) and lysine ASA (100 
mg/Kg i.p.) led to full survival of paraquat intoxicated rats [145-
147] [148]. Although several other mechanisms were also proposed 
for the protective effect of salicylates, the dose range used inhibited 
PQ-induced NF-kB activation [146]. The finding that NF-B activ-
ity is inhibited by salicylates indicates that their anti-inflammatory 
activity is partially related to the inhibition of this transcription 
factor. However, this hypothesis has been questioned since other 
studies have shown that SA, at concentrations that cause maximal 
inhibition of COX-2, has no effect on NF-B activation [149]. 
Saunders and colleagues [134] also corroborated these results and 
additionally proposed that the reduction of COX-2 and iNOS ex-
pression is rather mediated by inhibition of C/EBP  binding and 
transactivation [136] (Fig. 3). SA, at therapeutic concentrations, 
exerts direct inhibitory action on p90 ribosomal S6 kinase (RSK) 
thus reducing RSK-induced C/EBP binding and transcriptional 
activation of COX-2 [135]. The inhibition of the RSK family of 
kinases results in a inactivation of cAMP response element binding 
protein (CREB) and IB, which leads to an inhibition of CREB 
and NF-B-dependent gene transcription [150]. This pleiotropic 
transactivator is involved in the expression of various pro-
inflammatory cytokines and mediators and therefore the anti-
inflammatory and antioxidant properties of salicylates might be 
partially attributable to their ability to prevent C/EBP  activation 
[151]. Thus, ASA and SA at pharmacological concentrations (10 
M-1 mM) selectively inhibit IL-1 and phorbol ester myristate 
induced-C/EBP binding to DNA specific sites whereas at su-
prapharmacological concentrations (>5mM) inhibit TNF--
induced-NF-B activation [152] (Fig. 4). 
Among reactive oxygen species, HO. has been reported as the 
main messenger for NF-B activation (Shi et al. 1999b). Thus, it 
seems likely that the HO. scavenging activity of salicylates may 
also be involved in the inhibition of this transcriptional factor (Shi 
et al. 1999a). However, additional studies are necessary to support 
this assumption. 
Besides controlling the transcription factors NF-B, CREB and 
C/EBP, salicylates also target another transcription factor, the 
activator protein 1 (AP-1) [153]. AP-1 is a dimeric protein complex 
(homodimeric or heterodimeric) comprising the products of the jun
and fos oncogene families [154]. The activation of AP-1 is medi-
ated by a number of diverse signals that include UV radiation, oxi-
dative stress, TNF-, interferon  and antigen binding by T or B 
lymphocytes [155]. Some of the genes known to be regulated by 
AP-1 are involved in the immune and inflammatory responses, 
tumor promotion and progression, and most of these genes overlap 
with the NF-B target genes [156]. AP-1 is induced and regulated 
by the same stimuli as NF-B and is likewise inactivated by salicy-
lates (Dong et al. 1997) and probably through its free radical scav-
enging properties. The inhibition of AP-1 activation was also re-
cently corroborated by our group, also representing a potential 
mechanism that ultimately contributed for the beneficial protective 
effects of salicylates in paraquat intoxicated rats [146-147]. 
8.2. Inhibiton of Lectin-Like Oxidized LDL Receptor-1?  
One of the major causes of the coronary artery diseases is athe-
rosclerosis and the consequent rupture of the atherosclerotic plaque 
formed in the vessels [157]. Atheroma plaques are constantly 
stressed by a variety of biomechanical and hemodynamic forces, 
pro-oxidant activity and reduced NO synthesis, release of collagen 
degradating metalloproteinases (MMPs) and deposition of oxLDL, 
that may precipitate or trigger the rupture of vulnerable plaques 
[157]. 
Recently, Metha and colleagues [15] have proposed a new 
pathway by which ASA may protect endothelial cells from oxida-
tive stress injury. Cultured coronary artery endothelial cells exposed 
to oxLDL show an increment of both (LOX-1) mRNA and protein 
levels. ASA decreased the expression of the oxLDL-induced-LOX-
1 mRNA and protein in a time and dose-dependent manner (Fig. 4).
LOX-1 was first identified in endothelial cells but it is currently 
known that LOX-1 is expressed in macrophages, vascular smooth 
muscle cells and platelets [158]. LOX-1 is recognized as the mole-
cule that induces endothelial dysfunction and apoptosis, mainly 
triggered by oxLDL but also by other stimuli such as shear stress, 
endothelin, angiotensin II and activated platelets [158]. Activation 
of LOX-1, as consequence of O2· generation, induces RhoA and 
Rac1via MT1-MMP, which result in NADPH oxidase activation 
[159]. LOX-1 reduces endothelial NO production through reaction 
with NADPH oxidase-generated O2· and by LOX-1-mediated 
downregulation of eNOS [160]. Moreover, LOX-1 plays a role in 
the mediated NF-B activation and expression of adhesion mole-
cules and chemokines by oxLDL [161]. Additionally, stimulation of 
LOX-1 promotes apoptosis by increasing the pro-apoptotic factor 
Bax and reducing the anti-apoptotic factor Bcl2, and activates sev-
eral kinases from the family of the mitogen-activated protein kinase 
(MAPK) signaling pathway [158, 162]. SA exerted a similar LOX-
1 inhibitory effect but indomethacin, a cyclooxygenase inhibitor, 
failed to suppress LOX-1 expression [15]. This is not surprising 
since both ASA and SA but not indomethacin, inhibit O2· genera-
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tion, which is a known regulator of LOX-1 expression [160]. The 
suppression of LOX-1 expression is correlated with downstream 
targets of this receptor, namely p38MAPK and matrix metalloprote-
inase-1 (MMP-1) (Fig. 4). ASA prevented p38MAPK oxLDL-
induced phosphorylation and consequently decreased MMP-1 activ-
ity and protein expression [15]. It seems that MMP-1 plays a role in 
both plaque vulnerability and in expansive arterial remodeling, 
leading to its activation and degradation of collagen within the athe-
rosclerotic plaque, which can result in its rupture [157].  
Furthermore, ASA prevents endothelium dysfunction during 
atherosclerosis [163] probably by protecting LDL against oxidative 
modification [164]. In hypercholesterolemic rats, ASA treatment 
significantly reduced lipid peroxidation and avoided reduction in 
glutathione content [13, 165]. The mechanism whereby ASA pro-
tects LDL from oxidation is most likely related to its antioxidant 
activities specifically its hydroxyl radical scavenging ability [77], 
inhibition of basal O2· production via vascular NADPH oxidases 
[11], chelation of free cytosolic iron [27], induction of ferritin 
synthesis [31] and by inhibiting free radicals generation through the 
prostaglandin synthase reaction [166] (Fig. 4). Oxidation of native 
LDL results from lipid peroxidation products binding to lysine resi-
dues of apolipoprotein B and a mechanism by which ASA may 
inhibit at least the consequences of LDL-oxidation is acetylation of 
these residues [164]. 
9. CONCLUDING REMARKS 
Nonsteroidal anti-inflammatory drugs have been used to treat 
arthritis since the beginning of the 19th century, when the analgesic 
and anti-inflammatory properties of SA were first discovered [167]. 
Despite of 110 years of  clinical use, complete knowledge of ASA 
and its metabolites or other salicylates is still evolving with newly  
discovered pharmacological properties and clinical applications.  
Both ASA and SA have remarkable hydroxyl scavenging prop-
erties, which explain the neuroprotection [168] and cytoprotection 
in models of ischemia/reperfusion injury [26]. High concentrations 
of salicylates interfere with several kinases, including the MAPK 
cascade and the transcription factors NF-B and AP-1 responsible 
for the expression of a myriad of pro-inflammatory and pro-oxidant 
enzymes and cytokines [39, 156]. Several authors argue that the 
concentrations used to interfere with NF-B and AP-1 and other 
cellular kinases are not tolerable as they cause severe adverse ef-
fects in humans. Nevertheless it was shown that at therapeutic con-
centrations, SA and ASA inhibit COX-2, iNOS and IL-4 gene ex-
pression through interfering with binding of C/EBP [134, 149]. 
Even though both salicylates have overlapping activities, ASA has 
shown unique biological functions namely the induction of ferritin 
and synthesis of 15-epi-lipoxin A4 [31, 34, 50]. These novel lipid 
mediators could be considered as possible antioxidant effectors of 
ASA since it was demonstrated that ATL increases NO release, 
HO-1 expression, prevented nuclear NF-B translocation and inhib-
ited NAD(P)H oxidase activity, which was previously observed for 
ASA but not for SA or other NSAIDs [35-37]. 
Besides its own potent antioxidant activity, ASA yields two 
bioactive metabolites, SA and gentisic acid [79, 133], which may 
amplify the beneficial effects. Collectively, ASA has shown a broad 
of remarkable antioxidant mechanisms that are in accordance with 
the successful clinical use in the treatment and prevention of car-
diovascular diseases and more recently as a chemopreventive drug 
against colorectal tumor.  
ABBREVIATIONS 
5-LO = lipoxygenase 
15-epi-LXA4 = aspirin-triggered carbon-15 epimers lipoxins 
15-HETE = 15S-hydroxyeicosatetraenoic acid
AP-1 = activator protein 1 
ATL = acetylsalicylic acid-triggered lipoxins 
ASA = acetylsalicylic acid 
ATP = adenosine triphosphate 
Bax = bcl-2–associated X protein 
cGMP = cyclic guanosine monophosphate 
CO = carbon monoxide 
COX = cyclooxygenase 
CREB = cyclic adenosine monophosphate response element-
binding 
C/EBP  = CAAT enhancer binding protein beta 
DHBA = dihydroxybenzoic acid 
eNOS = endothelial nitric oxide synthase 
E-selectin = endothelial adhesion molecule 1 
Fe(II) = ferrous ion 
Fe(III) = ferric ion 
GA = gentisic acid 
H2O2 = hydrogen peroxide  
HO. = hydroxyl radical 
HO-1 = heme oxygenase 1 
ICAM-1 = inter-cellular adhesion molecule 1 
IL = interleukin 
iNOS = inducible nitric oxide synthase 
IKK = IB kinase complex 
LDL = low density lipoprotein 
LOX-1 = lectin-like oxidized low-density lipoprotein recep-
tor 1 
LPS = lipopolysaccharide 
LXA4 = lipoxin A4 
MAPK = mitogen-activated protein kinase
MMP = matrix metalloproteinase 
NAD(P)H = reduced nicotinamide adenine dinucleotide phos-
phate oxidase 
NF-B = nuclear factor kappa B 
NO = nitric oxide 
NSAID = non-steroidal anti-inflammatory drugs 
O2· = superoxide radical 
ONOO = peroxynitrite 
oxLDL = oxidized low density lipoprotein 
PMN = polymorphonuclear 
RNS = reactive nitrogen species 
ROS = reactive oxygen species 
SA = salicylic acid 
SAAG = salicyl acyl glucuronide 
SAPG = salicyl phenolic glucuronide 
SHRSP = stroke-prone spontaneously hypertensive rats  
SOD = superoxide dismutase 
SUA = salicyluric acid 
TNF- = tumor necrosis factor alpha 
TXA2 = thromboxane A2 
VCAM-1 = vascular cell adhesion molecule 1 
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Comment
In the present issue of the British Journal of Pharmacology,
the research group supervised by Vincenzo Mollace reports a
new finding of great interest concerning the antidotal effect
against paraquat (PQ)-induced toxicity, attained through
inhibition of quinone oxidoreductase 2 (QR2) (Janda et al.,
2012). This research may lead to safer paraquat use.
The introduction of PQ (1,1′-dimethyl-4,4′-bipyridylium
dichloride) as an herbicide in 1962 has brought to the world
one of the most controversial and studied pesticides over the
last 50 years. At first, it appeared as a cheap and extremely
effective, fast-acting and non-selective foliage-applied con-
tact herbicide, killing a wide range of grasses and dicoty-
ledonous weeds, and its use rapidly became widespread
worldwide. However, it soon became notorious due to its
toxic effects; human poisonings with this compound were
frequently fatal due to its severe acute toxicity and lack of
antidotes. For this reason, PQ was held responsible for thou-
sands of deaths from both accidental and voluntary ingestion
(the majority of the cases), as well as from dermal exposure
(Dinis-Oliveira et al., 2008). In July 2007, the European
Union (EU) Court of First Instance annulled the Directive
2003/112 authorizing the use of PQ in the EU. Among other
reasons, concerns about potential links between PQ and the
Parkinson’s disease and the requirement of human protec-
tion, which prohibits any exposure higher than the accept-
able operator exposure level, as well as the protection of
animal health, dictated the ban. In parallel, several non-
governmental organizations were involved in fierce cam-
paigns for a global ban of PQ, and some countries are
restricting its use or applying a phase-out procedure.
With such a dark shadow over this herbicide, PQ research
is becoming a complicated issue, both for scientists and for
grant providers. Is it worth investigating or providing grants
for the research on a compound that seems to be doomed?
BJP British Journal ofPharmacology
DOI:10.1111/j.1476-5381.2012.02017.x
www.brjpharmacol.org
44 British Journal of Pharmacology (2013) 168 44–45 © 2012 The Authors
British Journal of Pharmacology © 2012 The British Pharmacological Society
Although some research groups, including our own, have
already suffered this stigma in the financial support for PQ
research, in our opinion, this area of research is more impor-
tant than ever. It is noteworthy that PQ is still registered and
applied in over 100 countries. The reasons for this are obvious
and well beyond financial issues, namely its rapid action
upon contact with the leaves, its lack of effect on roots and
rhizomes, thus holding the soil together and preventing soil
erosion, and its rapid deactivation by strong sorption to soil,
thus limiting movement by leaching or surface run-off,
decreasing possible ecotoxicological effects and allowing
rapid reseeding or replanting after the killing of weeds (Bro-
milow, 2004). It is also worth mentioning that PQ can be
applied safely when used according to the manufacturer’s
guidelines (Hart, 1987). PQ is highly hydrophilic and thus
not absorbed through intact skin. Aerosolized PQ particles are
large in diameter and thus do not reach the human alveoli
when inhaled. Indeed, typical spray equipment generates
droplet sizes with a median volume diameter over 100 mm
(Dinis-Oliveira et al., 2008).
Looking at the number of PQ publications per year in the
National Library of Medicine database PubMed® (Figure 1),
one rapidly realizes that, within this century, it doubled from
2000 (134) to 2007 (266) and then stabilized, but curiously
the number of publications each year concerning PQ and
human poisoning was fairly stable until 2007, after which it
showed a sustained increase. Even more interesting is the
number of publications per year relating PQ to Parkinson’s
disease. In 2000, this number was residual (3) and then stead-
ily increased up to 10 times in 2007 (30), to stabilize there-
after, although another publication peak appears in 2011.
These data suggest that fatalities due to PQ poisoning con-
tinue to be a heavy burden worldwide and that the possible
involvement of PQ in the development or aggravation of
Parkinson’s disease is an area of increasing research
interest.
It has long been postulated that NAD(P)H-dependent dia-
phorases are responsible for the in vivo reduction of PQ to
the free radical monocation PQ.+, which is then rapidly
re-oxidized (returning to its original form) in the presence of
O2 with subsequent generation of superoxide anion radicals
and other reactive oxygen species that are responsible for PQ
toxicity (Dinis-Oliveira et al., 2008). On the other hand, as
now observed, the inhibition or silencing of the NAD(P)H-
independent flavoenzyme QR2 significantly attenuates PQ
toxicity in vitro, in primary pneumocytes and astroglial U373
cells, and strongly antagonizes PQ-induced systemic toxicity
and animal mortality (Janda et al., 2012). Most importantly,
Wistar rats administered a specific QR2 inhibitor 2 h after PQ,
which was subsequently maintained by several supporting
doses, all survived an otherwise fatal dose of PQ (Janda et al.,
2012). The novel results reported in this issue of the BJP add
to recent findings, which demonstrated that PQ-intoxicated
rats all survived if treated with sodium salicylate or lysine
acetylsalicylate (Dinis-Oliveira et al., 2007, 2009), and open
the door for new preventative and therapeutic strategies to be
applied to PQ-intoxicated patients. Although this may con-
stitute a questione disputate, breakthrough research on PQ, as
in the present case, may ultimately lead to an effective risk
control and allow the safer use of PQ in the future. Many
other pesticides, such as organophosphates, are involved in a
high number of voluntary intoxications, but do not pose a
problematic treatment scenario and, therefore, continue to
serve mankind. Hopefully, this may also happen with PQ, if
further research significantly increases its safety.
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Abstract 
 
The etiology of most neurodegenerative disorders is multifactorial and consists of an interaction 
between environmental factors and genetic predisposition. The role of pesticide exposure in 
neurodegenerative disease has long been suspected, but the specific causative agents and the 
mechanisms underlying are not fully understood. For the main neurodegenerative diseases such 
as, Parkinson’s disease, Alzheimer’s disease and Amyotrophic Lateral Sclerosis there are 
evidences linking their etiology with long-term/low-dose exposure to pesticides such as paraquat, 
maneb, dieldrin, pyrethroids and organophosphates. Most of these pesticides share common 
features, namely the ability to induce oxidative stress, mitochondrial dysfunction, α-synuclein 
fibrillization and neuronal cell loss. This review aims to clarify the role of pesticides as 
environmental risk factors in genesis of idiopathic PD and other neurological syndromes. For this 
purpose, the most relevant epidemiological and experimental data is highlighted in order to discuss 
the molecular mechanisms involved in neurodegeneration. 
 
 Keywords: Pesticides, Paraquat, Parkinson´s Disease, Alzheimer´s Disease, Amyotrophic Lateral 
Sclerosis, neurodegenerative diseases 
 
 
1.  Introduction 
The World Health Organization currently 
estimates that around a billion people 
worldwide are affected by a 
neurodegenerative disease (WHO, 2006). As 
aging corresponds to the greatest risk factor 
for neurodegeneration, the prevalence of 
neurological disorders is expected to increase 
dramatically in next few years due to the 
higher life expectancy worldwide (Brown et 
al., 2005). Another risk factor for 
neurodegeneration, alongside with the aging 
process, is long-term/low-dose pesticide 
exposure. The role of pesticide exposure in 
the genesis of neurodegenerative diseases 
has been especially scrutinized for 
Parkinson´s disease (PD) (Franco et al., 
2010).  
PD is a progressive movement disorder 
characterized by progressive bradykinesia 
(slowness of voluntary movement), rigidity, 
rest tremor, and postural disturbances. 
Nonetheless, it is also increasingly recognized 
that non-motor symptoms, including 
autonomic and cognitive impairment, sleep 
disturbances, olfactory dysfunction, and 
depression occur in PD patients, and these 
features are probably due to the spread of the 
pathology beyond the basal ganglia (Shulman 
et al., 2011). The PD´s motor manifestations 
are attributed to the progressive loss of 
dopaminergic neurons in the substantia nigra 
pars compacta (SNpc) resulting in secondary 
dysfunction of the basal ganglia, which are 
involved in the initiation and execution of 
movements (Shulman et al., 2011). The 
subcellular hallmarks of PD are the 
intraneuronal inclusions of various structures 
consisting mostly of fibrillar α-synuclein (Lewy 
bodies and Lewy neurites) (Halliday et al., 
2011). 
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The etiology of PD is currently unknown but it 
is assumed that there is a significant non-
genetic contribution. It seems that the disease 
results from combination and accumulation of 
environmental exposures, and complex gene-
environment interactions sustained by the 
slow and progressive development during 
aging (Cannon and Greenamyre, 2011; Dinis-
Oliveira et al., 2006). Most of the forms of PD 
are idiopathic, but approximately 10-30% of 
the cases have a familial history, and in a 
minority of them the disease follows a 
Mendelian inheritance pattern. The disease is 
characterized by an early-onset (typically 
under 40 years) and so far 15 PD loci 
(PARK1-15) and 11 genes for PARK loci, 
specially a-synuclein, leucine-rich repeat 
kinase 2, parkin, PTEN-induced putative 
kinase 1, DJ-1, and ATP13A2 have been 
described to cause typical forms of inherited 
PD or parkinsonian syndromes (Coppede, 
2012). Parkinsonism is often observed as one 
of the symptoms in other monogenic 
diseases, when mutations in non-PARK loci 
(MAPT, SCA1, SCA2, spatacsin, POLG1) 
occur. In sporadic PD, genetic polymorphisms 
in four loci (SNCA, MAPT, GBA and LRRK2) 
are considered strong risk factors (Coppede, 
2012). It is consensual that both etiologies 
share the same pathological pathways. SNpc 
is highly sensitive to diverse genetic, cellular 
and environmental factors that independently 
or concomitantly cause cell death over time. 
For instance, evidence suggests that 
mitochondrial dysfunction, accumulation of 
misfolded and aggregated proteins (ubiquitin- 
proteasome system and autophagy pathway 
impairment) and oxidative and nitrosative 
stress play an essential role in the 
pathogenesis of both idiopathic and familial 
forms of PD (Kanthasamy et al., 2012).  
Since the discovery of the ability of MPTP (1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine) to 
reproduce some of the features of PD, 
research has been focused on finding other 
environmental risk factors implicated in the 
etiology of PD, which revealed that 
occupational exposures to paraquat (PQ), 
maneb (MB) and rotenone have been 
associated with higher incidence of PD.  
Besides PD, several studies have also 
suggested that Alzheimer´s disease (AD), 
amyotrophic lateral sclerosis (ALS), dementia 
and deficits in cognitive function are linked to 
occupational pesticide exposure (Cannon and 
Greenamyre, 2011; Chang and Wu, 2009; 
Kamel and Hoppin, 2004b; Kamel et al., 2012; 
Migliore and Coppede, 2009a; Sutedja et al., 
2009). AD is a chronic disease characterized 
by progressive loss of memory and cognitive 
capacity, ultimately leading to dysfunction in 
daily life or work abilities. The 
neurodegeneration seen in AD involves two 
main protein aggregates, senile/amyloid 
plaques and neurofibrillary tangles (Palop and 
Mucke, 2010). Senile plaques are deposits of 
fibrils of the β-amyloid peptide, a fragment 
derived from the proteolytic processing of the 
amyloid precursor protein whereas 
neurofibrillary tangles are a compact 
filamentous network of helical filaments from 
hyperphosphorylated tau protein (Maccioni et 
al., 2001). Initially, the entorhinal cortex and 
hippocampus are particularly affected, as 
shown by the impaired synaptic transmission, 
especially reduction in the glutamatergic 
synaptic transmission strength and plasticity, 
and cholinergic dysfunction (Danysz and 
Parsons, 2012; Nyakas et al., 2011). The 
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cause for development of AD as other 
neurodegenerative diseases is not fully 
understood, however roughly 0.1% of the 
cases arise from mutation in 3 genes (APP, 
PSEN 1 and PSEN 2) that result in a  familial 
early-onset (<65 years) autosomal dominant 
forms (Migliore and Coppede, 2009b). Metals, 
pesticides, solvents, electromagnetic fields, 
brain injuries, inflammation, educational 
levels, lifestyles and dietary factors have been 
proposed as environmental AD risk factors 
(Cannon and Greenamyre, 2011; Dosunmu et 
al., 2007). Carbamates, organophosphates 
(OPs) and organochlorines are the pesticides 
more frequently associated with occupational 
exposure and AD (Hayden et al., 2010; 
Parron et al., 2011; Tyas et al., 2001; 
Zaganas et al., 2013).  
Amyotropic Lateral Sclerosis (ALS) is a 
neurodegenerative disease evidenced by 
progressive loss of motor neurons at the 
anterior horn of the spinal cord and brain, 
resulting in progressive weakness, muscle 
atrophy, and  respiratory failure within 3-5 
years after diagnosis (Al-Chalabi et al., 2012). 
Around 5% of the cases are familial forms of 
ALS that arise from mutations in several 
genes including SOD1, TARDBP, FUS, 
UBQLN2, C9orf72, and TAF15 (Al-Chalabi et 
al., 2012; Lill et al., 2011; Maccioni et al., 
2001). Studies in mutations in SOD1 have 
provided new insight into the pathogenesis of 
ALS, namely the generation of reactive 
oxygen (ROS) and nitrogen species (RNS), 
dramatic gliosis characterized by 
abnormalities of  astrocytes, widespread 
astrocytosis, increased expression of 
inducible nitric oxide synthase (NOS) and 
activated microglial cells (Almer et al., 1999; 
Cha et al., 2000; Nagy et al., 1994). 
Interestingly, the neuronal cytoplasmic 
inclusions of ALS are constituted by 
aggregates of proteins encoded by the 
mutated genes described above (Ince et al., 
2011). ALS and sporadic frontotemporal lobar 
degeneration share the same pathologic 
lesion, the ‘Ubiquitin-only inclusion’ body, 
within lower motor neurons and cerebral 
neurons (hippocampal and frontotemporal 
neocortex neurons), and both are considered 
proteinopathies (Ince et al., 2011). The 
remaining 95% of cases do not have an 
obvious family history of ALS and appear to 
occur sporadically throughout the community 
(Schymick et al., 2007). Despite this fact, the 
etiology of the majority of sporadic ALS cases 
is presumably due to several interactions 
between genetic and environmental factors. 
The genes that have been identified as being 
causative of ALS are related to DNA repair 
(APEX1 and hOGG1), angiogenesis (ANG 
and VEGF), paraoxonases (PON1, PON2 and 
PON3), iron metabolism (HFE), 
neurofilaments (NEFH), and survival motor 
neuron (SMN1 and SMN2) (Maccioni et al., 
2001; Migliore and Coppede, 2009b; 
Schymick et al., 2007). Several studies 
suggest that occupational exposure to 
pesticides is a significant risk factor of ALS 
(Bonvicini et al., 2010; Govoni et al., 2005; 
Kamel et al., 2005; Kanavouras et al., 2011; 
Qureshi et al., 2006). For instance, Horner 
and colleagues reported a two-fold increase in 
the risk of ALS among veterans of the 1991 
Gulf War over the subsequent 10 years 
(Coffman et al., 2005; Horner et al., 2003; 
Miranda et al., 2008). Although the 
information about the chemicals to which 
soldiers were exposed is scarce and biased, 
the possibilities include OPs, other pesticides, 
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nerve gases, pyridostigmine, petrochemicals 
and  depleted uranium (Spencer et al., 1998). 
Recently, two different research groups 
conducted a retrospective meta-analysis of 
studies relating ALS and pesticides as a 
group (Malek et al., 2012), and one of them 
investigated the association of ALS with 
specific pesticides, using data from the 
Agricultural Health Study, a cohort including 
84.739 private pesticide applicators and 
spouses (Kamel et al., 2012). From the eight 
case-control studies (Bonvicini et al., 2010; 
Chancellor et al., 1993; Deapen and 
Henderson, 1986; Granieri et al., 1988; 
Gunnarsson, 1994; McGuire et al., 1997; 
Morahan and Pamphlett, 2006; Savettieri et 
al., 1991) and one cohort study (Weisskopf et 
al., 2009), the major finding was the  strong 
association observed between agricultural 
activities and ALS,  although the chemical or 
class of agrochemical was not specified by 
the majority of studies (Kamel et al., 2012; 
Malek et al., 2012; Sutedja et al., 2009). On 
the other hand, in the Agricultural Health 
Study, ALS was not associated with 
pesticides as a group, but was associated 
with use of organochlorine insecticides, 
herbicides, pyrethroids, and fumigants (Kamel 
et al., 2012).  
There is mounting evidence that long-term/low 
dose pesticide exposure is potentially 
neurotoxic and increases risk of PD and with 
lesser extent other neurological diseases, 
such as AD and ALS. PQ and MB are the 
most studied pesticides, though pesticides 
such as dieldrin, pyrethroids and OPs are also 
described as neurotoxics. The pesticides 
addressed in this review represent the five 
important classes of pesticides that have been 
more extensively studied in this matter. The 
neonicotinoids, acetamiprid and imidacloprid 
belong to a new class of insecticides and the 
latter is considered the most widely used 
within this class in the world. Nonetheless, so 
far neonicotinoids are considered safer than 
other compounds due to their higher 
selectivity for the nicotinic receptors of insects 
than mammalian receptors (Casida and 
Durkin, 2013). There are few studies reporting 
nervous system depression following acute 
poisoning with imidacloprid or acetamiprid, but 
currently there is no evidence or human data 
reporting health effects on humans after 
prolonged exposure to neonicotinoids 
(Imamura et al., 2010; Karatas, 2009; Phua et 
al., 2009; Proenca et al., 2005).  
This review aims to clarify some of the 
mechanisms involved in the genesis of 
idiopathic PD and other neurological 
syndromes and the role of pesticides as 
environmental risk factors. 
 
2. Paraquat 
2.1 Oxidative stress and inflammation 
The herbicide PQ has increasingly been 
reported in epidemiological studies to 
enhance the risk of developing PD.  PQ 
belongs to the chemical class of bipyridyl 
(also called bipyridylium) quaternary 
ammonium herbicides characterized by two 
covalently linked methylpyridine rings 
(Calderbank, 1968). The toxicity of PQ has 
been extensively described concerning the 
effects to the main target organ, the lungs, 
and also the kidneys, liver and heart (Dinis-
Oliveira et al., 2008). However, only in the 
past decade the research has been focusing 
on the effect of PQ in the brain after several 
reports of brain damage in individuals 
exposed to lethal doses of PQ (Baltazar et al., 
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2013; Dinis-Oliveira et al., 2006; Grant et al., 
1980; Hughes, 1988; Soontornniyomkij and 
Bunyaratvej, 1992). The mechanisms of PQ-
induced neurotoxicity are not fully 
comprehended yet, but several pathways 
have been proposed: induction of oxidative 
stress, mitochondrial dysfunction, apoptosis 
and autophagy, inhibition of the ubiquitin- 
proteasome system, induction of 
synucleinopathy and tauopathy (Dinis-Oliveira 
et al., 2009; Franco et al., 2010) (Fig. 1). 
A reliable amount of evidence has 
demonstrated that oxidative stress is 
considered to have a key role in the 
pathogenesis of PD (Drechsel and Patel, 
2008). Dopaminergic neurons are markedly 
exposed to oxidative stress injury, mainly due 
to the oxidative metabolism of dopamine (DA), 
which contributes to sustain a higher 
production of ROS in the SNpc when 
compared to other regions of the brain (Fahn 
and Cohen, 1992). The other factors 
contributing to the selective vulnerability of the 
nigrostriatal system to oxidative stress include 
the following: 
(a) The capability of DA auto-oxidation 
products, quinones and semiquinones to 
adduct proteins containing a thiol group such 
as glutathione and DNA (Graham, 1978; 
Hastings, 1995; Levay and Bodell, 1993) 
(b) High aerobic respiration activity (Bueler, 
2009) 
(c) Increased iron concentration in the 
substantia nigra that leads to the production of 
hydroxyl radical (HO.) through Fenton reaction 
(Andersen, 2004; Kaur and Andersen, 2004). 
PQ is widely known as a redox cycling agent, 
capable of accepting one electron from 
several cellular diaphorases (enzymes that 
transfer one electron from NAD(P)H), mainly 
NADPH-cytochrome P450 reductase, to form 
the monocation radical (PQ.+). Other enzymes 
are able to reduce PQ2+ to PQ.+, which 
comprise mitochondrial NADH:ubiquinone 
oxidoreductase (Gray et al., 2007), xanthine 
oxidase, NOS (Day et al., 1999), NADPH-
oxidases from Nox family (Cristovao et al., 
2009), and thioredoxin reductase (Gray et al., 
2007). The PQ·+ is then rapidly reoxidized, 
regenerating its parent compound, in the 
presence of O2, originating superoxide (O2.-). 
The O2.- produced can react with nitric oxide 
(NO) to form peroxynitrite (ONOO-) or be 
dismutated by superoxide dismutase (SOD) to 
hydrogen peroxide (H2O2). In the presence of 
iron (II), H2O2 is reduced to HO., a far more 
damaging ROS that rapidly oxidizes DNA, 
proteins and lipids (Klein and Ackerman, 
2003) (Fig. 1). 
The role of oxidative stress in PQ-induced 
neurodegeneration has been demonstrated in 
several cellular models (Castello et al., 2007; 
Cocheme and Murphy, 2008; Shimizu et al., 
2003b; Wu et al., 2005) and in vivo studies 
(Czerniczyniec et al., 2011; McCormack et al., 
2005; McCormack et al., 2002; Thiruchelvam 
et al., 2000b; Wills et al., 2012). PQ exposure 
was shown to cause depletion of GSH and 
increase GSSG levels in the substantia nigra 
of mice (Kang et al., 2009), augment 
malondialdehyde and protein carbonyls 
concentration, as well as DNA fragmentation 
(Yang and Tiffany-Castiglioni, 2005). PQ-
induced increase in NADPH oxidase 
expression might result from initial ROS 
produced by the PQ redox cycle or 
mitochondria (Cristovao et al., 2009) (Fig. 1). 
However, continued production of ROS might 
be sustained by constant generation of 
NADPH oxidase-mediated O2.-. When cells 
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were pretreated with apocynin, a putative 
NADPH oxidase inhibitor, PQ-induced ROS 
generation and dopaminergic cell death were 
significantly reduced. PQ has been shown to 
activate other signaling pathways such as 
protein kinase delta (PKC δ) or ERK1/2, which 
were reported as NADPH oxidase 
transcriptional activators (Miller et al., 2007).  
Exposure of microglial cells to PQ resulted in 
a rapid phosphorylation of ERK1/2 and 
phosphorylation of the cytosolic subunits of 
NADPH oxidase by PKC δ, resulting in 
increased ROS production and cell death 
(Miller et al., 2007). 
Increasing evidences support that microglia, 
the resident macrophages in the brain, are a 
chronic source of inflammation and ROS 
responsible for progressive neuron damage 
(Surace and Block, 2012). Purisai and 
colleagues demonstrated that microglial 
activation is a priming event leading to PQ-
induced dopaminergic cell degeneration 
(Purisai et al., 2007) (Fig. 1). Furthermore, a 
single-PQ exposure triggered an increase in 
the number of cells with 
immunohistochemical, morphological and 
biochemical characteristics of activated 
microglia, including induction of NADPH-
oxidase, but failed to cause oxidative stress 
and neurodegeneration (Purisai et al., 2007). 
However, when PQ was repeatedly 
administered or challenged with other pro-
inflammatory stimuli, such as 
lipopolysaccharide (LPS), the susceptibility of 
dopaminergic neurons to toxic injury was 
dramatically exacerbated (Mangano and 
Hayley, 2009; Purisai et al., 2007). The 
current knowledge supports the hypothesis 
that inflammatory insults may influence 
dopaminergic neuronal sensitivity to 
subsequent environmental xenobiotics by 
modulating the state of glial and immune 
factors, and these findings may be important 
for multifactorial neurodegenerative 
conditions, such as PD (Mangano and Hayley, 
2009; Miller et al., 2007; Surace and Block, 
2012). 
Subchronic systemic injection of PQ (10 
mg/kg) to C57BL/6 mice induced a specific 
dose and age-dependent neurodegeneration 
of the dopaminergic neurons in the SNpc 
populations, whereas GABA-ergic cells in the 
substantia nigra pars reticulata and 
cholinergic neurons in the hippocampus were 
not affected (McCormack et al., 2002). 
Noteworthy, the authors claimed that the 
discrepancy observed between 
neurodegeneration and lack of significant DA 
loss represents another important feature of 
PQ model and is probably a reflection of 
compensatory mechanisms by which neurons 
that survive damage are capable of restoring 
neurotransmitter tissue levels (Ossowska et 
al., 2006). Other authors also corroborated 
the same findings (Kuter et al., 2007; 
Ossowska et al., 2005), nonetheless the 
combined exposure to PQ and MB resulted in 
nigral DA loss associated with decreased 
tyrosine hydroxylase (TH) protein levels and 
nigral dopaminergic neurodegeneration (Li et 
al., 2005; Thiruchelvam et al., 2002). 
McCormack and colleagues reported that 
ferritin transgenic mice are resistant to PQ-
induced neuronal loss and lipid peroxidation, 
possibly by avoiding the generation of HO. Via 
Fenton reaction (McCormack et al., 2005). In 
the same study, wild type C57BL/6 mice 
showed simultaneous dose-dependent loss of 
nigrostriatal dopaminergic neurons and an 
increase in the counts of neurons 
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immunoreactive for 4-hydroxinonenal, and 
nitrotyrosine, biomarkers of lipid peroxidation 
and nitrosative damage, respectively. 
Similarly to the in vivo studies (McCormack et 
al., 2005; McCormack et al., 2002), midbrain 
cells exposed to a single treatment with 10 
mM PQ did not show a decrease in the 
number of dopaminergic neurons, although 
sequential treatments with 10 mM PQ for 2 
days considerably killed dopaminergic 
neurons (Shimizu et al., 2003b).  These 
results strongly support that the constant 
exposure to low levels of PQ would lead to the 
vulnerability of dopaminergic neurons in the 
nigrostriatal system. Moreover, an indirect 
excitotoxic pathway involving the NMDA 
receptors has been proposed by Shimizu and 
colleagues (Shimizu et al., 2003a). Glutamate 
and ROS including NO have been 
hypothesized to play a pivotal role in neuronal 
cell loss (Sawada et al., 1996). The toxic 
mechanism of PQ involves the stimulation of 
glutamate efflux from non-NMDA receptors, 
resulting in activation of NMDA receptor-
channels. The high intracellular influx of Ca2+ 
stimulates NOS. Released NO can diffuse to 
the dopaminergic terminals and further induce 
mitochondrial dysfunction and interaction with 
other ROS, with subsequent formation of 
peroxynitrite, resulting in continuous and long-
lasting dopamine overflow (Shimizu et al., 
2003a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. PQ increases NADPH oxidase expression possibly due to the ROS produced by the PQ redox cycle 
or mitochondria or the activation of NF-κB. Activated microglia releases inflammatory cytokines and 
superoxide radicals, which damage the adjacent neurons. Brain and striatal neurons uptake of PQ is 
supposed to be mediated by the neutral amino acid transport system (NAAT) in a Na+-dependent manner. 
Within the cells, PQ2+ is reduced to PQ.+ by several oxidoreductases. The PQ·+ is then rapidly reoxidized, 
regenerating PQ2+, in the presence of O2, originating superoxide (O2.-). The redox cycle leads to the 
generation of ROS and cellular damage. The other neurotoxicity mechanisms of PQ include mitochondrial 
dysfunction, apoptosis and autophagy, inhibition of the ubiquitin- proteasome system, induction of 
synucleinopathy. 
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2.2 Mitochondrial-derived ROS  
Impairment of mitochondrial dynamics and 
function has emerged as one of the key 
mechanisms underlying the pathogenesis of 
both sporadic and familial PD (Bueler, 2009). 
Schapira and colleagues showed, for the first 
time, that the activity of the mitochondrial 
respiratory complex I (NADH-quinone 
oxidoreductase) is reduced in the substantia 
nigra of PD patients (Schapira et al., 1989). 
The susceptibility of nigral dopaminergic 
neurons to impairments of complex I activity is 
due to the oxidative metabolism of dopamine 
and iron content and, possibly from the low 
mass content of mitochondria in this region, 
compared to other neurons in the midbrain. 
The potential role of mitochondria in PQ-
induced ROS production is controversial but 
ongoing research has revealed that 
mitochondria can be a major source of PQ-
induced ROS production (Castello et al., 
2007; Cocheme and Murphy, 2008). Mice 
deficient in two mitochondrial antioxidant 
enzymes, MnSOD and Gpx are more 
sensitive to PQ than wild type (Van Remmen 
et al., 2004). Mitochondrial expression of 
antioxidant enzymes, such as catalase or 
peroxiredoxin 5, protects against PQ toxicity 
more effectively than cytosolic expression 
(Mockett et al., 2003; Nguyen-nhu and 
Knoops, 2003). Castello and colleagues 
(Castello et al., 2007) claimed that 
mitochondrial respiratory complexes I and III 
both serve as targets for PQ-mediated ROS 
generation, with complex III showing a higher 
sensitivity, while other authors argued that  
complex I is the most likely site for damage 
(Cocheme and Murphy, 2008) (Fig. 2).  
Mitochondrial aconitase (m-aconitase) is 
highly sensitive to O2.-, which causes oxidation 
of the [4Fe-4S]2+, promoting the removal of a 
labile iron that via Haber-Weiss reaction forms 
H2O2 (Cantu et al., 2009). In accordance, 
exposure to PQ was shown to induce m-
aconitase-dependent increase in H2O2, Fe2+ 
and cell death as seen by the attenuation of 
H2O2 production when m-aconitase expression 
was reduced by RNA interference (Cantu et 
al., 2011). 
 
2.3 Inhibition of proteossomal pathways 
and Synucleinopathies/ tauopathies  
Progressive loss of DA neurons of the 
nigrostriatal system and deposition of 
filamentous α-synuclein aggregates are the 
main characteristics of PD (Puschmann et al., 
2012). Indeed, besides the fact that α-
synuclein is a natively unfolded protein that 
plays a central role in the control of synaptic 
membrane processes and biogenesis, when it 
becomes misfolded, it aggregates, and 
accumulates in neuronal inclusion bodies, the 
Lewy bodies (Bellucci et al., 2012). 
Remarkably, several studies indicate that 
multiplications or mutations of the SNCA gene 
are causative of autosomal dominant PD, and 
specific polymorphisms in the promoter region 
of the SNCA gene (REP1) increase the risk to 
develop PD. Other alterations that promote α-
synuclein aggregation include nitration, 
hyperphosphorylation at Ser129, and the 
presence of DA adducts (Valente et al., 2012).  
PQ markedly induced the in vitro 
conformational changes in α-synuclein, and 
accelerated the rate of aggregation of α-
synuclein (Uversky et al., 2002; Uversky et al., 
2001). In vivo experiments have corroborated 
these results, showing that brain levels and 
aggregation of α-synuclein were significantly 
increased in PQ-treated mice, 2 days after 
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each of three weekly PQ injections and with 
protein levels returning to control values by 
day 7 post-treatment (Manning-Bog et al., 
2002). α-Synuclein overexpression induces 
the formation of membrane pore-like 
structures that increase membrane 
conductance (Feng et al., 2010). The same 
authors concluded that leak channel 
conductance occurred prior to substantial cell 
death suggesting that pore formation may 
contribute to the overall cell vulnerability 
(Feng et al., 2010). More recently, Feng and 
colleagues demonstrated that co-treatment 
with PQ and DA in dopaminergic cells 
enhances α-synuclein-induced leak channel 
conductivity leading to a disruption of ionic 
imbalance, and eventually cell death (Feng 
and Maguire-Zeiss, 2011). PQ-treated mice 
striata showed significant accumulation of α-
synuclein and hyperphosphorylation of Tau 
through activation of p-GSK-3β, a major Tau 
kinase (Wills et al., 2012). Notably, the 
specific sites of phosphorylation of Tau serine 
residues in PQ treated mice striata are the 
same sites found in PD post mortem striata 
(Wills et al., 2010). Besides, high levels of 
hyperphosphorylated (p-Tau) is strictly 
dependent on the presence of α-synuclein, as 
indicated by lack of any p-Tau formation in 
MPTP-treated α-synuclein −/− mice or in 
neuronal cells lacking α-synuclein (Duka et 
al., 2009; Duka et al., 2006). PQ, MPP+, and 
rotenone, but not MB, are known to induce 
synucleinopathy and tauopathy (Duka et al., 
2009; Duka et al., 2006; Hoglinger et al., 
2005; Mitra et al., 2011; Wills et al., 2012). 
Ubiquitin- proteasome system and autophagy 
are the two major pathways of degradation of 
misfolded, oxidized, and aggregated proteins. 
In PD, ubiquitin- proteasome system is 
impaired possibly due to depletion of ATP 
levels caused by mitochondrial dysfunction, 
oxidative stress or in cases of familial PD, 
mutations in parkin and UCHL1 genes 
(Valente et al., 2012). Ubiquitin- proteasome 
system dysfunction leads to α-synuclein 
aggregation and the protein itself is capable of 
reducing even more the proteasomal activity 
(Branco et al., 2010). DJ-1deficient mice 
treated with PQ showed impaired proteasome 
activity and increased ubiquitinated protein 
levels. Nevertheless, the authors claimed that 
PQ exposure or deficiency in DJ-1 gene alone 
did not stimulate a decrease in proteasome 
activity. The same study also showed that 
19S ATPase Rpt6 and 20S β5 subunits and a 
transcription factor Nrf2 were decreased in 
DJ-1-deficient mice treated with PQ. On 
opposition, more recent studies have shown 
that administration of PQ (10 mg/kg), twice 
weekly for six weeks, significantly reduced the 
26S proteolytic activity without loss of either 
19S or 20S components or changes in the 
assembly of the 26S proteasome (Wills et al., 
2012). The authors hypothesized that PQ 
seems to interact directly with the 20S 
component of the proteasome. In view of the 
fact that PQ induces overexpression α-
synuclein and p-tau it is expected that 
proteasomal activity is reduced, due in part to 
the direct inhibitory effects of α-synuclein and 
p-Tau (Wills et al., 2012). 
 
2.4 Cell death 
PQ induces selective neurodegeneration in 
dopaminergic neurons in the SNpc triggering 
different mechanisms of cell death. Apoptosis 
induced by PQ has been shown to involve 
mainly the intrinsic mitochondrial pathway (Fei 
et al., 2008), and more recently, some 
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evidences suggest the contribution of 
endoplasmatic reticulum (ER) stress and 
(Niso-Santano et al., 2006) an autophagic 
process in neuronal cell death (Gonzalez-Polo 
et al., 2007b).  
PQ triggers apoptosis via the intrinsic pathway 
by releasing cytochrome c and activation of 
caspase-9 due to the induction of Bcl-2 family 
members such as Bak, Bid, BNip3, and NOXA 
(Fei et al., 2008) (Fig. 2). Authors suggested 
that PQ neurotoxicity is mediated by a Bak-
dependent mechanism by induction of Nox 
and BNip3 binding to Mcl-1 and Bcl-xL, 
respectively. This binding de-represses Bak, 
making it available to create mitochondrial 
outer membrane permeabilization with further 
release of cytochrome c, which will interact 
with Apaf-1 and procaspase-9 to create the 
apoptosome. The fully active apoptosome 
processes and activates executioner caspase-
3 triggering apoptosis (Fei et al., 2008) (Fig. 
2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Mitochondrial dysfunction is a defect occurring early in the pathogenesis of both sporadic and 
familial Parkinson´s Disease (PD). Pesticide-induced dopamine neurons death has been also associated with 
their ability to alter the mitochondrial function. Paraquat (PQ) inhibits mainly the complex I and III, and Maneb 
(MB) and dieldrin inhibit only the complex III of the mitochondrial respiratory chain, generating reactive oxygen 
(ROS) and nitrogen species (RNS), leading to decreased ATP synthesis, oxidation of matrix proteins and 
mitochondrial DNA damage. PQ induces the BH3-only members Noxa and BNip3, and MB induces Noxa and 
Mcl-1. Noxa specifically binds to Mcl-1 and BNip3 binds to Bcl-xL, two major inhibitors of Bak. Binding of Noxa 
to Mcl-1 and BNip3 to Bcl-xL causes disinhibition of Bak. PQ and MB also disinhibit Bim, Blk, leading to 
disinhibition of Bax. The availability of Bak and Bax causes transient membrane disruptions, referred to as 
mitochondrial outer membrane permeabilization (MOMP), leading to the release of cytochrome c. Cytoplasmic 
cytochrome c complexes with Apaf-1 and procaspase-9 to form an apoptosome that activate executioner 
caspases, such as caspase-3, leading to apoptosis. 
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The ER is highly sensitive to oxidative stress, 
Ca2+ disturbances, and hypoxia (Boyce and 
Yuan, 2006). These disturbances cause 
accumulation of unfolded proteins in ER, 
triggering stress responses (Xu et al., 2005). 
Activation of inositol-requiring enzyme 1 
(IRE1), apoptosis signal regulating kinase 
(ASK1), C/EBP homologous protein, and 
stressed-activated kinases lead to the 
activation/induction of pro-apoptotic Bcl-2 
family members, which promotes the crosstalk 
between ER and the mitochondria-triggered 
apoptotic pathway, including release of 
cytochrome c from mitochondria and 
activation of caspase-3 (Paschen and 
Mengesdorf, 2005) (Fig. 3). An increasing 
body of evidence indicates that the stress-
activated kinases, including c-Jun N-terminal 
kinase (JNK) and p38 kinase, play a critical 
role in the PQ-induced degeneration process 
(Choi et al., 2010; Klintworth et al., 2007). 
Sequential phosphorylation of JNK and the 
activation of caspase-3, and p53 transcription 
factors (Yang and Tiffany-Castiglioni, 2008) 
have been reported in animal and in vitro 
models of PD using PQ (Peng et al., 2004) 
(Fig. 3). These first studies demonstrated the 
involvement of p38/JNK signaling, however, 
how oxidative stress activates these pathways 
has not been established in culture or in 
animal models of PD. The current knowledge 
suggests that ASK1 acts upstream of JNK 
and p38 kinases throughout the 
phosphorylation of MKK3/6 and MKK4/7 
(Yang et al., 2009) (Fig.3). Moreover, Niso-
Santano and colleagues investigated the role 
of the transcription factor Nrf2, a master 
regulator of cytoprotective genes, and its 
target thioredoxin (Trx), which binds and 
inhibits ASK1. PQ induced a dose-dependent 
decrease in Trx levels correlated with a major 
increase in phosphorylated ASK1, suggesting 
that Nrf2/Trx is crucial in PQ-induced 
apoptosis (Niso-Santano et al., 2010) (Fig. 3).  
Autophagy is a mechanism involved in the 
degradation of oxidatively damaged proteins 
and in organelle turnover. This phenomenon 
has been observed in neurons from patients 
with various neurodegenerative diseases such 
as Huntington’s disease, AD and PD (Anglade 
et al., 1997; Kegel et al., 2000; Nixon et al., 
2000). However, the implication of autophagy 
in PD and whether environmental xenobiotics 
upregulate or downregulate autophagy is still 
controversial (Janda et al., 2012). The 
accumulation of α-synuclein-rich protein 
inclusions induced by some pesticides 
(rotenone and PQ) suggests that the 
autophagy pathways are rather inhibited than 
promoted. The first in vitro studies reported 
that PQ triggers autophagy, shown by the 
significant increase in LC3II levels, weak 
inhibition of mTOR phosphorylation, and 
increase in LC3-GFP autophagic vesicles 
(Gonzalez-Polo et al., 2007a). The same 
authors claimed that PQ elicits autophagy as 
a defense mechanism to degrade the oxidized 
proteins by ROS since the inhibition of 
autophagy, using 3-MA, accelerated the 
apoptotic death process (Gonzalez-Polo et al., 
2007a). From the six genes linked with 
hereditary PD, α-synuclein, Parkin, PTEN-
induced kinase 1 (PINK-1), and DJ-1 
(Krebiehl et al., 2010) are the genes most 
strongly implicated in autophagy impairment. 
Gonzalez-Polo and colleagues defended that 
autophagy induced by PQ was dependent on 
DJ-1, as its knockdown reversed the 
autophagic response to PQ (Gonzalez-Polo et 
al., 2009). Unlike the in vitro experiments, the 
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only in vivo study suggests an impairment of 
macroautophagy and proteasome function 
upon exposure to PQ (Wills et al., 2012). Both 
MB and PQ increased the levels of mTOR, an 
inhibitor of autophagy, and reduced LC3 II to 
LC3 I ratio, despite increases in autophagic 
proteins, such as beclin 1 and Agt12. In 
parallel, increased mTOR was also observed 
in postmortem human PD striata, and a 
reduction in the LC3 II to LC3 I ratio as well 
(Wills et al., 2012). The controversial data 
raises doubts about the role of PQ in the 
autophagy pathway even though the in vivo 
studies suggest an impairment of 
macroautophagy. Further work will be 
necessary to elucidate the mechanisms 
underlying PQ-related modulation of 
autophagy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. PQ production of ROS through the redox cycling, activation of microglia and astrocytes, inhibition of 
mitochondrial electron transport chain, and/or induction/activation of ROS generating enzymes such as 
NADPH oxidases, mediates the activation of cell death signaling cascades. Oxidative stress triggers the 
induction of endoplasmatic reticulum stress and activation of inositol-requiring enzyme 1 (IRE1), then 
activating the ASK1/JNK signaling cascade. PQ induces a dose-dependent decrease in Trx levels leading to 
an increase in phosphorylated ASK1, suggesting that Nrf2/Trx is crucial in PQ-induced apoptosis. 
Phosphorylation of JNK induces p53 transcription factor that lead to activation/induction of pro-apoptotic Bcl-2 
family members, culminating in apoptosis. Adapted from (Franco et al., 2010). 
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2.5 Crosstalk between experimental and 
human data 
Recently, case-control studies, cohort studies 
and cross-sectional studies were combined in 
two meta-analyses (van der Mark et al., 2012; 
Van Maele-Fabry et al., 2012). Despite not 
being completely consensual, the main 
conclusions reinforce the idea that there is 
evidence of an increased risk of PD 
associated with PQ exposure. The results 
suggested that heterogeneity was rather due 
to differences in the exposure assessment 
than with study design, source of control 
population, adjustment of results for potential 
confounders, or geographical area (van der 
Mark et al., 2012).  
Kamel et al. (Kamel et al., 2007)  analyzed the 
Agricultural Health Study (Alavanja et al., 
1996) data from licensed private pesticide 
applicators and spouses to evaluate the 
relation of self-reported PD to pesticide 
exposure. There was a weak negatively 
association of prevalent PD with ever use of a 
pesticide and with personally mixing or 
applying pesticides and a positively 
association with incident PD. Incident PD was 
associated with the highest category of 
cumulative days of pesticide use at enrollment 
with personally applying pesticides more than 
half the time but not with prevalent PD. 
Considering only chemicals for which there 
were four or more exposed cases, OR´s for 
prevalent PD were elevated (>1.4). Actually, 
frequent use of PQ, the OR´s were 1.8 (95% 
CI 1.0, 3.4) for prevalent PD cases and 1.0 
(95% CI 0.5, 1.9) for incident PD cases 
(Kamel et al., 2007).  
Tanner and colleagues also analyzed the 
Agricultural Health Study data and conducted 
a case-control study focused to assess 
whether pesticides linked to mitochondrial 
dysfunction or oxidative stress, in a population 
with well characterized pesticide exposure, 
are associated with PD or clinical features of 
parkinsonism in humans (Tanner et al., 2011). 
From the eight pesticides classified as 
oxidative stressors, and from the seven 
classified as mitochondrial complex I 
inhibitors, only PQ and rotenone, respectively, 
were associated with PD.  In 110 PD cases 
and 358 controls, use of PQ (OR = 2.5; 95% 
CI, 1.4–4.7 for men and women, and 2.7; 95% 
CI, 1.4-5.1 for men only), and rotenone (OR = 
2.5; 95% CI, 1.3–4.7) were associated with 
PD, but for cumulative lifetime days of use, 
only PQ was positively correlated with 
duration of use (OR=3.6 95% CI, 1.6-8.1 for 
greater than the median). Despite the size of 
the study, wide variability of exposure, quality 
of diagnosis with movement disorders 
experts, and reliability of pesticide exposure 
information, the authors did not distinguish 
prevalent and incident cases, potential bias 
might have occurred during selection, and the 
subgroup analyses were not justified (Mandel 
et al., 2012). Also, the study could not rule out 
the possibility that the results were attributable 
to combined exposures or other agents other 
than those analyzed. 
Even though long-term occupational exposure 
to pesticides might be linked with PD, most of 
the studies have not found a significant 
association with specific pesticides, namely, 
PQ. In a cohort study performed among men 
with high prevalence of parkinsonism and 
daily exposed to pesticides, Engel et al. found 
that the association of PD with PQ was 
negative (prevalence ratio= 0.8; 95% CI 0.5, 
1.3). There was no correlation with duration of 
exposure as for the highest tertile of years of 
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exposure and for highest acre-years of 
exposure the prevalence ratios were < 1 
(Engel et al., 2001). A study conducted in 
Taiwan with 120 patients and 240 controls, 
where the herbicide PQ is commonly sprayed 
over rice fields, reported an OR of 3.22 (95% 
CI, 2.41–4.31) for PD in PQ users compared 
with nonusers, and 6.44 (95% CI, 2.41-17.2 
for the highest duration of use. However, 
subjects were highly exposed to other 
pesticides which difficult the comprehension 
of PQ involvement. (Hertzman et al., 1990) 
compared personal histories of 57 cases and 
122 age-matched controls in British Columbia 
to identify possible environmental 
determinants of PD and reported an increased 
risk of PD for working in orchards (OR = 3.69, 
95% CI = 1.34-10.27) and a marginally 
significant increased risk associated with 
working in planer mills (OR = 4.11, 95% Cl = 
0.91-18.50). Based on Fisher's exact test of 
the association between PD development and 
PQ was statistically significant (p=0.01). In a 
population-based case–control study of 
incident PD in western Washington State, the 
only increased risk estimate was for men 
exposed to parathion, whereas for PQ the 
association was negative (OR=0.9, 95% CI 
0.15- 5.43) (Firestone et al., 2010). These 
findings corroborate the previous study 
carried out by the same authors where there 
was no significantly increased odds ratio from 
exposure to PQ (OR=1.67; 95% CI 0.22- 
12.76) (Firestone et al., 2005). Three studies 
provided information about exposure to 
pesticides and increased risk of incident PD in 
agricultural areas of California (Costello et al., 
2009; Gatto et al., 2009; Wang et al., 2011). 
In all studies, ambient exposure to pesticides 
was estimated from applications to agricultural 
crops employing a validated geographic 
information system (Gatto et al., 2009), 
concluded that, for PQ, the risk from well 
water consumption and ambient exposure 
were generally small and uninformative, which 
might be explained by the observations that 
exposure to PQ may require concomitant MB 
exposure to increase PD risk, as reported by 
Costello et al (see below). The latest study 
from the same group, reported that for 
combined exposure to ziram, MB and PQ, and 
for combined exposure to ziram and PQ there 
was a significantly increased odds ratio but 
exposure to PQ alone (OR = 1.26; 95% CI 
0.86, 1.86) adjusted for age, sex, education, 
smoking, family history of PD and race was no 
significantly increase was observed (Wang et 
al., 2011).  
Concerning the evidences for the role of PQ 
exposure (e.g. during application of this 
herbicide, production or following acute 
poisoning) in the etiology of PD, many 
aspects have to be addressed. Firstly, PQ is 
poorly absorbed through intact human skin 
(0.03 µg/cm2 over 24 h), with only 0.3% of the 
applied dose being absorbed within 24 h 
(Wester et al., 1984). Furthermore, the few 
occupational studies performed have shown 
that even after a dermal exposure of PQ 
during application, urine levels were either 
undetectable (Chester et al., 1993; Van 
Wendel de Joode et al., 1996) or very low, 
with 83.3, 47.1 and 63.9% of the samples 
being below the LOQ before-, during- and 
after-paraquat spray days, respectively (Lee 
et al., 2009). PQ has low volatility and the 
fraction of respirable particles (<5 μm) 
produced by standard spray nozzles is low, 
limiting the absorption by inhalation. 
Assessment of PQ exposure during handling 
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of this herbicide reveals that dermal exposure 
is relatively high and that the degree of 
exposure via inhalation is below the 
permissible exposure limits set by United 
States National Institute of Occupational 
Safety and Health (Baharuddin et al., 2011). 
Moreover, other occupational studies do not 
report the quantification of PQ in biological 
samples and therefore understanding the 
extension of the PQ absorbed through skin 
and air is neglected (Dalvie et al., 
1999;Machado-Neto et al., 1998).  
Secondly, the question of how PQ, a charged 
hydrophilic compound, enters the brain 
remains to be clarified. In rodents, transport 
into brain has been proposed to occur via a 
specific neutral amino acid transporter, 
although it reaches a brain concentration ten 
times lower than in peripheral tissues 
(McCormack and Di Monte, 2003; Shimizu et 
al., 2001). Rappold and colleagues 
demonstrated that, when PQ2+ is reduced to 
the monovalent cation PQ.+ (in the presence of 
either a reducing agent or NADPH oxidase on 
microglia), it is efficiently taken up by cells 
through DAT and organic cation transporter 3 
(Rappold et al., 2011). Other studies, in the 
rhesus monkey and C57BL/6J mice reported 
that PQ uptake and the pattern of PQ 
distribution in the brain is similar across 
species, with higher concentrations being 
found in areas of the brain not fully protected 
by the blood–brain barrier such as the 
olfactory bulb, pineal gland and lateral 
ventricles (Bartlett et al., 2009; Breckenridge 
et al., 2013). It was also reported that PQ is 
slowly eliminated from brain, but whether PQ 
is bound to tissues or organelles within the 
brain, or whether specific neurons or other 
cells selectively retain PQ is unknown 
(Breckenridge et al., 2013). On the other 
hand, in vivo evaluation of the toxicokinetics 
of PQ shows that it accumulates in a linearly 
way, with a half-life of approximately one 
month in adult C57BL/6J mice after a single 
dose (10 mg/kg) resulting in accumulation of 
similar levels of PQ in the different regions of 
brain (striatum, frontal cortex, hippocampus, 
and cerebellum) (Prasad et al., 2009; Prasad 
et al., 2007). Even when a low concentration 
of PQ (0.3 mg/ml) was given orally in drinking 
water, the brain concentration was ∼0.12 
ng/mg after 8 weeks of exposure (Prasad et 
al., 2009). However, neither of the studies 
quantified the urine and plasma levels, which 
hinder a possible correlation between the 
experimental data, the human exposure levels 
and epidemiological data.  
Despite the literature evidences of the ability 
of PQ to reproduce some of the features of 
PD in mice models, the results should be 
interpreted carefully. Breckenridge and 
colleagues (Breckenridge et al., 2013) 
conducted a thorough experiment to evaluate 
the potential effects of PQ in the SNpc and 
striatum of male C57BL/6J mice. The scheme 
of treatment was similar to previous reported 
experiments (McCormack et al., 2005; 
McCormack et al., 2006; McCormack et al., 
2002; Richardson et al., 2005) whereas PQ 
dose was 10 mg/kg i.p once per week for 
three consecutive weeks. Unlike others, their 
main finding is that under their conditions, 
there was minimal evidence of PQ-related 
neuronal degeneration without alteration of 
the concentration of dopamine (DA), 
homovanillic acid (HVA) or 3,4-
dihydroxyphenylacetic acid (DOPAC), or 
increase DA turnover in the striatum. 
However, it should be noted that among the 
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published animal studies on PQ neurotoxicity 
there is a lack of consistency in dose, species 
or strain, age of animals and timing of 
treatment. The doses fluctuate between 5-25 
mg/kg, the frequency of dose ranges from 1-2 
times per week, the length of the study from 
1-4 weeks. The majority of the studies with 
PQ and PD use as model the C57BL/6 or 
C57BL/6J  mice but other studies have also 
use the swiss albino mice (Mitra et al., 2011) 
and the rats strain Sprague-Dawley or Wistar 
(Czerniczyniec et al., 2011; Songin et al., 
2011). Breckenridge and colleagues 
(Breckenridge et al., 2013) tested one type of 
inbred mouse strain that is considered the 
most susceptible to PQ neurotoxicity, the 
C57BL/6J mice, at 2 months of age. The 
difference between studies might also be 
linked with the age of the animals. Peng and 
colleagues suggested that age contributes to 
the greater susceptibility to PQ due to the 
age-related iron accumulation in the 
substantia nigra (Peng et al., 2010; Peng et 
al., 2007; Peng et al., 2009). Other recent 
studies also report significant PQ-induced TH 
staining loss in SNpc in 4–6 month old 
C57BL/6J mice (Jiao et al., 2012; Yin et al., 
2011).  
 
3. MB and PQ + MB 
In rodent models, MB was shown to alter 
behavioral function, reduce locomotor activity 
and increase aggressiveness (Morato et al., 
1989). Direct injection of MB to the rat lateral 
ventricles resulted in selective dopaminergic 
neurodegeneration, induced extensive striatal 
DA efflux, and preferentially inhibited 
mitochondrial complex III (Zhang et al., 2003). 
Barlow and colleagues also reported that MB 
and other dithiocarbamates were able to 
increase synaptosomal DA accumulation in 
vitro at concentrations as low as 500 nM, 
possibly by delaying DA efflux (Barlow et al., 
2003). Furthermore, MB was shown to 
increase the tissue content of [14C]PQ in vivo 
by a mechanism that appeared to be distinct 
from the DA transporter (DAT), suggesting 
that dithiocarbamates might augment other 
xenobiotics neurotoxicity by modulating their 
toxicokinetics (Barlow et al., 2003). 
MB has been shown to exacerbate the pro-
oxidant condition through its ability to disrupt 
the glutathione antioxidant system in 
dopaminergic neurons (Barlow et al., 2005), to 
catalyze the auto-oxidation of DA (Fitsanakis 
et al., 2002), and to disturb the mitochondrial 
function, as an inhibitory uncoupler of the 
electron transport chain (Domico et al., 2006). 
Additionally, exposure of dopaminergic cells 
to 6 µM Mn-EBDC for 7 days produced not 
only significant neurotoxicity but also 
decreased proteasomal function, and led to α-
synuclein aggregation with formation of 
cytoplasmic inclusions that were 
immunoreactive for α-synuclein (Zhou et al., 
2004). Despite in vitro inhibition of 
proteasomal activity and induction of α-
synuclein aggregation, MB effects in vivo are 
somewhat different. MB was ineffective in 
increasing α-synuclein or p-Tau levels. When 
PQ and MB were concomitantly administered, 
the effects were similar to when PQ was 
administered alone (increased α-synuclein 
aggregation and p-Tau levels), which 
suggests that MB does not enhance the 
effects of PQ (Wills et al., 2012). Moreover, 
unlike PQ, MB did not directly inhibit soluble 
proteasomal activity, nor did it intensify the 
direct inhibitory effect of PQ on this activity. In 
the same study, MB increased levels of the 
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autophagy inhibitor mammalian target of 
rapamycin, mTOR, suggesting impaired 
axonal autophagy, despite increases in 
certain autophagic proteins, such as beclin 1 
and Agt12 (Wills et al., 2012). 
Due to the fact that MB and PQ are used in 
geographically overlapping areas, and rural 
workers exposed to both pesticides have an 
increased risk of developing PD by 75% 
(Costello et al., 2009), several authors used 
PQ+MB as a PD model (Thiruchelvam et al., 
2000a; Thiruchelvam et al., 2000b). C57BL/6 
mice exposed to PQ (10 mg/kg) and MB (30 
mg/kg), i.p., once a week for 4 weeks, showed 
reduced locomotor activity, significant DA fiber 
loss, and altered levels of DA and its 
metabolites, 3,4-dihydroxyphenylacetic acid 
(DOPAC) and homovanillic 
acid (Thiruchelvam et al., 2000a). These 
effects were preferentially expressed in the 
nigrostriatal dopaminergic system 
(Thiruchelvam et al., 2000b). Fei and Ehtell, 
found that MB potentiates PQ neurotoxicity by 
triggering Bax-dependent cell death through 
activation of three strong Bak inhibitors, Bfl-1, 
Bcl-xL and Mcl-1, and also induced Bax 
activators that included Bik and Bim (Fei and 
Ethell, 2008).  
Idiopathic PD is typically considered an aging-
related neurodegenerative disorder, but its 
onset is still unclear, whether it could arise 
from events that occur during premature 
development, during adult life or from lifetime 
cumulative effects. Mice exposed 
developmentally to PQ+MB showed reduced 
levels of dopaminergic neurons (38% loss) in 
adulthood, while re-exposure of mice to the 
mixture of pesticides lead to a 70% loss of 
dopaminergic neurons in the substantia nigra 
and a concomitant decrease in locomotor 
activity (Thiruchelvam et al., 2002). 
Developmental exposure to PQ or MB alone 
produced minimal changes. Conversely, the 
response to a second stimulus in adult life 
was exaggerated, suggesting that there is a 
period of silent neurotoxicity that predisposes 
adult animals to the toxicity of a re-exposure. 
Moreover, subsequent studies have shown 
that ageing enhances sensitivity of 
nigrostriatal pathway to the combined 
exposure of PQ+MB (Thiruchelvam et al., 
2003). Reduced levels of locomotor activity 
24h and even 3 months after treatment were 
age-related, since 5 and 18 months old mice 
did not recover, whereas 6 week old mice 
exhibited total recovery. Also, levels of striatal 
DA and dopaminergic neurons in the 
substantia nigra, particularly for PQ+MB 
treatment in both 5 and 18 month old mice 
were decreased and unchanged 3 months 
after the final exposure (Thiruchelvam et al., 
2003). 
 
4. Dieldrin  
Dieldrin, an organochlorine, is one of the most 
environmentally persistent insecticides. 
Despite having been banned in the 1970s in 
most of the developed countries, its low 
volatility, and high lipophilic properties lead to 
an extensively bioaccumulation and 
biomagnification in non-target species and 
soil. Nowadays, humans continue to be 
chronically exposed to dieldrin through 
contaminated food, polluted ground water, 
and environmental residues (Jorgenson, 
2001).  
Post mortem studies indicate that exposure to 
dieldrin is closely associated with PD, since 
dieldrin levels in the caudate nucleus from PD 
patients were significantly higher than those in 
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control brains (Corrigan et al., 1996; Corrigan 
et al., 1998; Corrigan et al., 2000). Also, 
previous studies revealed that dieldrin was 
detected in 6 of 20 PD brains, and in none of 
14 control samples with a highly significant 
positive association between the insecticide 
and the diagnosis of PD (Fleming et al., 
1994). 
In vitro, dieldrin appears to be a relatively 
selective dopaminergic neurotoxin in 
mesencephalic cultures, indicated by the low 
neurotoxicity to GABA-ergic neurons 
compared to dopaminergic neurons 
(Sanchez-Ramos et al., 1998). Moreover, in 
rat and mice dopaminergic cell lines, dieldrin 
yields a depletion of intracellular DA levels, a 
decrease of DA metabolites, including 3,4-
dihydroxyphenylacetic acid and homovanillic 
acid (Hatcher et al., 2007), a depolarization of 
mitochondrial membrane potential, generation 
of ROS (Chun et al., 2001), and apoptosis 
(Kitazawa et al., 2001) (Fig. 4). Dieldrin also 
activates brain microglia, inducing NADPH-
dependent ROS production (Mao et al., 2007). 
A mechanism underlying dieldrin-induced 
apoptosis has been recently proposed. 
Kitazawa and co-workers reported that PC12 
cells exposed to dieldrin release cytochrome 
c, which is followed by the activation of the 
caspases cascade and caspase-3-dependent 
proteolytic activation of PKC δ (Kanthasamy 
et al., 2008; Kitazawa et al., 2003) (Fig. 4). In 
accordance, dieldrin-induced Poly (ADP-
ribose) polymerase cleavage, chromatin 
condensation and DNA fragmentation, and 
caspase-3 activation were completely blocked 
in Bcl-2-overexpressed PC12 cells as 
compared to control cells. These findings 
suggest that dieldrin primarily alters 
mitochondrial function to initiate apoptotic cell 
death, since overexpression of the anti-
apoptotic protein Bcl-2 prevents these events 
(Kitazawa et al., 2004). In mesencephalic 
dopaminergic neurons, dieldrin can rapidly 
induce the hyperacetylation of histones, 
specifically histones H3 and H4. The histone 
hyperacetylation in the striatum and 
substantia nigra was also observed in mice 
exposed to dieldrin (5.0 mg/kg) for 30 days 
(Fig. 4). The authors also found that the 
protein level of CBP, a well-known histone 
acetyltransferase, was increased in a time-
dependent manner. This fact might be due to 
dieldrin-induced proteasomal dysfunction, 
resulting in accumulation of pivotal histone 
acetyltransferase. The inhibition of CBP 
attenuated dieldrin-induced histone 
acetylation, caspase-3 activation, and PKC δ 
proteolytic activation, and DNA fragmentation 
in dopaminergic neurons (Song et al., 2010 
287). 
Dieldrin has been shown to induce a 
conformational change in α-synuclein and 
promote fibrillization of α-synuclein (Uversky 
et al., 2001) (Fig. 4). The overexpression of α-
synuclein has been reported to inhibit 
proteasomal function (Snyder et al., 2003). 
For that reason, Sun and colleagues exposed 
α-synuclein overexpressing dopaminergic 
neurons to dieldrin (Sun et al., 2005). Their 
results showed that dieldrin impairs ubiquitin 
proteasome function additively with α-
synuclein, and enhances the susceptibility of 
dopaminergic neurons to apoptotic cell death. 
Together, the results suggest that 
combination of α-synuclein overexpression 
due to genetic mutations or exposure to 
environmental pesticides that also increase α-
synuclein levels, are likely to contribute to the 
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overall vulnerability of dopaminergic neurons 
(Sun et al., 2005). 
As mentioned above, exposure to pesticides 
during the perinatal period or early age may 
result in either permanent damage, 
progressive lesions of the nigrostriatal 
dopaminergic system or enhanced adult 
vulnerability to a future neurotoxicant 
challenges. Perinatal exposure of mice to low 
levels of dieldrin (0.3, 1, or 3 mg/kg every 3 
days) resulted in a long-term enhancement of 
protein and mRNA levels of the DAT and 
vesicular monoamine transporter 2 (VMAT2) 
(Richardson et al., 2006). The increase 
DAT:VMAT ratio appears to be correlated with 
higher susceptibility of dopamine neurons to 
degeneration in PD (Miller et al., 1999). 
Indeed, when dieldrin-exposed mice were 
challenged with MPTP (2×10 mg/Kg s.c) at 12 
week of age, the neurotoxicity was 
exacerbated as shown by the increase of α-
synuclein levels and a greater reduction of 
striatal DA, which was associated with a 
greater DAT:VMAT2 ratio.  
Although dieldrin shows many features of PD 
including the ability to induce mitochondrial 
dysfunction, oxidative stress and apoptosis, 
induction of α-synuclein aggregation, and DA 
depletion, it fails to provoke motor deficits and 
dopaminergic neuron loss. Other issues are 
the lack of more extensive studies that 
associate dieldrin exposure with PD, the high 
concentrations used in in vitro and in vivo 
studies and whether induction of oxidative 
stress is a primary or secondary event in this 
pesticide-induced neurotoxicity. 
 
5. Pyrethroids 
Pyrethroids are a class of synthetic 
insecticides derived from the naturally 
occurring pyrethrins isolated from the 
Chrysanthemum genus of plants (Ray and 
Fry, 2006). Pyrethroids are divided into two 
classes of compounds based on their toxic 
signs and structure:  
a) Type I or T (tremor) syndrome (i.e. 
permethrin, allethrin, cimethrin, bifenthrin, 
bioallethrin) - are devoid of a cyano moiety at 
the α-position (α-cyano), produce aggressive 
behavior, fine tremor progressing to whole-
body tremor and prostration;  
b) Type II or choreoathetosis 
syndrome (CS) (i.e. deltamethrin, 
cypermethrin, fenvalerate, cyfluthrin) - 
possess a α-cyano moiety, produce 
hypersensitivity, coarse tremor, clonic seizure 
and profuse salivation (Nasuti et al., 2003) 
(Table 1).  
The main target of pyrethroids-induced 
neurotoxicity is voltage-gated sodium 
channels. These insecticides slow the 
activation or opening of the channels, shifting 
the voltage dependence of the gates to more 
hyperpolarized potentials (Clark and 
Symington, 2012). Therefore, the channel is 
held open for longer periods, allowing more 
sodium ions to cross, maintaining a sustained 
membrane depolarization. Pyrethroids also 
decrease the opening probability of voltage-
gated chloride channels which amplify the 
sodium channel-mediated signs of 
intoxication. At relatively high concentrations, 
deltamethrin and cypermethrin inhibit GABA-
gated chloride channels and, as with voltage-
gated chloride channels, these effects are 
specific of type II pyrethroids (Ray and Fry, 
2006). These mechanisms are responsible for 
the observed hyperexcitability of peripheral 
sites (type I) or central nervous system (type 
II) in acute poisonings (Table 1).  
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Figure 4. Dieldrin and other cyclodienes are lipophilic compounds and are therefore capable of readily cross 
the blood brain barrier. Several in vitro and in vivo studies have shown that dieldrin reproduces many features 
of Parkinson´s Disease (PD). Dieldrin-induced release cytochrome c is followed by the activation of the 
caspases cascade and caspase-3-dependent proteolytic activation of protein kinase delta (PKC δ). Dieldrin 
has the ability to induce mitochondrial dysfunction, oxidative stress, oxidation of DNA, RNA, lipids and 
proteins. The dysfunction of the ubiquitin proteasome system (UPS) and reduced protein degradation is also 
responsible for dieldrin´s induction of hyperacetylation of histone, probably due to the accumulation of pivotal 
histone acetyltransferases. Dieldrin induces α-synuclein aggregation. Together, UPS dysfunction and α-
synuclein accumulation enhances the susceptibility of dopaminergic neurons to apoptotic cell death. 
 
 
Currently, the major concerns of exposure to 
pyrethroids are developmental neurotoxicity 
and nigrostriatal dopaminergic 
neurodegeneration (Shafer et al., 2005; Singh 
et al., 2012a) (Table 2). Rat pups exposed to 
deltamethrin 0.7 mg/kg/day over postnatal 
days 9-13, resulted in a delayed appearance 
of radial glial fibers, which guide the migration 
of granule cells of cerebellum (Patro and 
Patro, 2005). The same group, years later, 
showed that deltamethrin at the same dose 
regimen and postnatal period, induced the up-
regulation of S100β, a biomarker of brain 
damage, reduced dendritic arbor with short 
primary dendrites of purkinje neurons and  
much reduced stumpy and hypertrophied 
dendritic branches (Patro et al., 2009). 
However, the effect of these insecticides in 
muscarinic receptors, disruption of voltage-
dependent sodium channels and other cellular 
targets, are poorly correlated with the adverse 
outcomes in adulthood (Ray and Fry, 2006; 
Shafer et al., 2005). 
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Low dose of permethrin (0.8-1.5 mg/kg) given 
to C57 B1/6 mice caused a 33% increase in 
DA uptake (Karen et al., 2001), similarly with 
another studies (Bloomquist et al., 2002; 
Pittman et al., 2003), and a significant 
increase of DAT protein levels 28 days post 
treatment (Gillette and Bloomquist, 2003). 
Unlike DAT, the up-regulation of α-synuclein 
protein was maximal one day post-treatment 
and returned to normal levels by the 14- and 
28-day (Gillette and Bloomquist, 2003). 
 
 
Table 1. Summary of the structural and biological differences between class I and II of pyrethroids. 
Pyrethroids 
Type I 
Devoided of a cyano moiety at the α-position, 
produce aggressive behavior, fine tremor 
progressing to whole-body tremor and 
prostration  
(i.e. permethrin, allethrin, cimethrin, bifenthrin, 
bioallethrin) 
Type II 
Possess a α-cyano moiety, produce 
hypersensitivity, coarse tremor, clonic seizure 
and profuse salivation 
(i.e. deltamethrin, cypermethrin, fenvalerate, 
cyfluthrin) 
Mechanisms of Neurotoxicity 
 
Voltage-gated sodium 
channels 
 
Voltage-gated chloride 
channels 
 
GABA-gated chloride 
channels 
 
Slower activation or 
opening of the channels, 
shifting the voltage 
dependence of the gates to 
more hyperpolarized 
potentials. 
Type I and Type II 
Decreased opening probability of 
the channels which amplify the 
sodium channel-mediated signs of 
intoxication. 
Only Type II pyrethroids 
Inhibition of GABA-gated 
chloride channels. 
Only Type II pyrethroids 
 
 
 
Kou and colleagues showed that 3-month 
exposure to permethrin (1.5 mg/kg, once a 
week) had no effect on the expression of TH 
and DAT protein in striatal dopaminergic 
terminals, while exposure for longer period (6 
months) to either 0.8 mg/kg or 1.5 mg/kg up-
regulated TH expression, but did not alter the 
expression of DAT (Kou and Bloomquist, 
2007). Concomitant treatment of permethrin 
(0.8 mg/kg or 1.5 mg/Kg) with MPTP (20 
mg/Kg) for 3 or 6 months did not augment the 
neurotoxicity of MPTP on the striatal 
dopaminergic system (Kou and Bloomquist, 
2007). Despite some changes were observed 
across the studies, there is lack of 
neurodegeneration of dopaminergic neurons 
after long-term, low-dose exposure to 
permethrin alone. 
Deltamethrin is a type II pyrethroid insecticide, 
for which the main target is the central 
nervous system as the compound has little or 
no peripheral effects common to other 
pyrethroids. Deltamethrin induces apoptotic 
cell death in cultured cerebral cortical neurons 
(Wu et al., 2003), affects different neuronal 
subtypes in hippocampus, and interferes with 
cholinergic and dopaminergic 
neurotransmission mechanisms in different 
model (Wu and Liu, 2000). Lazarini and 
colleagues reported that deltamethrin 
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increases DOPAC levels without changes in 
DA levels in the adult striatum after prenatal 
exposure of dams to a non-toxic deltamethrin 
dose. During their adult life, male rats showed 
a decreased immobility latency to float and in 
general activity after the swimming test 
(Lazarini et al., 2001). Dermal exposure to 
deltamethrin (30 mg/kg/day, 4 weeks) using 
an administration schedule mimicking a 
possible long-lasting occupational skin 
contamination is accompanied by 
cerebrocortical injury and loss of hippocampal 
and striatal DA and DA transporter (Tayebati 
et al., 2009). 
Cypermethrin has been the pyrethroid that 
has raised more concerns regarding the 
increase  
of risk of developing PD. Singh and 
colleagues conducted several studies that 
highlighted the nigrostriatal dopaminergic 
neurotoxicity of this pesticide (Singh et al., 
2011a; Singh et al., 2012a; Singh et al., 
2012b; Singh et al., 2011b). Their main 
findings show that cypermethrin induces 
neurodegeneration only after long-term 
exposure (12 weeks) in adult rats and that 
postnatal pre-exposure enhances the 
susceptibility, when rechallenged during 
adulthood (Singh et al., 2012b).  Cypermethrin 
induced-reduction of DA levels, impairment in 
motor activities and loss of TH+ cells are 
microglial activation-dependent (Singh et al., 
2011a). Besides microglial activation, other 
mechanisms of cypermethrin-mediated 
neurotoxicity have been proposed such as 
generation of ROS, modulation of antioxidant 
enzymes and CYP2E1 (Giray et al., 2001; 
Tiwari et al., 2010) (Table 2). 
 
 
6. Organophosphates and carbamates 
OP are a group of acetylcholinesterase 
(AChE) inhibitors and represent the largest 
group of insecticides sold worldwide. Acute 
OP poisonings leads to the development of 
three main syndromes: i) acute cholinergic 
crisis; ii) intermediate syndrome (IMS), and iii) 
OP-induced delayed polyneuropathy (OPIDP) 
(Moretto, 1998). Both IMS and OPIDP result 
of an acute exposure to OP, usually after a 
suicide attempt or accidental ingestion. The 
acute cholinergic crisis results from the 
inhibition of AChE leading to overstimulation 
of nicotinic and muscarinic receptors in the 
central and peripheral nervous systems and 
the consequent signs and symptoms (Lotti, 
2001).  
IMS is considered a spectrum disorder of the 
neuromuscular junction that occurs 24–96 h 
after ingestion of an OP in conscious patients 
who received treatment for the acute 
cholinergic syndrome. Respiratory failure 
associated with IMS is a major contributor to 
the high morbidity, mortality, and cost of OP 
poisoning (Abdollahi and Karami-Mohajeri, 
2012). The pathophysiology of IMS remains 
poorly understood although several possible 
causes such as delayed AChE inhibition, 
muscle necrosis, down regulation or 
desensitization of postsynaptic acetylcholine 
receptors, failure of postsynaptic acetylcholine 
release, and oxidative stress-related 
myopathy have been considered to be 
involved in IMS (Jayawardane et al., 2008; 
Jayawardane et al., 2009; Yang and Deng, 
2007). The toxicokinetics and chemical 
properties of certain OP critically contribute to 
the higher probability to develop IMS. For 
instance, more lipophilic OP are well 
distributed into fat, leading to a delayed and 
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prolonged AChE inhibition. Other factors 
reflect the detoxification of OP such as 
polymorphisms in cytochrome P450-
paraoxonase 1 (PON1), glutathione S-
transferases, and cytochromes P450 
(Androutsopoulos et al., 2011; Furlong, 2000; 
La Du et al., 2001; Xiao et al., 2003). 
OPIDP is a relatively rare sensory-motor distal 
axonopathy in humans characterized by 
degeneration of long axons in the central and 
peripheral nervous system that appears about 
2–3 weeks after exposure or later [reviewed 
by (Jokanovic et al., 2011)]. The irreversible 
inhibition of neuropathy target esterase (NTE) 
is thought to be the main mechanism involved 
in the pathogenesis of OPIDP (Lotti and 
Moretto, 2005).   
 
 
Table 2. Referenced studies in developmental neurotoxicity of pyrethroids. 
Model Compound/ Dose Major Findings References 
Rat pups PND 0–7 and 
9–13 
 
Deltamethrin 0.7 
mg/kg/day, i.p. 
 
 
Up-regulation of S100β. 
Reduced dendritic arbor 
with short primary 
dendrites of purkinje 
neurons. 
(Patro et al., 2009) 
Rat pups PND 5-19 Cypermethrin 1.5 mg/kg, 
2x week (2 weeks); 
rechallenged in 
adulthood 15 mg/kg (2x 
week,4,8,12 weeks) i.p 
Neurodegeneration only 
after 12 weeks in adult 
rats. Postnatal 
preexposure enhances 
the susceptibility, when 
rechallenged during 
adulthood 
(Singh et al., 2012b) 
Rat pups PND 5-19 Cypermethrin 1.5 mg/kg, 
2x week (2 weeks); 
rechallenged in 
adulthood 15 mg/kg (2x 
week,4,8,12 weeks) i.p 
Reduction of DA levels, 
motor dysfunction and 
loss of TH+ cells-
microglial activation 
dependent 
(Singh et al., 2011a) 
Rat pups PND 5-19 Cypermethrin 1.5 mg/kg, 
2x week (2 weeks); 
rechallenged in 
adulthood 15 mg/kg (2x 
week,,4,8,12 weeks) i.p 
ROS generation, lipid 
peroxidation and 
modulation of VMAT 2, 
CYP2E1, GSTA4-4 
expressions 
(Tiwari et al., 2010) 
Pregnant rats GD 6-15 Deltamethrin 0.08 mg/kg, 
p.o., once daily 
PND 21: no differences 
in locomotion frequency 
and immobility duration 
of male and female; 
increased male rearing 
frequency. 
PND60 males: 
decreased immobility 
latency to float; 
increased DOPAC, 
DOPAC/DA 
(Lazarini et al., 2001) 
CYP2E1: cytochrome P450 isoform 2E1; DA: dopamine; DOPAC: 3,4-dihydroxyphenylacetic acid; GSTA4-4: 
glutathione-S-transferase; PND: postnatal days; ROS: reactiv oxygen species; TH+: tyrosine hydroxylase 
positive; VMAT 2: vesicular monoamine transporter 2. 
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At least 70% of peripheral nerves NTE must 
be inhibited and subsequently aged to cause 
the instigation of OPIDP (Johnson, 1990). The 
irreversible phosphorylation of NTE induces a 
toxic gain of function by leading to calcium 
entry, elevation of axonal calpain activity and 
Wallerian-type degeneration (Glynn, 2000).  
Carbamates also act by carbamylating the 
same site on AChE and NTE, which reversibly 
inhibits these enzymes activity. Carbamates 
include insecticides and drugs, such as 
pyridostigmine and disulfiram. Several clinical 
cases of polyneuropathy associated with 
exposure to high levels of carbamates have 
been reported (Lotti and Moretto, 2006). In 
three cases, intoxication with 
methylcarbamates resulted in a clinical and 
electrophysiological evaluation consistent with 
peripheral polyneuropathy with distal 
axonopathy similar to that of OPIDP (Dickoff 
et al., 1987; Umehara et al., 1991; Yang et al., 
2000). More recently, Hu and colleagues 
reported a case of self- poisoning with a 
mixture of methomyl–alphamethrin that 
resulted in cortical blindness and delayed 
neuropathy (Hu et al., 2010).  
Despite the toxic cholinergic effects of OP, 
there is now substantial evidence that non-
cholinergic mechanisms might be associated 
with the adverse consequences from repeated 
exposures to low levels of certain OP, such as 
impairments in attention, memory, and other 
domains of cognition, as well as chronic 
illnesses where these symptoms are 
manifested (e.g., Gulf War Illness, AD) (see 
reviews, (Androutsopoulos et al., 2013; Terry, 
2012)). Chronic low-level exposure to the OP 
dichlorvos, in adult rats, triggered neuronal 
apoptosis, elicited an oxidative stress and 
inflammatory response with impaired 
mitochondrial complexes I, III and IV activities 
(Kaur et al., 2007). Binukumar and colleagues 
also showed that dichlorvos caused 
nigrostriatal dopaminergic degeneration, 
reduction in striatal DA and tyrosine 
hydroxylase levels and positive inclusions for 
α-synuclein and ubiquitin, resembling the PD 
features (Binukumar et al., 2010). Others 
suggested that OP, at doses that were not 
associated with acute signs of toxicity, can 
lead to deficits in axonal transport, 
mitochondrial dynamics (Middlemore-Risher 
et al., 2011; Terry et al., 2007; Terry et al., 
2003) similar to what has been proposed to 
be involved in the pathogenesis of ALS and 
AD (Reddy et al., 2012; Shi et al., 2010; 
Stokin and Goldstein, 2006). Cdk5-dependent 
hyper-phosphorylation of tau has been 
considered a biomarker for AD pathology 
(Maccioni et al., 2001). Chlorpyriphos induced 
the dysregulation of the D1 
receptor/cAMP/PKA signaling pathway, 
potentiation of corticostriatal glutamatergic 
transmission, hyperphosphorylation of tau, 
and induction of aberrant activity of the 
neuronal protein kinase Cdk5 (Torres-Altoro 
et al., 2011). As mentioned above, the 
toxicokinetics of OP significantly contribute to 
their toxicity. PON1 is an A-esterase which 
detoxifies several organophosphate-oxons 
that result from phase-I metabolism of OP 
such as diazinon, parathion and chlorpyriphos 
(Costa et al., 2003). There are two main 
polymorphisms in PON1, one that affects the 
catalytic site of the enzyme, PON1 192Q/R 
polymorphism and other, PON1 55L/M 
polymorphism that is associated with low 
serum concentration of the enzyme. 
Importantly, PON1 genotypes might be 
associated with PD, AD and ALS 
CHAPTER II 
 
60 
(Androutsopoulos et al., 2011; Dardiotis et al., 
2013). Carriers of PON1-L55M allele, variant 
MM genotype and homozygotes for 192R 
allele possess an increased risk in developing 
PD (Akhmedova et al., 2001; Manthripragada 
et al., 2010). However, the data is 
controversial and several studies have not 
found an association between PON1 
genotypes and PD (Akhmedova et al., 1999; 
Wingo et al., 2012). The studies focused in 
the study of the role of PON1 genotypes in AD 
prevalence have also found positive and 
negative associations (Androutsopoulos et al., 
2011). In a large population of 730 Caucasian 
and 467 African American AD cases, the 
authors found a significant association with 
PON1 S161C/T polymorphism (Erlich et al., 
2006). More recently, the groups of Leduc and 
Erlich have corroborated these results, 
showing that low levels of PON1 protein, 
lesser catalytic activity towards paraoxon, and 
presence of the methionine allele of the 55L/M 
polymorphism are risk factors for AD (Erlich et 
al., 2012; Leduc et al., 2009). Morahan and 
colleagues, found that PON1 promoter 
polymorphisms were strongly associated with 
ALS by reducing PON1 expression and 
possibly modulating the susceptibility of motor 
neurons to OP (Morahan et al., 2007). As for 
the other neurodegenerative diseases, 
despite the epidemiological results 
demonstrating the association of PON1 and 
ALS, it is still controversial whether 
paraoxonases are implicated in this disease 
pathogenesis (Androutsopoulos et al., 2011). 
The main concern regarding the neurotoxicity 
of OP is related to neurobehavioral changes 
after long-term exposure to low doses of OP.  
Recently, Starks and colleagues conducted a 
study to assess neurobehavioral function in 
licensed pesticide applicators enrolled in the 
Agricultural Health Study in Iowa and North 
Carolina (Starks et al., 2012). The study 
included 701 male participants and 
quantitative measures of nine neurobehavioral 
tests to assess memory, motor speed and 
coordination, sustained attention, verbal 
learning and visual scanning and processing. 
Frequent use of at least one OP pesticide was 
negatively associated with performance on 
three of nine neurobehavioral tests and with 
significantly better performance on six of nine 
tests. Only malathion was significantly 
associated with reduced performance on a 
test of visual scanning and processing (Starks 
et al., 2012). The inconsistency of association 
between long-term low or moderate exposure 
to OP and impaired neurobehavioral function 
or other neurological effects is seen across 
several other epidemiological studies (Colosio 
et al., 2009; Farahat et al., 2003; Kamel and 
Hoppin, 2004a). The main limitations of the 
available data are the reduced number of 
neurobehavioral function tests used per study, 
and the fact that several studies include cases 
of a previous acute poisoning to high levels of 
OP (Roldan-Tapia et al., 2006). Therefore, the 
observed neurological alterations could be 
due to an unspecific brain injury, resulting 
from ischemia/hypoxia, or post-traumatic 
stress disorder. 
Colosio and colleagues reviewed 24 papers 
published on human neurobehavioral effects 
of OP and/or carbamates, and found that only 
6 papers considered the whole spectrum of 
functions, the studies yielding positive or 
uncertain results being 13 for cognitive 
function, 11 for psychomotor function, 11 for 
sensory-motor function, and 11 for 
psychological function impairment. In 46% of 
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the positive studies a previous severe acute 
poisoning was reported (Colosio et al., 2009). 
Another limitation of the studies is the 
absence of qualitative and quantitative 
measurement of OP, correlation to AChE 
activity and neurobehavioral function. Few 
studies have evaluated these aspects and 
found positive correlation (Rasoul et al., 2008; 
Rothlein et al., 2006). In other studies, 
confounding factors such as exposure to 
different OP and other pesticides, laboratory 
methodology, and size of the population, 
might have led to the poor validity of the 
cause-effect relationship of OP exposure to 
the neurobehavioral effects, despite the 
consistency in the neurobehavioral findings 
(Rohlman et al., 2011).  Even experimental 
studies in animal models fail to reproduce low 
dose, long-term exposures to OP. In general, 
the doses used are sufficiently high to exert 
signs of acute toxicity and exposure is no 
longer than 1-3 months. Additionally, 
neurobehavioral adverse effects only appear 
when AChE is inhibited (Moser, 2007).  
Over the past decade, a growing body of 
epidemiological and experimental evidence 
suggests that the oxon metabolites of 
phosphorothionates insecticides, especially 
chlorpyriphos (CP) and diazinon, are 
responsible for the neurodevelopmental 
toxicity of OP (Bouchard et al., 2011; Flaskos 
et al., 2007; Flaskos and Sachana, 2010; 
Rohlman and McCauley, 2010) (Table 3). In 
different type of primary neuronal or culture 
cells, CP affected the expression of activated 
of Ca2+/cAMP response element binding 
protein (CREB), a transcription factor involved 
in brain development, and impaired neurite 
outgrowth, an in vitro index of neuronal 
differentiation (Flaskos et al., 2011; Schuh et 
al., 2002). CP also decreased the activity of 
choline acetyltransferase, glutamate 
decarboxylase, glutamine synthase and cyclic 
nucleotide phosphohydrolase, biomarkers of 
neuronal cells, astrocytes and 
oligodendrocytes, respectively (Monnet-
Tschudi et al., 2000). Flaskos and colleagues 
reviewed several studies revealing that CP 
and diazinon oxons´s deleterious effects on 
neuritogenesis are not etiologically related to 
the inhibition of the enzymatic activity of AChE 
(Flaskos, 2012). In fact, besides the AChE 
classical role in synaptic transmission, it also 
has other ‘non-classical’ effects such as cell 
adhesion, shown by the detection of a new 
class of proteins, the cholinesterase-like 
adhesion molecules (Paraoanu and Layer, 
2008). These adhesion properties are 
intimately involved in AChE promotion of 
neurite outgrowth and neural network 
formation. The suggested mechanism by 
which AChE might regulate neuritogenesis is 
associated with its non-catalytic morphogenic 
activity, protein-protein interactions that may 
act as a neurite-attractive, as well as network-
stabilizing protein during neural development, 
and neurodegenerative diseases. Alterations 
in glial cell development results in a higher 
vulnerability to myelination, synaptic plasticity, 
and architectural modeling, which is extended 
until adolescence (Garcia et al., 2002). In glial 
cells, CP was shown to inhibit cell replication 
and disrupt cell differentiation. Additionally, 
CP altered the integrity of the microtubule 
network and decreased the levels of the 
microtubule-associated protein MAP 1B and, 
particularly, tubulin, as well as a reduction in 
the levels of the cytoskeletal glial fibrillary 
acidic protein (GFAP) (Garcia et al., 2005). In 
summary, the above in vitro data reveals that 
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organophosphate-oxons are capable of 
disrupting separately most phases of nervous 
system development namely, neuronal cell 
proliferation, differentiation and apoptosis and 
glial cells proliferation and differentiation.  
 
 
Table 3. Referenced in vitro studies in long-term exposure to low doses of organophosphates and 
neurodevelopment. 
Model Concentration/dose Major findings References 
Fetal rat ( DIV 5–15 and  
DIV 25–35) aggregating 
cell culture of 
telencephalon 
CP (10-8–10-4 M), CP 
oxon (10-10–10-5 M), 
parathion (10-10–10-4 M), 
paraoxon (10-10–10-5 M), 
during 10 days 
Decreased choline 
acetyltransferase, 
glutamate 
decarboxylase, 
glutamine synthase and 
cyclic nucleotide 
phosphohydrolase 
activities 
(Monnet-Tschudi et al., 
2000) 
Rat pups hippocampal 
and cortical neurons 
CP and CP oxon (0.001-
10 µM) 
AChE-independent 
increase of pCREB 
(Schuh et al., 2002) 
N2a neuroblastoma cells CP oxon (1–10 μM) Inhibition of axon 
outgrowth; reduced 
levels of protein-43 and 
NFH 
(Flaskos et al., 2011) 
PC12 
pheochromocytoma and 
C6 glioma cells 
CP and CP oxon (30 µM) AChE-independent 
inhibition of DNA 
synthesis 
(Qiao et al., 2001) 
N2a neuroblastoma cells DZ (10 µM) Inhibition of neurite 
outgrowth 
Flaskos et al., 2007) 
C6 glioma cells CP ( 5 µg/ml) Impairment of G-protein 
signaling,  impairment of 
cell differentiation, 
reduced expression of 
the transcription factor 
Sp1, ↑ROS; the effects 
were greater in 
undifferentiated C6 cells 
but were still detectable 
in differentiating cells 
(Garcia et al., 2001) 
C6 glioma cells DZ oxon (1, 5 and 10 
µM) 
Decreased GFAP 
expression, reduced 
levels of tubulin and 
MAP1B. Reduced 
outgrowth of extensions 
from C6 cells under  
differentiation-promoting 
conditions  
(Sidiropoulou et al.,2009) 
C6  glioma cells CP and CP oxon ( 1–10 
µM) 
Inhibition of the 
outgrowth  of 
differentiating cells, 
reduced levels of tubulin 
and  MAP1B 
(Sachana et al., 2008) 
AChE: acetylcholinesterase; CP: chlorpyriphos; DZ: diazinon; GFAP: Glial fibrillary acidic protein; MAP1B: 
microtubule associated protein 1B; NFH: neurofilament heavy chain; pCREB: phosphorylated Ca2+/cAMP 
response element binding protein; ROS: reactive oxygen specie 
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Bouchard and colleagues, conducted a birth 
cohort study to assess the association 
between prenatal and postnatal exposure to 
OP pesticides, indicated by urinary dialkyl 
phosphate (DAP) metabolite concentrations, 
in urine collected during pregnancy and from 
children at 6 months and 1, 2, 3, 3.5, 5 years 
of age and cognitive abilities of 7-year-olds 
(Bouchard et al., 2011). Prenatal, but not 
postnatal, urinary DAP concentrations were 
associated with poorer intellectual 
development in 7-year-old children (Bouchard 
et al., 2011). Rauh and colleagues reported 
that prenatal exposure to high levels of CP 
was associated with higher cognitive deficits 
evaluated by two different indices, Working 
Memory Index and Full-Scale IQ in children at 
7 years of age (Rauh et al., 2011). 
Accordingly, Horton and colleagues found that 
males exposed to CP during the prenatal 
period were more susceptible to experience a 
decrement in working memory than females 
(Horton et al., 2012).  
 
7. Concluding remarks 
In humans, pesticides can be responsible for 
diverse acute and long-term health effects. 
Even though not consistent, there is a growing 
body of epidemiologic evidence linking long-
term/low-dose pesticide exposure to cancer, 
reproductive health issues, neurodegenerative 
diseases such as AD, PD, and 
neurodevelopment impairments in children. 
Experiments concerning the environmental 
etiology of PD are more frequent than for 
other diseases, and several different animal 
models have been proposed (Cicchetti et al., 
2009; Drechsel and Patel, 2008; Moretto and 
Colosio, 2011). However, a crucial issue is 
translation for real human exposure to 
pesticides, tissue concentration reached, and 
dose regimen used in animal experiments. In 
these models, a relatively high dose or few 
consecutive doses of a single compound is 
usually administered during a short period of 
time (days or weeks) and the behavioral 
and/or biochemical analyses are performed 
within few weeks as well. In contrast, 
increased health risks are associated with 
exposure to low levels for several years to 
decades to a combination of different 
environmental toxicants. Therefore, there is 
an urgent need to standardize the doses, age, 
species or strain, duration of treatment and 
the methodology to assess 
neurodegeneration. 
Particularly, PQ and MB exposure has been 
largely associated with PD. Other pesticides 
such as rotenone, dieldrin and diquat have 
also been shown to reproduce some features 
of PD in animal models. However, no single 
compound, including the non-pesticide MPTP, 
is able to reproduce all the hallmarks of 
human PD (Blesa et al., 2012; Cicchetti et al., 
2009). Combined exposure to PQ+MB, or 
MPTP+PQ/MB yields potentiated damage to 
dopaminergic system, producing cell damage 
and loss, even when the doses of each 
compound are non-toxic. Most likely, PD 
might result from a prolonged contact to sub-
toxic multi-hits at different targets within the 
dopaminergic system.  
Despite the numerous studies, association 
between neurobehavioral adverse effects and 
OP is only consistent regarding subjects 
acutely poisoned, instead of the uncertainty in 
data concerning subjects chronically exposed 
to low doses of OP. Because of the 
complexity of the effects of environmental 
exposures on human health, the current 
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available data do not support a good 
correlation between actual pesticide exposure 
and development of PD or other 
neurodegenerative diseases. Further research 
should focus on the improvement of the 
characterization of exposure in 
epidemiological studies (pesticide 
identification and quantification), particularly 
the categorization of previously acute 
poisoned subjects and prevalent/incident 
cases. Future investigations should also 
concentrate in designing animal studies that 
better simulates human exposure and 
measures the same aspect of neurological 
function and outcomes. 
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Taking into consideration the above-mentioned regarding the burden of PQ poisoning, the 
increasing pressure from government and regulatory agencies to reduce the pesticide 
poisoning, and the current inexistence of a safe formulation, the global aim of this thesis 
was to develop a safer PQ formulation with the incorporation of LAS as the antidote, 
preserving the herbicide effectiveness and maintaining a low environmental impact. 
The strategy pursued to achieve the proposed main objective comprised the following 
original studies: 
 
Study I 
(i) To test if the incorporation of LAS in the standard PQ formulation (Gramoxone® 
20%) improves the survival rate in intoxicated male Wistar rats. 
(ii) To assess the herbicidal activity of the new formulation, PQ+LAS. 
(iii) To determine the stability of the new formulation regarding the herbicidal effect 
and toxicity to rats. 
 
 
Study II 
(i) To evaluate the toxicity of the PQ+LAS formulation to primary producers. The 
toxicity of the new formulation was compared to the standard product concerning 
the toxicity against the species of microalga Chlorella vulgaris. 
 
 
Study III 
(i) To evaluate the acute oral toxicity of this new formulation following an up-and-
down protocol (UDP). 
(ii) To evaluate the acute toxicity of the new formulation PQ+LAS. 
(iii) To study LAS influence in PQ toxicokinetics. 
(iv) To clarify the mechanisms involved in the protective effect of LAS 
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acetylsalicylate with low mammalian 
toxicity and effective herbicidal 
activity 
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New formulation of paraquat with lysine
acetylsalicylate with low mammalian toxicity
and effective herbicidal activity†
Maria Teresa Baltazar,a,b∗ Ricardo Jorge Dinis-Oliveira,a,b,c,d Lu´cia
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Carvalhoa∗
Abstract
BACKGROUND: Currently, the commercial formulations of the herbicide paraquat are highly toxic to humans, and no effective
antidote is available for paraquat poisoning. The aim of the present study was to develop a safe formulation, combining
paraquat and the known antidote lysine acetylsalicylate. The toxicity of a mixture of Gramoxone (20% paraquat) and lysine
acetylsalicylate in adult Wistar male rats and the herbicidal efficacy against grass lawn (50% of Poapratensis and 50% of Festuca
arundinacea) were evaluated. This new formulation was administered to Wistar rats by gavage at 125 mg kg−1 of paraquat ion
and lysine acetylsalicylate at 79, 158 or 316 mg kg−1 body weight, and the survival rate was observed for 30 days.
RESULTS: The survival rate of the paraquat group was only 40%, while lysine acetylsalicylate provided effective protection,
with full survival observed in the groups that received 125 mg kg−1 of paraquat ion and 316 mg kg−1 of lysine acetylsalicylate.
Both formulations of paraquat, either in the absence or in the presence of lysine acetylsalicylate, provided the same herbicidal
activity against the tested herbal species.
CONCLUSIONS: The present formulation of paraquat containing lysine acetylsalicylate, significantly decreases mammalian
toxicity while maintaining effective herbicidal activity.
c© 2012 Society of Chemical Industry
Keywords: paraquat; antidote; lysine acetylsalicylate; herbicide
1 INTRODUCTION
The continued growth of the human population requires an
increased food supply that needs to be obtained in a sustainable
way. This implies the adoption of manageable agriculture
practices, maintaining or improving crop yields on existing
farmed landwhile avoiding expansionof agricultural activities into
remaining areas of natural vegetation. One of the crucial factors is
often weed control, which requires effective and environmentally
friendly herbicides, as mechanical control is either difficult with
machinery or very laborious when done by hand, frequently
resulting in soil erosion and lower productivity.1
Paraquat (PQ) (1,1′-dimethyl-4,4′-bipyridilium dichloride) is one
of the leading herbicides used in no-till farming methods that
were developed to reduce soil erosion and reduce labour and fuel
costs.2 The adoption of direct drilling planting methods using PQ
has also demonstrated other environmental benefits, including
preservation of soil organic matter, soil aeration, edaphic fauna,
structure and functioning, preventionof soil erosionand reduction
in production of methane gas.1
PQ is non-systemic, as it is only slightly translocated within
plants, partially because of the rapid desiccation of the green
tissues, and so underground parts such as tubers and roots are
not affected and usually regrow.3 This would be a disadvantage of
the long-term control of perennial-weed herbicide, but for PQ it
represents a real advantage in termsof cropplant protectionwhen
sprayed accidentally because only the green part receiving the
herbicide is affected.4 Herbicidal activitybecomesevident through
rapid appearance of a brownish colour and the desiccation of
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green plant tissue following exposure to direct sunlight. Indeed,
bipyridylium quaternary ammonium herbicides, such as PQ, are
activated by light and oxygen and express their phytotoxicity
quite rapidly, depending of the photosynthetic rate of the plant.5
Interceptionof electronflowfromphotosystem I, byPQ, essentially
shunts the electron transport chain, leading to an inhibition of
oxidised nicotinamide adenine dinucleotide phosphate reduction
during photosynthesis.6 By accepting one electron, PQ is reduced
to the paraquat monocation free radical (PQ•+), which is rapidly
reoxidised by O2 to PQ2+, initiating a series of reactions leading
to production of superoxide anion (O2•−) with subsequent cell
membrane disruption and plant death.7
Unfortunately, suicide attempts with PQ and other pesticides
are a major public health problem in developing and developed
countries, causingahugenumberofdeaths.8,9 InSouthKorea, from
1996 through 2005, PQ was the most frequent cause of pesticide
fatal poisoning, accounting for 538 (35.5%) of all pesticide-related
deaths,10 and, in Trinidad and Tobago between 1986 and 1990,
63% of all suicide deaths were due to PQ.11
In self-poisoning, PQ is usually taken orally and absorbed
through the gastrointestinal tract, inducing toxicity through
redox cycling and consequent generation of deleterious
ROS.12 Although organophosphates account for the majority
of pesticide poisonings, the very high fatality rate (>50%)
of PQ poisonings makes it the foremost single pesticide
causing death in many countries, including Sri Lanka,13 South
Trinidad,11 Samoa14 and South Korea.10,15 Even though the major
cause of intoxication is intentional self-poisoning,16 accidental
ingestion of diluted paraquat, as well as occupational poisoning,
through skin absorption from a leaking backpack, have been
reported.17–19
In spite of attempts to develop more effective therapeutics,
no successful effective treatment has been found so far.20 An
alternative approach to lowering PQ toxicity to mammals is
to modify the PQ formulation. In attempt to reduce toxicity,
the formulation of PQ has been modified several times since
its introduction in the market. Firstly, a blue dye, a stenching
agent and an emetic were added to the liquid concentrate in
the late 1970s.21 In 2004, a new PQ formulation designed to
reduce its toxicity was introduced by Syngenta in Sri Lanka,
under the trade name Inteon.22 This new formulation included
three components designed to reduce PQ absorption: (i) an
alginate to thicken the formulation in the acidic environment
of the stomach; (ii) an increase in the amount of emetic to
induce vomiting more quickly; (ii) a purgative to speed its
elimination from the small intestine, which is the main site of
its absorption.22 Although this survey has shown that Inteon
reduces the mortality of patients following PQ ingestion and
increases survival time, a more recent study has shown that the
beneficial effect associated with the Inteon formulation could
not be sustained.23 Therefore, in spite of the slight enhancement
of survival, the existing formulations of PQ in the market are still
highly toxic.
In the past few years, the authors’ research group has focused
on the development of new antidotes to PQ poisoning. In
previous studies it was demonstrated that sodium salicylate
(NaSAL) has a great potential to be used as an antidote against
PQ-induced lung toxicity, through an effective inhibition of
pro-inflammatory factors such as nuclear factor kappa-B (NF-
κB), scavenging of ROS, inhibition of myeloperoxidase activity,
inhibition of platelet aggregation and by preventing death of
pulmonary cells through apoptotic pathways.24,25 Importantly,
this treatment was associated with full survival of PQ-intoxicated
rats. Subsequently, lysine acetylsalicylate (LAS), which releases
salicylate in vivo and is available in hospitals for parenteral
administration, was administered 2 h after PQ poisoning and
proved to assure full survival of the animals26 It is noteworthy
that the incorporation of LAS in PQ formulation will overcome
the disadvantage of the critical time between intoxication
and treatment, with an expected increase in survival rate
and decrease in morbidity. Although the mixing of PQ with
an antidote appears to be a logical approach, there are no
data showing that LAS or PQ would maintain its properties
in a mixture, i.e. be effective as an antidote or herbicide
respectively. Therefore, the overall aim of this study was to
develop a safer PQ formulation with the incorporation of LAS
as the antidote and preserving the herbicide effectiveness.
A further objective was to determine the stability of the
formulation.
2 MATERIAL AND METHODS
2.1 Chemicals and drugs
The commercial formulation of PQ used was Gramoxone [20%
PQ (1,1′-dimethyl-4,4′-bipyridilium dichloride) hydrate; molecular
mass 257.2 gmol−1], kindly supplied by Syngenta Crop Protection
Lda (Lisboa, Portugal). Ampoules of LAS (molecular mass 326.35 g
mol−1) andwater for injections were a generous gift from Labesfal
Gene´ricos (Campo de Besteiros, Portugal). The formulation
administered corresponds to the same available for human
treatment in Portugal. The plant material was purchased from
Flor do Norte (Arcozelo, Portugal).
2.2 Animals
Adult male Wistar rats (aged 8 weeks) obtained from Charles River
SA (Barcelona, Spain),with ameanbodyweightof 221±21g,were
used. Animals were kept in standard laboratory conditions (12/12
h light/darkness, 22 ± 2 ◦C room temperature, 50–60% humidity)
for at least 1 week before starting the experiments. Animals were
allowed to have free access to tap water for human consumption
and rat chow ad libitum during the quarantine period. Animal
experiments were approved by the Portuguese Agency for Animal
Welfare (General Board of Veterinary Medicine in compliance with
the Institutional Guidelines and the European Convention).
2.2.1 Evaluation of survival rate
For the evaluation of survival rate, after the quarantine period, 25
animals were randomly divided into five groups of five animals
each. They were maintained in groups of five animals per cage.
Tap water and rat chow were given ad libitum during the entire
experiment. The PQ administered dose (125 mg kg−1 of PQ ion)
corresponds to the previously reported oral LD50.26–28 Based
on previous work,26 the approach was to mix the commercial
formulation of PQ (Gramxone) with increasing concentrations
of LAS. The molar proportions between PQ and LAS were 1:0.5;
1:1 and 1:2. The PQ + LAS mixture was diluted in distilled water,
as both compounds are water soluble. The administration of the
vehicle (distilled water), the PQ and the PQ + LAS mixture was
done by gavage in a volume of 0.5 mL per 250 g body weight. The
five groups were treated as follows (given doses were per kg body
weight): (i) control group, n = 5, animals treated with distilled
water; (ii) PQ group, n = 5, animals exposed to Gramoxone
PQ (125 mg kg−1); (iii) PQ + LAS (1:0.5), n = 5, animals exposed
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to the mixture of PQ (125 mg kg−1) + LAS (79 mg kg−1); (iv)
PQ + LAS (1:1), n = 5, animals exposed to the mixture of PQ
(125 mg kg−1) + LAS (158 mg kg−1); (v) PQ + LAS (1:2), n =
5, animals exposed to the mixture of PQ (125 mg kg−1) + LAS
(316 mg kg−1). For assessment of formulation stability as regards
safety, ten additional animals were divided into two groups, and
the survival rate was monitored after treatment with the same
formulation that resulted in full survival [PQ (125 mg kg−1) +
LAS (316 mg kg−1)], but in this case the formulation had 2 and 6
months of shelf life. Body weight, motor activity, dyspnea, nasal
haemorrhage and hair characteristics were noted and recorded if
present, and survival was monitored for 30 days.
2.3 Assessment of herbicidal efficacy
2.3.1 Controlled environment chamber experiment
Herbicidal efficacy was assessed in a grass lawn consisting
of a mixture of 50% Poa pratensis (smooth meadow grass,
common meadow grass or Kentucky bluegrass) and 50% Festuca
arundinacea (Lolium arundinaceum; Schedonorus phoenix). The
lawnsweredivided into14cm×14cmsquares andwere randomly
separated into four groups of four squares each. Every group of
four squares was placed in a rectangular tray with water in the
bottom. The grass was maintained in a ventilated room at 18.7
± 0.2 ◦C with a humidity of 69.8 ± 5.9% and illuminated with
cool-white fluorescent lights at a photoperiod light intensity of
61.3 ± 5.3 µE m−2 s−1 (16:8 h light/dark cycle). In all chemical
applications, the grass was sprayed with a hand sprayer with a
volume sufficient to ensure a complete cover (medium volume 6
mL). The sprayed area was limited with a plastic funnel of 8 cm
diameter, and the distance of application was maintained as well
as the pressure applied. All exposures containing both PQ and LAS
or PQ or LAS alone were diluted and applied as soon as possible
aftermixing. The commercial formulationwasdilutedaccording to
themanufacturer’s instructions (Syngenta Crops, Lda), mixing 100
parts of water for each part of product (final concentration 1%).
The four grass groups were treated as follows: (i) control group,
n = 4, grass recieved only water; (ii) LAS group, n = 4, grass
exposed to LAS (5.1 g L−1); (iii) PQ group, n = 4, grass exposed to
PQ (2 g L−1); (iv) PQ + LAS 0 months group, n = 4, grass exposed
to PQ (2 g L−1) + LAS (5.1 g L−1); (v) PQ + LAS 2 months group,
n = 4, grass exposed to PQ (2 g L−1) + LAS (5.1 g L−1) with 2
months of shelf life; (vi) PQ + LAS 6 months group, n = 4, grass
exposed to PQ (2 g L−1) + LAS (5.1 g L−1) with 6 months of shelf
life. The experiment was monitored for 6 days, and the herbicidal
activity was determined by visual assessment and expressed as
percentage of necrotic (yellow-brownish colour) and desiccated
(loss of water) area. For that purpose, the desiccation and necrosis
effects were semi-quantified by analysing four images of each
group using digital photo software (Irfanview, ImageJ, Image
Analyzer).
2.4 Statistical analysis
All statistical calculations were performed with GraphPad Prism
v.5.00 for Windows (GraphPad Software, San Diego, CA).
Comparisonof thesurvival curveswasperformedusingthe logrank
test. Data obtained from the results of the herbicidal activity
experiments were expressed as mean ± SD (standard deviation).
Statistical comparison of different treatments was done by two-
way ANOVA on ranks followed by Bonferroni’s post hoc test. In
all cases, P values lower than 0.05 were considered as statistically
significant.
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Figure 1. Survival rate of Wistar rats following gavage administration of
water (control), paraquat (PQ) and PQ plus lysine acetylsalicylate (LAS)
groups: (PQ+ LAS 1:0.5; PQ+ LAS 1:1; PQ+ LAS 1:2) groups. * P < 0.05 for
PQ versus PQ + LAS 1:2 group.
3 RESULTS
3.1 Survival rate
Rats exposed to Gramoxone (PQ group) only displayed 40%
survival at the end of 30 days (Fig. 1). All deaths occurred
within 48 h in the PQ-intoxicated group. The concomitant
administration of PQ and LAS in different proportions elicited
different results. In the PQ + LAS 1:0.5 group, 60% survival
was observed, while in the group that received a higher dose
of LAS (PQ + LAS 1:1) only 40% survival was registered, but
this variation is not statistically significant, which indicates that
both doses are ineffective. However, for the highest dose of
LAS (PQ + LAS 1:2), an increase in the survival rate to 100%
was obtained. During the monitored period of time, the PQ +
LAS 1:2 group showed only mild signs of apnea within 48 h
of poisoning and recovered completely after 72 h. All the rats
intoxicated with similar solutions but with 2 and 6months of shelf
life survived (100% survival), showing moderate signs of injury,
smooth nose haemorrhage and reduced activity only in the first
48 h, and their condition ameliorated during the follow-up time
(30 days).
3.2 Assessment of herbicidal efficacy
3.2.1 Controlled environment chamber experiment
The area of grass sprayed with PQ (2 g L−1) became slightly
desiccated within 24 h of application and became more necrotic
in the following days, reaching the maximum effect after 6 days
(Fig. 2). The addition of LAS (5.1 g L−1) to the foliar spray solution
(concomitant application) showed no differences from the PQ
group at the end of the experiment (Fig. 2). Simultaneous foliar
application of PQ and LAS provided similar efficacy to PQ alone.
Indeed, in both groups the damage was time dependent, and the
first signs of desiccation were observed within 24 h (Fig. 3). At
the end of the experiment (6 days after application) the results
were similar in both groups. In the experiments carried out with
two- and six-month-old formulations, the herbicidal activity was
maintained.However, theefficacy showeda significantdecrease (P
<0.01 forPQversusPQ+LAS2months,andP<0.001 forPQversus
PQ+ LAS 6months) in the desiccation and necrosis percentage by
comparison with the PQ group (Fig. 3). LAS treatment (5.1 g L−1)
did not show any phytotoxicity under the conditions of this study.
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Control 0h LAS 0h PQ+LAS 0h PQ 0h
Control 48h LAS 48h PQ+LAS 48h PQ 48h
Control 96h LAS 96h PQ+LAS 96h PQ 96h
Control 144h LAS 144h PQ+LAS 144h PQ 144h
14 cm
4 cm
Figure 2. Foliar application of control (water), lysine acetylsalicylate (LAS) (5.1 g L−1), paraquat (PQ) (2 g L−1) and PQ+ LAS (2 g L−1 + 5.1 g L−1) solutions
in grass lawn (50% of Poa pratensis and 50% of Festuca arundinacea). Simultaneous application of PQ + LAS showed similar herbicidal activity to PQ
alone. No phytotoxicity was observed in the control and LAS group. The sprayed area is limited by the dashed white line. Plants were photographed
every 2 days before the next foliar application.
4 DISCUSSION AND CONCLUSION
The results obtained in the present study clearly demonstrate that
LAS, in a dose of 316 mg kg−1, concomitantly administered by
gavage with 125 mg kg−1 of PQ, prevented PQ-induced toxicity
andmortality inWistar ratswithout affecting theherbicidal efficacy
of PQ. Thus, for the first time it was shown that the inclusion of
an antidote in the PQ commercial formulation (Gramoxone) was
capable of improving the survival rate of treatedWistar rats. These
findings corroborate previous results showing that both NaSAL
and LAS were effective antidotes when administrated 2 h after PQ
poisoning.25
In the past few decades, a considerable and consistent amount
of evidence has demonstrated that LAS and itsmetabolite salicylic
acid (SA) have antioxidant properties. ASA possesses antioxidant
activity by scavenging the hydroxyl radical and chelation
of transition metals, stimulation of NO synthesis, increased
expression of lipoxins, inhibition of neutrophil oxidative burst,
inhibitionofNF-κB, activator protein 1 andprotein kinases24,25 and
inhibitionof the lectin-like oxidised LDL receptor-1.29 These effects
are possible mechanisms underlying the observed protective
effect of LAS against PQ-induced toxicity and may contribute
to the success of this novel formulation. Although it is not the
most common pesticide used in suicide attempts, PQ has a
higher incidence of fatalities than other commonpesticides.30 The
problem of intentional or accidental ingestion of PQ encouraged
the introductionof formulationchanges (abluecolour, a stenching
agent and an emetic) to the concentrated formulation.21 However,
the value of these measures is still questionable since the
mortality rateafter intoxication remainshigh,13,31 unintentionalPQ
ingestionbeing theonlyetiologyofexposure thathasdecreased in
the past few years.17,21 Several detoxification strategies aiming to
prevent gastrointestinal absorption, such as gastric lavage and the
administration of mineral absorbents (activated charcoal, Fuller’s
earth and bentonite), have been used with limited efficacy; for
example, gastric lavage remains controversial and should not be
used without administration of an adsorbent.32–35 The target of
recent research on new PQ formulations has been the reduction
of PQ gastrointestinal absorption through the incorporation of
an alginate that forms a gel in the acidic environment of the
stomach, limiting the absorption through the epithelia of the
small intestine.36 Nevertheless, efforts to reduce the absorption
of PQ did not improve the survival rate following accidental or
intentional ingestionofPQ-containingagriculturalproducts.23 The
incorporation of a molecule with a broad spectrum of activity and
pleiotropic functions, such as LAS,might reduce the highmortality
rate associated with PQ poisoning.
Inorder toobtainaproductentirelycompatiblewithcommercial
needs, the herbicidal effect of the novel formulation was also
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Figure 3. (A) PQ: grass sprayed with the commercial available formulation of PQ (2 g L−1); PQ + LAS 0 months: grass sprayed with a freshly prepared
PQ + LAS (2 g L−1 + 5.1 g L−1) formulation; PQ + LAS 2 months: grass sprayed with a PQ + LAS (2 g L−1 + 5.1 g L−1) formulation with 2 months of
shelf life; PQ + LAS 6 months: grass sprayed with a PQ + LAS (2 g L−1 + 5.1 g L−1) formulation with 6 months of shelf life. (B) Percentage of necrosis and
desiccation after foliar application of paraquat (PQ) (2 g L−1), PQ + lysine acetylsalicylate (LAS) (2 g L−1 + 5.1 g L−1) fresh solution (PQ + LAS 0 months)
and PQ + LAS with 2 and 6 months of shelf life. ** P < 0.01 for PQ versus PQ + LAS 2 months; *** P < 0.001 for PQ versus PQ + LAS 6 months.
assessed in the present study against grass species belonging
to the Poaceae family. The species of this family are included in
OECD guidelines as possible test species for use in plant toxicity
testing.37 In thepresentexperimentalmodel, thePQ+LASsolution
showed the same efficacy as the standard PQ formulation. Grass
leaves became slightly desiccated within 24 h of application of
both solutions. Some authors claim a 3 h PQ-induced toxicity
with similar concentrations applied, although the light intensities
employedwere substantially different, 250µEm−2 s−1 as opposed
to61.3±5.3µEm−2 s−1 used in thepresent study.38 PQ is activated
by sunlight, so it is expected that, with increasing light intensity,
the damage to the leaves will increase as well. The present results
showed that, even with a lower light intensity, PQ induced a
significant damage at day 6 (Fig. 2). A key consideration here is the
compatibility of the PQ (200 g L−1) + LAS (510 g L−1) mixture, as
LAS has good water solubility.
Importantly, LAS does not chemically react with PQ or
antagonisePQherbicidal activity.Actually, SA, themainmetabolite
of LAS, forms a soluble crystalline charge-transfer (CT) complex
withPQdichloride.39 Thiswas first hypothesisedon thebasis of the
chemical behaviour of SA, which is similar to that of polyphenols
containing a free hydroxyl group.40 In view of the fact that LAS
is acetylated in that position, it is unable to form a CT complex
with PQ, which represents the most probable reason by which
herbicidal effectiveness is maintained. Another advantage of LAS
is that, in vivo, 50% is immediately hydrolysed (de-acetylated)
to SA in the gastrointestinal mucosa, and the remaining 50% is
hydrolysed within 15 min of gastric and intestinal absorption. On
the one hand this pharmacokinetic behaviour may allow complex
formation between PQ and SA in the stomach, thus preventing
its absorption, and on the other hand the remaining PQ absorbed
may be systemically complexedwith SA. This putativemechanism
of complexation with PQ in vivomight also contribute to the safer
profile of LAS.
The new formulation developed showed an improved safety
profile, as demonstrated by the full survival rate of male rats
intoxicated with this formulation. Importantly, in addition to
the experiments performed immediately after the preparation
of the formulation, 100% survival was also recorded in animals
treated with two- and six-month-old formulations (that is,
after their preparation), indicating a good protective efficacy
of the formulation in the long term. In spite of the excellent
results concerning the mammalian toxicity of the six-month-old
formulation, the herbicidal activity was weaker at the end of the
experimentbycomparisonwith theefficacyof the freshlyprepared
solution. This partial loss of activity could be explained either by
increased hydrolysis of LAS into SAwith time, as it is known that SA
can interferewith theherbicidal effect of PQ, or by thedegradation
of PQ itself.38
All the formulations containing PQ were banned from use in
the European Union in 2007. Among other reasons, concerns
about potential links between PQ and Parkinson’s disease and the
requirement of human protection, which prohibits any exposure
higher than the acceptable operator exposure level, as well as
the protection of animal health, dictated the ban.41 Most of all,
its high toxicity and lack of antidote contributed to this decision.
Nevertheless, PQ is still used in the United States, in South America
and in Asia in countries like Malaysia, India, Vietnam and China.
After nearly 50 years on the market, farmer demand for PQ
continues to grow, with weed resistance to glyphosate and soil
conservation needs being important aspects. The present study
shows that this new formulation has the potential to reduce the
risks associated with PQ intoxication in mammals, and thus might
considerably improve the safety of the product. Nevertheless,
these results are preliminary, and further work is necessary to
assess the formulation stability, the full scale-up costs and the
development of a technology able to prevent LAS hydrolysis
within the formulation.
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a  b  s  t  r  a  c  t
Large  amounts  of herbicides  are  presently  used  in  the  industrialized  nations  worldwide,  with  an
inexorable  burden  to the  environment,  especially  to aquatic  ecosystems.  Primary  producers  such  as
microalgae  are  of especial  concern  because  they  are  vital  for the  input  of energy  into  the  ecosystem  and  for
the maintenance  of  oxygen  in water  on  which  most  of  other  marine  life  forms  depend  on.  The  herbicide
paraquat  (PQ)  is  known  to  cause  inhibition  of  photosynthesis  and  irreversible  damage  to photosynthetic
organisms  through  generation  of  reactive  oxygen  species  in  a  light-dependent  manner.  Previous  studies
have  led  to  the development  of  a new  formulation  of PQ  containing  lysine  acetylsalicylate  (LAS) as  an
antidote,  which  was  shown  to prevent  the  mammalian  toxicity  of PQ,  while  maintaining  the  herbicidal
effect.  However,  the  safety  of this  formulation  to  primary  producers  in  relation  to  commercially  available
PQ formulations  has  hitherto  not  been  established.  Therefore,  the aim  of  this  study  was to  evaluate  the
toxicity  of  the PQ + LAS  formulation  in comparison  with  the  PQ,  using  Chlorella  vulgaris  as a  test  organ-
ism.  Effect  criterion  was  the inhibition  of  microalgal  population  growth.  Following  a  96 h  exposure  to
increasing  concentrations  of  PQ,  C. vulgaris  growth  was  almost  completely  inhibited,  an  effect  that  was
significantly  prevented  by LAS at the  proportion  used  in  the formulation  (PQ  + LAS) 1:2 (mol/mol),  while
the  highest  protection  was  achieved  at the  proportion  of 1:8.  In conclusion,  the present  work  demon-
strated  that  the  new  formulation  with  PQ +  LAS  has  a  reduced  toxicity  to  C.  vulgaris  when  compared  to
Gramoxone®.. Introduction
A considerable amount of the herbicides applied in crop fields
nters into freshwater aquatic ecosystems through surface runoff
r leaching, among other processes, leading to environmental
ontamination and toxic effects potentially harming the aquatic
∗ Corresponding author. Tel.: +351 220 428 500/+351 916120135.
E-mail addresses: mteresabaltazar@gmail.com (M.T. Baltazar), felixdc@ff.up.pt
F. Carvalho).
166-445X/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.aquatox.2013.10.034© 2013 Elsevier B.V. All rights reserved.
organisms (Tornqvist et al., 2011). This phenomenon has moti-
vated great concerns, especially regarding the toxicity towards the
phytoplankton, and microalgae in particular. Microalgae, as major
primary producers, are essential for the equilibrium of the aquatic
ecosystems, and therefore adverse effects of pollutants on these
organisms may have reflexes in the whole ecosystem, potentially
compromising its biodiversity, structure and function (Campanella
et al., 2001), and the services that it provides.
Among herbicides, PQ (1,1′-dimethyl-4,4′-bipyridilium dichlo-
ride) is responsible for the highest human morbidity and mortality
worldwide, being responsible for several hundred thousand deaths
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ince its introduction; for this reason its use has been fiercely dis-
ouraged, and even banned in several countries (Baltazar et al.,
013b). Despite its mammalian toxicity, PQ has an environmen-
al risk lower than other herbicides, in great part due to its reduced
eaching or surface runoff, attributable to its rapid deactivation in
he soil (Bromilow, 2004). Nevertheless, microalgae are very sen-
itive to PQ and, consequently, even small amounts of herbicide
eaching the aquatic environment can still be toxic (Ibrahim, 1990;
a et al., 2002, 2004, 2006; Saenz et al., 1997). PQ inhibits the pho-
osynthesis in green algae by accepting electrons from photosystem
 leading to an inhibition of oxidized nicotinamide adenine dinucle-
tide phosphate reduction (Qian et al., 2009). PQ is then reduced to
he paraquat monocation free radical (PQ•+), which is rapidly reoxi-
ized by O2 to PQ2+, initiating a series of reactions leading to the
roduction of superoxide anion (O2•−) with subsequent cell mem-
rane disruption and cell death (Dinis-Oliveira et al., 2008b; Zweig
t al., 1965).
Microalgae are extremely useful as biosensors and as tools to
ssess the toxicity of hazardous substances in water (Ma  et al.,
004). In addition, their short generation times and rapid responses
o environmental changes have made these toxicity tests highly
aluable for comparison purposes (Ma  et al., 2002; OEDC, 2006).
or these reasons, studies designed to evaluate aquatic toxicity fre-
uently use microalgae, rather than macrophytes as test organism.
n particular, Chlorella vulgaris is the species of microalgae most
ommonly used to represent primary producers.
The toxicity tests in algae typically evaluate population-based
arameters, such as the specific growth rate, biomass, cell yield,
nd chlorophyll fluorescence (Prado et al., 2009). Previous stud-
es reported variable EC50 values for PQ, ranging from 0.2 g/L
o 140 g/L, in a 96 h growth inhibition test carried out with the
reen microalga C. vulgaris (Ma  et al., 2002; Saenz et al., 1997).
he acute toxicity of PQ, on three other microalgae (Scenedesmus
imorphus, Scenedesmus quadricauda and Ankistrodesmus falcatus)
as also previously studied, showing that Scenedesmus dimorphus
as the most susceptible among the species studied (Ibrahim,
990). More recently, other authors reported the effects of PQ on
arameters other than growth or biomass, namely cellular viability,
etabolic activity as given by flow cytometry, DNA damage, mea-
urement of reactive oxygen species (ROS), and expression profile
f genes involved in oxidative stress defense mechanisms, such as l-
scorbate peroxidase, glutaredoxin and glutathione-S-transferase
elated genes (Jamers and De Coen, 2010; Prado et al., 2009; Qian
t al., 2009).
Previous studies have shown that the antioxidant and anti-
nflammatory properties of salicylates, namely, salicylic acid (SA),
he metabolite of acetylsalicylic acid and lysine acetylsalicy-
ate (LAS), proved to be useful as antidotes against PQ toxicity
Dinis-Oliveira et al., 2007a, 2007b, 2009a, 2009b). These studies
ulminated in the development of a new formulation of PQ con-
aining lysine acetylsalicylate as an antidote, which was  shown to
revent the mammalian toxicity of PQ, while maintaining the her-
icidal effect (Baltazar et al., 2013a). However, the safety of this
ew formulation to primary producers has not yet been established.
herefore, the aim of this study was to evaluate the toxicity of the
Q/LAS formulation in comparison with the PQ, using C. vulgaris as
he test organism.
. Material and methods
.1. Chemicals and drugsThe commercial formulation of paraquat used was  Gramoxone®
20% (w/v) PQ (1,1′-dimethyl-4,4′-bipyridinium dichloride
ydrate; molecular mass = 257.2 g/mol], kindly supplied byology 146 (2014) 137– 143
Syngenta Crop Protection Lda (Lisboa, Portugal). Ampoules of
LAS (molecular mass = 326.35 g/mol) were a generous gift from
Labesfal Genéricos (Campo de Besteiros, Portugal).
2.2. Chlorella vulgaris culture conditions
The green alga C. vulgaris was  used as test organism. Cultures
have been maintained at 20 ± 1 ◦C with continuous aeration and
continuous (24 h) photoperiod provided by solar spectrum cool
fluorescent light with an intensity of 75–80 E/m2/s for several
generations in the Laboratory of Ecotoxicology and Ecology of
CIIMAR and Laboratory of Ecotoxicology of ICBAS, University of
Porto. C. vulgaris cultures were maintained in exponential growth
in 5L Erlenmeyer flasks containing 4 L of liquid MBL  medium (Stein,
1973) partially renewed every two days. The culture medium and
all the glass material was  sterilized at 121 ◦C for 1 h prior to use.
2.3. Growth inhibition test
2.3.1. Paraquat formulation toxicity assays
C. vulgaris toxicity test was  conducted for 96 h following the
Organization for Economic Co-operation and Development (OECD)
Guideline 201 “Freshwater Alga and Cyanobacteria, Growth Inhi-
bition Test” (OEDC, 2006). All treatment and control experiments
were prepared from the C. vulgaris culture and each 400 mL Erlen-
meyer flask was  inoculated with exponentially growing cultures,
to achieve an initial cell density of 1 × 104 cells mL.  For the eval-
uation of PQ toxicity, each flask of media (400 mL)  containing C.
vulgaris was  then exposed to Gramoxone® (PQ solution) diluted to
concentrations of 20, 40, 80, 160, 320, 640 and 1280 g/L, except
the control that was not exposed to the PQ formulation (Saenz et al.,
1997). Three replicates from three independent assays (3 cultures)
were used in all the experiments. Every 24 h, the medium tem-
perature and pH (Jenway pH Meter 3310) were measured. Culture
growth was determined by the cell density of samples collected
every 24 h, by counting cells using a Neubauer improved bright-
line chamber and a microscope (Leica DM 2000). At the end of the
bioassay (96 h) the endpoints, average specific growth rates per day
[ (day 0–4) [d−1]] and the inhibition of average specific growth
rate were calculated from cell density measurements.
2.3.2. Combined effect of paraquat and lysine acetylsalicylate on
C. vulgaris growth
The experiments with the mixture of PQ and LAS were divided
into two  different assays. PQ EC75 value (1.38 mg/L) determined
in the toxicity test previously described was used for the mix-
ture assays. LAS was  mixed with PQ at different concentrations
[0.5 (2.18 mg/L), 1 (4.36 mg/L) and two  times (8.72 mg/L) the molar
concentration of PQ]. In the other assays, PQ EC50 (0.5 mg/L) was
used for the mixture assays with higher concentrations of LAS that
correspond to molar proportions of 2 (2.42 mg/L), 4 (4.82 mg/L), 8
(9.65 mg/L), 16 (19.3 mg/L) and 32 times (38.6 mg/L):
(a) Each flask of CM (400 mL)  containing C. vulgaris was  divided in
the following groups: (i) control group, (ii) PQ EC75 group, (iii)
PQ + LAS 1:0.5 group, (iv) PQ + LAS 1:1 group, (v) PQ + LAS 1:2
group (vi) LAS 0.5 group, (vii) LAS 1 group, (viii) LAS 2 group;
(b) Evaluation of the toxicity of higher concentrations of LAS. The
concentration of LAS tested corresponded to the higher concen-
tration used (38.6 mg/L). Each flask of CM (400 mL)  containing C.
vulgaris was divided in the following groups: (i) control group,
(ii) LAS 32, (iii) PQ EC50 group, (iv) PQ + LAS 1:2 group, (v)
PQ + LAS 1:4 group, (vi) PQ + LAS 1:8 group, (vii) PQ + LAS 1:16
group, (viii) PQ + LAS 1:32.
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.4. Stability and biotransformation experiments
For the evaluation of the stability of the compounds, each
ask of 400 mL  containing only culture medium was divided
n the following groups: LAS 32 (38.6 mg/L and PQ + LAS 1:32
0.5 mg/L + 38.6 mg/L). The same solutions were added to the cul-
ure medium in the presence of C. vulgaris for the evaluation of
utative biotransformation. Both assays were undertaken accord-
ng with the described above for the first experiment. All the
arameters determined for the toxicity test at 96 h were also per-
ormed.
.4.1. Lysine acetylsalicylate, salicylic acid and paraquat
uantification in filtrate and algal cells
After 96 h of exposure to the compounds in the biotransforma-
ion experiment, an aliquot of 0.5 mL  from PQ, LAS 32 and PQ + LAS
:32 groups were centrifuged (4000g, 20 min, 4 ◦C) and the super-
atant recovered and stored (−20 ◦C) for further analysis. The pellet
as reconstituted in HCl 0.01 M and stored (−20 ◦C) until analysis.
efore analysis, both solutions were filtered (0.45 m Milipore®).
AS and SA were quantified by a previously reported high-
erformance liquid chromatography (HPLC) with UV detection
ethod (Kees et al., 1996). Standards of LAS and SA were prepared
n HCl 0.01 M and the internal standard, 4-hydroxybenzoic acid,
as added to an aliquot of the standards, supernatant and recon-
tituted pellet at the final concentration of 20 g/mL and 50 L
f the sample was then injected in a HPLC system consisting of a
ump (Gilson model 302; Gilson Medical Electronics, Villiers le Bel,
rance) connected with a manometric model (Gilson, model 802 C)
nd Spherisorb S10 ODS2 Column (Oasis®) of 25 cm × 4.6 mm.  An
utosampling injector (Gilson, model 231–401) was  used to make
he injections into the HPLC system by means of a 20 L loop. The
etection was carried out on ultraviolet detector (Gilson UV/VIS-
55) at 237 nm (Kees et al., 1996). The mobile phase was  a solution
f water:acetonitrile:orthophosphoric acid (85%) (80:19.9:0,1), pH
.5, filtered through a 0.45 m filter (Milipore, Avenida del Liano
astellano, 13-28034 Madrid, Spain) and degassed with nitrogen
as. The flow rate was 1 mL/min. Data collection and processing
ere carried out using Clarity software®, basic edition, clarity ver-
ion 2.6.6.574.
PQ extraction from the supernatant and cell lysate was per-
ormed according to (Moreira et al., 2012). Briefly, an aliquot of
.5 mL  of each aqueous supernatant, 1.5 mL  of phosphate buffered
aline solution (pH 8.0) and 20 L of the internal standard, ethyl
araquat (EPQ) solution (100 g/mL) were pipetted into a 15 mL
lastic tubes. Ten milligrams of NaBH4 were added to the mixture
n order to reduce PQ and the EPQ to the hydrogenated derivatives
ccordingly to (Draffan et al., 1977). The reduction was left to occur
t 60 ◦C for 10 min  and the mixture was then kept in cold water
or 2 min. Solid phase extraction (SPE) was performed using Bond
lut® C18 cartridges installed on a vacuum manifold. The cartridges
ere preconditioned with 2 mL  of methanol and 2 mL  phosphate
uffer (pH 8). The sample was transferred to the SPE column, which
as washed with 2 mL  of deionized water. Afterwards, the sam-
les were eluted under vacuum, at a flow/rate of 1.5 mL/min with
 mL  of methanol. The eluate was evaporated at room temperature
nder a gentle stream of nitrogen. The residue was  reconstituted in
00 L of methanol and 1 L was injected in the GC-IT/MS system
Moreira et al., 2012).
.5. Data and statistical analysisOne-way ANOVA followed by a Dunnett” test for multiple com-
arisons was employed to ascertain if growth rates determined
o each treatment were significantly different from those of the
ontrol (Zar, 1996). No observed effect concentration (NOEC) andFig. 1. Growth curves of Chlorella vulgaris exposed to different concentrations of
paraquat (PQ). Values are given as mean ± S.D.
lowest observed effect concentration (LOEC) values were taken
from ANOVA significant results, reported for p < 0.05.
The average specific growth rate per day was calculated as the
logarithmic increase in biomass in each test from the equation
(OEDC, 2006):
i−j =
InBj − InBi
tj − ti
where i−j is the average specific growth rate from time i to j, Bi is
the biomass at time i and Bj is the biomass at time j.
For each treatment, the percent inhibition of growth rate was
calculated for each treatment replicate using the equation (OEDC,
2006):
%I = c − t
where %I is the percent inhibition in average specific growth rate,
c and t are the mean value for average specific growth rates ()
of the control and treatment, respectively. The %I values calculated
for each experiment were transformed by probit analysis and plot-
ted against the logarithm of the test substance concentration to
obtain the toxicity curves. From each curve, the 20%, 50% and 75%
inhibition concentrations (EC20, EC50 and EC75 respectively) were
calculated.
Results are presented as means ± standard deviation and statis-
tical comparisons between groups were performed with one-way
ANOVA (in case of normal distribution) or Kruskal–Wallis test
(one-way ANOVA on ranks–in case of distribution is not normal).
Statistical calculations were performed with the GraphPad Prism
version 5.00 for Windows (GraphPad Software, San Diego CA, USA)
and SPSS 17.0 software package for Probit analyses. In all cases, p
values lower than 0.05 were considered as statistically significant.
3. Results
3.1. Growth inhibition test
Growth rate of microalgae cultures exposed to PQ was signif-
icantly reduced after 48 h of exposure, at concentrations above
40 g/L (p < 0.05). For concentrations higher than 160 g/L the
growth rate was even more significantly reduced (p < 0.001) and
this growth pattern was  maintained until 96 h of exposure (Fig. 1).
After 96 h of exposure to the higher PQ concentration, C. vulgaris
growth was almost completely inhibited, showing a growth rate
of 0.296 day−1, near 25% of control cultures growth rate. The EC20,
EC50 and EC75 values calculated from the toxicity curves (log con-
centration vs. probit transformation of %I values), at the end of
96 h, are shown in Table 1. The toxicity curve (log of PQ concen-
tration vs.% of growth inhibition) at 96 h obtained for different PQ
concentrations is shown in Fig. 2.
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Table 1
Estimated no observed effect concentration (NOEC), lowest observed effect concentration (LOEC), and concentrations of paraquat (PQ) inducing 20%, 50% and 75% (EC20, EC50
and EC75, respectively) inhibition of Chlorella vulgaris population growth after 96 h of exposure. 95% confidence intervals are indicated within brackets.
NOEC LOEC EC20(95%CI) EC50(95%CI) EC75(95%CI) Pearson’ correlation coefficient
PQ (g/L) 80 160 195.951(162.197–230.111) 525.483(452.687–620.434) 1158.498(944,580–1498,678) 0.982
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Fig. 4. Chlorella vulgaris population growth inhibition after 96 h of exposure to
paraquat (PQ). EC50 (0.5 mg/L). Increasing concentrations of lysine acetylsalicylate
(LAS) were added to the formulation, corresponding to 1:2; 1:4; 1:8; 1:16; 1:32 of
PQ + LAS in molarity. Values are given as mean ± S.D. * versus PQ (p < 0.05); ** p < 0.01;
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1ig. 2. Chlorella vulgaris growth inhibition probit curve as a function of log concen-
ration of paraquat (PQ). The r2 obtained is also indicated.
When LAS was added to the PQ formulation, the toxicity pro-
le was maintained. Noteworthy, despite the lack of differences
etween the growth rates of PQ and PQ + LAS (Fig. 3A), the % of
nhibition of growth was reduced in both groups PQ + LAS 1:1 and
Q + LAS 1:2 (Fig. 3C). On the other hand, C. vulgaris growth was
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ig. 3. A) Chlorella vulgaris population growth curves exposed to paraquat (PQ) IC75 (1
ormulation, corresponding to 1:0.5, 1:1 and 1:2 (PQ + LAS) in molarity. Standard devia
xposed only to LAS. C)% of inhibition of growth of Chlorella vulgaris exposed to PQ IC75. 
:0.5;  1:1; 1:2 of PQ + LAS in molarity. Values are given as mean ± S.D. * versus PQ (p < 0.05***  p < 0.001.
stimulated by LAS as shown in Fig. 3B. In subsequent experiments,
LAS was  added at higher concentrations to evaluate optimal pro-
tective concentrations. From the proportion of 1:8, LAS conferred a
protection against PQ toxicity of approximately 1.8 fold as observed
by the reduction in the % of inhibition of growth (Fig. 4).
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.38 mg/L), three concentrations of lysine acetylsalicylate (LAS) were added to the
tions were omitted for better visualization. B) Growth curves of Chlorella vulgaris
Increasing concentrations of LAS were added to the formulation, corresponding to
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.2. Stability and biotransformation experiments
Regarding the stability of LAS in the culture medium, analysis by
PLC of cell-free supernatants, at the end of the experiment (96 h),
howed that approximately 50% of the added LAS was  depleted
Fig. 5A). The depletion of LAS was mainly due to its spontaneous
ydrolysis into SA in aqueous medium, as shown in Fig. 5B Surpris-
ngly, when LAS was added to the medium containing C. vulgaris,
A was almost undetectable at the end of 96 h, being only quanti-
ed in the first minutes after exposure (Fig. 5B). Consequently, to
nderstand the C. vulgaris-mediated biotransformation of LAS, the
uantification of LAS and SA was performed daily in the supernatant
nd in the cellular pellet. As demonstrated in Fig. 6, the peak of SA
oncentration is achieved after 48 h of exposure and SA abruptly
isappears afterwards. The time course of LAS biodegradation is
lso shown in Fig. 6. In contrast, PQ was stable throughout the
xperiment, whether C. vulgaris was present or not in the culture
edium (data not shown).
. Discussion and conclusionThe present work was undertaken to assess if the new formula-
ion of PQ including LAS had a lower toxicity than the commercially
vailable (Gramoxone®) to freshwater primary producers using
. vulgaris as test organism. Our results clearly demonstrated that (SA) (5B) in the extracellular media of the groups LAS 32 and PQ + LAS 1:32, in the
ells were removed by centrifugation before analysis by HPLC. CV: Chlorella vulgaris;
LAS is able to protect green algae from PQ-induced toxicity. During
application of PQ, non-target species can be affected through the
dispersion of the herbicide in the environment, by entering into
aquatic ecosystems from agricultural runoff or leaching, among
other processes. PQ is toxic to a wide variety of microorgan-
isms (Carr et al., 1986), especially to primary producers, such as
microalgae (Ibrahim, 1990; Saenz et al., 1997). The toxicological
mechanisms of PQ in photosynthetic organisms and bacteria at the
biochemical, physiological and molecular level are well understood
(Carr et al., 1986; Diaz et al., 1980; Ekmekci and Terzioglu, 2005;
Smith, 1988). In plants and algae, PQ2+ inhibits photosynthesis by
accepting electrons from photosystem I, leading to the generation
of PQ.+, which initiates a series of oxidative reactions, leading to
cell membrane disruption and plant death (Dinis-Oliveira et al.,
2008b; Slade, 1966; Zweig et al., 1965). The deviation of electron
flow to NADP+ inhibits its reduction to NADPH, thus compromising
the normal functioning of photosystem I. In the presence of O2,
PQ.+ is reoxidized to PQ2+ and one electron is transferred to O2
forming superoxide radicals and leading to the generation of other
reactive species such hydroxyl and peroxyl radicals (Slade, 1966).
Additionally, at the molecular level, PQ inhibits the psaB and the
rbcL gene that codes for the photosystem I reaction center protein
and for the large subunit of ribulose-1,5-bisphosphate carboxylase
oxygenase (Rubisco), respectively (Qian et al., 2009). After only
24 h of herbicide exposure, significant DNA damage was observed
in microalgal cells, with a 23.67% of comets in cultures exposed to
0.05 M,  revealing the genotoxicity of this herbicide (Prado et al.,
2009).
Previous toxicity tests of PQ in microalgae have been performed
in several species with a wide difference in sensitivity (Ibrahim,
1990; Jamers and De Coen, 2010). Saenz and colleagues, found
that EC50 of PQ in C. vulgaris, following exposure for 96 h, was
140 g/L and for Scenesdesmus species ranged from 47 to 670 g/L
(Saenz et al., 1997). Ma  et al. assessed the toxicity of 40 herbi-
cides to Raphidocelis subcapitata and C. vulgaris and their results
showed that C. vulgaris was more sensitive to PQ than R. sub-
capitata (0.2 g/L versus 18.7 g/L, respectively) (Ma  et al., 2002,
2006). Comparatively, under our laboratory conditions, C. vulgaris
was more resistant to PQ, since the EC50 calculated was 525 g/L
(Table 1), four times higher than the EC50 previously described for
C. vulgaris (Ibrahim, 1990; Jamers and De Coen, 2010; Ma  et al.,
2002, 2006; Saenz et al., 1997).
Most of the previous studies on PQ toxicity to microalgae use
biomass, growth rate and its inhibition as endpoints. In accordance,
in our experimental model we evaluated the inhibition of C. vulgaris
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opulation growth in the presence of Gramoxone® and the new
ormulation PQ + LAS. For proportions of PQ + LAS 1:2 (mol/mol) or
igher it was already possible to observe a slight protection, shown
y a decrease of the % of growth inhibition (Fig. 3C and Fig. 4). LAS
onferred a protection against PQ toxicity of approximately 1.8 fold
hen LAS was added in concentrations above 9.65 mg/L (Fig. 4).
In mammals, LAS and SA possess a well-known antioxidant
nd anti-inflammatory activity with remarkable hydroxyl scav-
nging properties, inhibition of the transcription factors NF-B
nd AP-1 and inhibition of gene expression of COX-2, iNOS and
L-4 (Baltazar et al., 2011). In the present experiment LAS was
sed as a fundamental component of a new herbicide formula-
ion recently developed by our group (Baltazar et al., 2013a). LAS is
he water-soluble lysine salt of acetylsalicylic acid, which is rapidly
eacetylated to SA in aqueous solutions at pH values above 7. At the
eginning of the experiment, SA was already detected, suggesting
hat the degradation of LAS occurred rapidly in the culture medium.
s shown in Fig. 6, after 48 h almost all LAS has been hydrolyzed
o SA. It was also observed that SA is, to some extent, biotrans-
ormed by C. vulgaris after 48 h (Fig. 6), not being detected after
6 h in the culture media (Fig. 5B). The rapid removal of SA by C. vul-
aris is in accordance with other recent studies which suggest that
icroalgae, and mainly Chlorella species, play an important role in
he bioremoval and biotransformation of a variety of toxic organic
ollutants such as bisphenol (Hirooka et al., 2005), nonylphenol
Gao et al., 2011), tributylin (Tam et al., 2002), estrogenic con-
aminants (Della Greca et al., 2008), pyrene (Lei et al., 2002), and
etals (Khoshmanesh et al., 1996; Nacorda et al., 2010; Wilde and
enemann, 1993). Due to the rapid uptake of SA, it seems that the
rotection against PQ toxicity might be due to the release of SA
n the aquatic medium resultant from the hydrolysis of LAS. In
act, SA is a well-known plant natural signaling molecule for the
ctivation of defense-related genes in response to pathogen infec-
ion and stress factors (Klessig and Malamy, 1994). Pre-treatment
f seedlings with 0.5 mM SA for 24 h before exposure to 10 M
Q and light reduces PQ-induced chlorophyll losses, H2O2 pro-
uction, lipid peroxidation, electrolyte leakage, and completely
locked the inhibitory effect of the herbicide on photosynthesis
Ananieva et al., 2004). Czerpak and colleagues have shown that
A stimulates algal growth, protein synthesis and the expression
f nucleic acids, which partially might explain the higher algal
rowth in the groups treated with LAS versus the control group
s shown in Fig. 3B (Czerpak et al., 2002). SA also increases the
ntensity of photosynthesis in algae, possibly due to an increase
f the photosynthetic pigments (chlorophyll a, b and total
arotenoids) synthesis (Czerpak et al., 2002). One of the major ways
n which plants regulate their defense mechanisms in response to
biotic and biotic stresses is the ROS sensing, producing and scav-
nging system (Foyer and Noctor, 2013). SA exogenously added
o barley plants prevented PQ induced-toxicity by enhancing the
ctivity of antioxidant enzymes (Ananieva et al., 2004). SA-deficient
ahG transgenic rice plants showed a reduction of the glutathione
ool and consequently, a greater susceptibility to oxidative dam-
ge induced by PQ (Kusumi et al., 2006; Yang et al., 2004). High
evels of necrotrophic pathogen-induced SA corresponded to high
evels of glutathione, supporting the concept that in plants there
s a tight correlation between both molecules (Kuzniak et al.,
013).
Although the studies mentioned above support the theory that
A protection against PQ toxicity might be related to the antioxi-
ant capacity of these drugs (Ananieva et al., 2004; Baltazar et al.,
011; Kawano and Muto, 2000), another mechanism might be
nvolved. Dinis-Oliveira and colleagues proved that SA and PQ
eact in aqueous medium forming stable charge-transfer com-
lexes (Dinis-Oliveira et al., 2008a), which in theory prevents
Q from undergoing the redox cycling, thus limiting its toxicity.ology 146 (2014) 137– 143
As mentioned before, in our experimental model, SA is rapidly
released from LAS hydrolysis in the aqueous medium (Fig. 5B and
Fig. 6), thus available to complex with PQ. Silverman and col-
leagues have shown that the simultaneous foliar application of
PQ with sodium salicylate significantly reduced the PQ-induced
toxicity (Silverman et al., 2005). The authors concluded that the
SA-mediated protection was  independent from systemic acquired
resistance (SAR) induction, ethylene, and alternative respiration,
but rather related to interferences with PQ uptake, stimulation
of antioxidant defenses, and direct scavenging of radical species
(Silverman et al., 2005). Once again, despite the important contri-
bution of SA antioxidant activity, the reactivity of PQ with SA should
also be considered. Although higher plants have the same target
sites in photosynthesis as Chlorella, our group recently demon-
strated that PQ + LAS in the proportion of 1:2 maintained the
herbicidal effect (Baltazar et al., 2013a). In our previous studies,
the herbicidal activity of the formulation with six-month-old was
weaker at the end of the experiment by comparison with the effi-
cacy of the freshly prepared solution. This partial loss of activity
could be explained by the hydrolysis of LAS into SA with time within
the solution. In order to avoid the interference of SA with the her-
bicidal effect of PQ, the formulation has to be applied immediately
after preparation to overcome the instability problem with LAS.
At the same time, the hydrolysis of LAS in the aquatic medium is
advantageous to the environment as seen by the stimulation of algal
growth in the presence of SA.
In conclusion, our work demonstrated that the new formula-
tion with PQ + LAS has a reduced toxicity to C. vulgaris, suggesting
a lower risk of its use to freshwater primary producers relatively
to other PQ formulations. Together, it seems that SA metabolism,
antioxidant capacity and modulation of oxidative stress contributes
to SA-signalling and perception pathways of cytoprotection against
PQ toxicity. However, in order to further investigate the environ-
mental effects of this new formulation, similar studies using other
aquatic organisms, different trophic levels of freshwater ecosys-
tems and soil persistency or biodegradation studies should be
conducted.
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Abstract 
 
The incorporation of lysine acetylsalicylate (LAS) in the commercial formulation of paraquat (PQ), 
Gramoxone®, has been shown to significantly increase the survival of intoxicated mammals, while 
maintaining the herbicidal effect. The aim of the present study was to clarify the mechanisms 
involved in the protective effect of LAS in a rodent model, through monitoring PQ levels and the 
histological and biochemical biomarkers of toxicity in male Wistar rats following intoxication with PQ 
formulations in the absence and presence of LAS. Gramoxone® and the formulation with LAS were 
administered by gavage, at the doses of 125 mg/kg of PQ and 125 mg/kg of PQ + 316 mg/kg of 
LAS, respectively. The obtained results showed that LAS improves the safety of PQ formulation, by 
increasing its elimination, and preventing lung and kidney injury. LAS prevented the biochemical 
and histological alterations in lung induced by PQ at the end of 24h and 48h. This was evidenced 
by a significant reduction in lipid peroxidation, the maintenance of reduced glutathione levels and 
decreased levels of oxidized glutathione, as well as the normalization of the urinary biomarkers, 
creatinine and N-acetyl- β- glucosaminidase. LAS treatment also caused a significant reduction in 
PQ-induced activation of nuclear factor kappa B (NF-κB) in lung. The results allow us to conclude 
that lysine acetylsalicylate improves the safety of PQ formulation in rats, by increasing its 
elimination, and preventing lung and kidney injury. 
 
Keywords:  Paraquat, antidote, lysine acetylsalicylate, herbicide. 
 
 
Introduction 
The human fatality rate resulting from 
intoxications with the herbicide paraquat 
(1,10-dimethyl-4,40-bipyridinium chloride; PQ) 
is very high due to both its inherent toxicity 
and the lack of effective treatments. As PQ is 
still widely used in numerous countries, 
several measures to prevent poisoning or 
reduce its toxicity have been implemented 
since its introduction in the market (Baltazar et 
al., 2013a; Dinis-Oliveira et al., 2009a; Dinis-
Oliveira et al., 2009b; Dinis-Oliveira et al., 
2007a; Dinis-Oliveira et al., 2007b). Initially, 
risk mitigation measures were applied in the 
PQ formulation, as the addition of a blue-
green dye, stenching agents, thickeners, 
reduction of the concentration of PQ (10%-
20%), improvement of the safety caps and 
labeling (Sabapathy, 1995). More recently, a 
new formulation (INTEON®) was developed 
to prevent the absorption of PQ and increase 
its elimination through the incorporation of an 
emetic, an alginate to thicken the formulation 
in the acidic environment of the stomach, and 
an osmotic purgative to speed its elimination 
from the small intestine (Heylings et al., 2007; 
Wilks et al., 2008). However, subsequent 
surveys were unable to link the improvement 
of the survival rate with the new formulation 
(Wilks et al., 2011).  
In fact, PQ poisonings are still associated with 
a mortality rate of 40 to 60%, and most of the 
fatal cases occur within 24–72 h, due to multi-
organ failure (Gil et al., 2008; Senarathna et 
al., 2009). PQ toxicity is especially severe in 
the lungs due to its accumulation, against a 
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concentration gradient, through the highly 
developed polyamine uptake system, and due 
to its capacity to continuously generate 
reactive oxygen species (ROS) through a 
redox cycle involving PQ radicals and oxygen 
(Smith, 1982, 1987). The development of 
pulmonary lesions is characterized by an early 
destructive phase (1-3 days) with an acute 
alveolitis and extensive influx of inflammatory 
cells; and a delayed proliferative phase (3-7 
days) that involves the development of 
extensive fibrosis in the lung, which results in 
the loss of the normal alveolar architecture, 
interfering with gaseous exchange, and 
subsequently causing death from anoxia.  
Taking into account the mechanism of PQ 
toxicity, involving a strong inflammatory 
reaction and ROS production, it was 
postulated that an antidote against PQ 
poisoning should have excellent antioxidant 
and anti-inflammatory properties, involving the 
inhibition of nuclear factor κB (NF-κB), AP-1 
and COX-1 activation (Gawarammana and 
Buckley, 2011). Nevertheless, in spite of 
anecdotal successful clinical cases (Dinis-
Oliveira et al., 2006c; Jenq et al., 2005; Lee et 
al., 2009), the efficacy of the decontamination 
with fuller´s earth, and with the anti-
inflammatory and immunosuppressive 
therapies is still very poor (Dinis-Oliveira et 
al., 2009a; Dinis-Oliveira et al., 2006c; 
Suntres, 2002; Suntres and Shek, 1995; Yeh 
et al., 2006).   
Recently, salicylates have emerged as 
effective antidotal candidates to overcome the 
lack of an effective treatment due to their well-
known anti-inflammatory and antioxidant 
action (Baltazar et al., 2011). Animals 
exposed to a toxic dose of PQ (25 mg/kg, ip) 
and treated 2h after with sodium salicylate 
(NaSAL) (200 mg/kg ip) had a significant 
reduction in PQ-induced oxidative stress, 
platelet activation, and NF-κB activation in 
lung (Dinis-Oliveira et al., 2007b). NaSAL also 
prevented the PQ induction of apoptosis in rat 
lung and all of these changes were 
accompanied by the full survival of the 
animals (Dinis-Oliveira et al., 2007a; Dinis-
Oliveira et al., 2007b). Additionally, further 
research was performed with the salicylate 
prodrug, lysine acetylsalicylate (LAS) to 
overcome the problem with solubility for future 
intravenous and intramuscular administrations 
in hospitals, and similar efficacy was 
obtained(Dinis-Oliveira et al., 2009b).  
Our most recent approach to decrease the 
risk liability of PQ was to develop a new 
formulation of PQ containing the antidote LAS 
with decreased mammalian toxicity while 
maintaining effective herbicidal activity 
(Baltazar et al., 2013a). The PQ solution used 
to develop the formulation was the 
commercialized by Syngenta Ldt., Gramoxone 
(20% w/v) to ensure a realistic approach to 
this study. The survival rate of rats orally 
exposed to 125 mg/kg of PQ ion was only 
40%, while the presence of LAS in the 
formulation (125 mg/kg of PQ ion and 316 
mg/kg of LAS) provided effective protection, 
as confirmed by the full survival observed. 
Noteworthy, both formulations of PQ, either in 
the absence or in the presence of LAS, 
provided the same herbicidal activity (Baltazar 
et al., 2013a).   
In the present work, we evaluated the acute 
oral toxicity of this new formulation following 
an up-and-down protocol (UDP), 
recommended by the Organisation for 
Economic Co-operation and Development 
(OECD), in alternative to the conventional 
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LD50 testing. Additionally, it was also our aim 
to provide comprehensive PQ measurements, 
as well as lung histological evaluation and 
biochemical data in plasma and urine that 
could help to clarify the mechanisms involved 
in the protective effect of LAS, which led to full 
survival in the previous study (Baltazar et al., 
2013a). 
 
Material and Methods 
Chemicals and drugs 
The commercial formulation of PQ used was 
Gramoxone® [20% PQ (1,1´-dimethyl-4,4´-
bipyridinium dichloride hydrate; molecular 
mass=257.2 g/mol], kindly supplied by 
Syngenta Crop Protection Lda (Lisboa, 
Portugal). Ampoules of LAS (molecular mass 
= 326.35 g/mol) and water for injections were 
a generous gift from Labesfal Genéricos 
(Campo de Besteiros, Portugal). The 
formulation of LAS corresponds to the same 
available for human treatments in Portugal. 
The reagents for the albumin, total protein, 
total bilirubin, direct bilirubin, cholesterol, high-
density lipoprotein (HDL), low-density 
lipoprotein (LDL), triglycerides (TG), glucose,  
creatinine, urea,  aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), 
amylase, creatinine kinase (CK), creatinine 
kinase MB (CK-MB), lactate dehydrogenase 
(LDH), lactate, uric acid, α-1-antitrypsin, 
potassium, sodium, alkaline phosphatase 
(ALP), γ-glutamyl-transpeptidase (GGT),  C-
reactive protein (CRP) were obtained from PZ 
Cormay S.A.  N-acetyl- β- glucosaminidase 
(NAG) reagents were obtained from Diazyme 
Europe GmbH. 
 
 
 
 Animals 
A total of 57 adult male Wistar rats (aged 8 
weeks) obtained from Charles River S.A. 
(Barcelona, Spain), with a mean body weight 
of 269 ± 37g, were used. Animals were kept in 
standard laboratory conditions (12/12 h 
light/darkness, 22±2ºC room temperature, 50-
60% humidity) for at least 1 week before 
starting the experiments. Animals were 
allowed access to tap water and rat chow ad 
libitum during the quarantine period. Housing 
and experimental treatment of the animals 
were in accordance with the Guide for the 
Care and Use of Laboratory Animals from the 
Institute for Laboratory Research. The 
experiments complied with current 
Portuguese laws. 
 
Determination of the acute oral toxicity by 
the up-and-down (UDP) procedure 
A total of 17 adult female Wistar rats (aged 
between 8-12 weeks) obtained from Charles 
River S.A. (Barcelona, Spain), with a mean 
body weight of 199 ± 15 g, were used. Doses 
were administered by gavage, in a standard 
volume of 0.5 mL according to the UDP 
schedule, and were made by diluting 
Gramoxone® in water or mixing Gramoxone® 
with LAS in the proportion 1:2. OECD 
Guideline 425 was followed to estimate the 
acute oral toxicity (LD50) value along with its 
confidence interval (OECD, 2008). The main 
test of this guideline was used. Briefly, it 
consists of a single-ordered dose progression 
in which animals are dosed individually (one 
at a time) and observed, for 48h, before a 
subsequent dose is administered to another 
animal. The first animal receives a dose a 
step below the level of the best estimate of 
the LD50. For PQ, the oral LD50 in male 
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Wistar rats described is 125 mg/kg (Dinis-
Oliveira et al., 2009b; Kimbrough and Gaines, 
1970; Murray and Gibson, 1972) and for that 
reason the first animal received the dose 
below in the progression, 40 mg/kg. The dose 
progression for each subsequent animal was 
determined by the short-term (48 h) fate of the 
previously dosed one. If an animal survived 
within the short term interval, the next animal 
received a higher dose. If this last animal died 
within this time period, the dose progression 
proceeded with a lower dose (see Tables 1 
and 2) as prescribed in the Acute Oral Toxicity 
(AOT) software program (OECD, France) 
used for the analysis of dosing data. The 
animal’s long-term fate at the end of 14 days 
after exposure was also recorded. Dosing 
continued until one of the three standard 
stopping criteria was met: i) three consecutive 
animals survived at the upper bound of 
dosing, ii) five reversals occurred in any six 
consecutive animals tested (when a reversal 
is created by a pair of responses in a situation 
in which a nonresponse is observed at a 
particular dose and a response is observed at 
the next dose tested, or vice versa), or iii) at 
least four animals have followed the first 
reversal and the specific likelihood ratios (see 
(OECD, 2008)) exceed the critical value. All 
animals were observed individually for 
toxicological signs, especially in the first hours 
post-dosing and until the end of experiment 
(14 days). Body weight, locomotor activity, 
dyspnea, nasal hemorrhage, skin and fur 
characteristics were recorded if present. After 
the stopping criteria had been reached, an 
estimate of the LD50 value and the 
associated confidence limits were calculated 
using the AOT software (Guideline 425) 
Statistical Program version1.0. 
Acute toxicity at the end points 24h and 
48h 
Experimental protocol 
After the quarantine period, 40 animals were 
randomly divided into eight groups of five 
animals each. Each animal was individually 
housed in a metabolic cage where it was kept 
during the whole time of experiment (24h and 
48h). Animals were fasted for 24h before 
sacrifice, but water was given ad libitum 
during the whole experiment. Urine and feces 
were collected over ice during the 24h or 48h 
period, for quantification of PQ and 
biochemical parameters. The PQ 
administered dose (125 mg/kg of PQ ion) 
corresponds to the oral LD50 reported by other 
authors (Dinis-Oliveira et al., 2009b; 
Kimbrough and Gaines, 1970; Murray and 
Gibson, 1972). Based on our previous results 
showing full survival, the proportion of PQ and 
LAS used in the experiments was 1:2 in 
molarity (Baltazar et al., 2013a). The aqueous 
administrations of vehicle (distilled water), PQ 
and the mixture PQ+LAS were all done by 
gavage in a volume of 0.5 mL/250 g of body 
weight.  
Each group of animals was treated as follows: 
(i) Control group, n=10: animals were treated 
with distilled water and sacrificed at 24 h (n=5, 
control 24 h), and 48 h (n=5, control 48 h). (ii) 
LAS group, n=10: animals were treated with 
LAS (316 mg/kg) and sacrificed at 24 h (n=5, 
LAS 24 h), and 48 h (n=5, LAS 48 h). (iii) PQ 
group, n=10: animals were treated with 
Gramoxone® (125 mg/kg PQ ion) and 
sacrificed at 24 h (n=5, PQ 24 h), and 48 h 
(n=5, PQ 48 h). (iv) PQ+LAS group n=10: 
animals treated with PQ (125 mg/kg) + LAS 
(316 mg/kg) and sacrificed 24 h (n=5, 
PQ+LAS 24 h), 48 h (n=5, PQ+LAS 48 h). 
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Sample collection and processing of 
samples 
Twenty four and fourty eight hours after 
administrations, anesthesia was induced with 
xylazine/ketamine (10 mg/kg/100 mg/kg i.p). 
Animals were placed in the decubito supino 
position and the thorax was opened by two 
lateral transversal incisions and one central 
longitudinal incision to expose the aorta 
artery. Blood was collected with a heparinized 
needle from the aorta artery into a heparinized 
containing tube.  Lungs were removed, 
cleaned of all major cartilaginous tissues of 
the conducting airways, weighed, and 
processed as follows: the left lung was 
homogenized (1:4 m/v) with an Ultra-Turrax® 
homogenizer in cold mixture of phosphate 
buffer [(1.44 g Na2HPO4, 0.24 g KH2PO4, 8 g 
NaCl e 0.2 g KCl), pH 7.4] and centrifuged 
(3000g, 4°C, for 10 min). Aliquots of the 
resulting supernatants were transferred to 
eppendorfs and centrifuged again (13000 g, 
4ºC, for 10 min). The resulting supernatants 
were divided in aliquots and stored (−80°C) 
until posterior quantification of PQ, 
mieloperoxidase (MPO) activity, and protein 
content. Perchloric acid (10%) was added to 
the resulting supernatant described above in 
the proportion of 1:1 and then centrifuged at 
13000 g, 4ºC, for 10 min. The resulting 
supernatant was stored (−80°C) until 
quantification of total glutathione (GSHt), 
reduced glutathione (GSH), oxidized 
glutathione (GSSG) and lipid peroxidation. 
The right lung was prepared for histological 
and immunohistochemical analysis, as 
following described. 
Blood samples were centrifuged (3000g, 4°C, 
for 10 min) and plasma was aliquoted and 
stored (−80°C) for further biochemical 
analysis (albumin, total protein, total bilirubin, 
direct bilirubin, cholesterol, HDL, LDL, TG, 
glucose,  creatinine, urea, AST, ALT, 
amylase, CK, CK-MB, LDH, lactate, uric acid, 
α-1-antitrypsin, potassium, sodium, ALP, 
GGT, CRP) and PQ quantification. Feces 
were homogenized in distilled water (1:4 m/v) 
and were kept in constant shaking overnight, 
then centrifuged (3000g, 4°C, for 10 min). The 
supernatants were stored (−80°C) until 
quantification of PQ. Urine samples were 
centrifuged (3000g, 4°C, for 10 min) and 
stored (−80°C) until quantification of PQ, urea, 
creatinine and NAG. Clearance of creatinine 
was calculated as follows: 
Clearance of creatinine (mL/min/kg) = 
Urinary creatinine × urine volume 24h
Plasmatic creatinine × 1440 × body weight  
 
Biochemical analysis  
Plasma biochemical parameters were 
measured in duplicate on an AutoAnalyzer 
(PRESTIGE 24i, PZ Cormay S.A.). Urinary 
urea, creatinine and total proteins were 
measured in duplicate according to formerly 
described methods (Fabiny and 
Ertingshausen, 1971; Talke and Schubert, 
1965). Urinary NAG activity was assayed in 
duplicate as previously reported (Yuena C.T, 
1982). One Unit of NAG was defined as the 
amount of enzyme that releases one µmol of 
p-nitrophenol in the assay conditions. Results 
were expressed in U/L. 
Tissue protein was quantified in triplicate 
according to the method of (Lowry et al., 
1951), using bovine serum albumin as 
standard. Lung lipid peroxidation was 
evaluated in triplicate by the thiobarbituric acid 
reactive substances methodology (Buege and 
Aust, 1978). Results were expressed as nmol 
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of malondialdehyde (MDA) equivalents/mg 
protein using an extinction coefficient (ε) of 
1.56×105M−1 cm−1.  
The GSH and GSSG contents in lung 
perchloric acid supernatant were determined 
by the DTNB-GSSG reductase recycling 
assay in triplicate as described before (Pontes 
et al., 2008) with some modifications. Briefly, 
the thawed acidic supernatant was neutralized 
with equal volume of 0.76 M KHCO3 and 
centrifuged for 10 min at 13,000g (4 ºC). For 
measurement of GSHt, 100 µL/well of the 
neutralized supernatants, standards or blank 
were added in triplicate to 96-well microtiter 
plates, followed by 65 µL/well of freshly 
prepared reagent containing 0.69 mM NADPH 
and 4 mM DTNB in 72 mM phosphate buffer. 
Plates were then incubated at 30 ºC in a plate 
reader (BioTek Instruments, Vermont, US), for 
15 min prior to the addition of 40 µL/well of a 
10 IU/mL glutathione reductase solution in 
phosphate buffer. The stoichiometric 
formation of 5-thio-2-nitrobenzoic acid was 
followed for 3 min at 415 nm and compared to 
a standard curve. For the determination of 
GSSG, 10 µL of 2-vinylpyridine were added to 
200 µL aliquots of acidic supernatant and 
mixed continuously for 1 h for derivatization of 
GSH. GSSG was then measured as 
described above for total glutathione. The 
molar GSH levels were calculated by 
subtracting the GSSG content from the total 
glutathione content (GSH = GSHt – 2 × 
GSSG). 
Lung MPO activity was measured according 
to a previously described assay (Andrews and 
Krinsky, 1982) with slightly alterations. Briefly, 
the resulting supernatant was solubilized in 
hexadecyltrimethylammonium bromide (1:1 
v/v) to a final concentration of 0.5% (w/v). 
Then, the samples were sonicated to disrupt 
the granules and solubilize the MPO and 
afterwards centrifuged at 4,000g at 4 ºC for 5 
min. The assay mixture consisted of 75 µL 
sample, blank or standard, 75 µL of TMB (1.6 
mM), dissolved in dimethyl sulfoxide and 525 
µL of assay buffer (220 mM phosphate, pH 
5.4, with 110 mM NaCl). The enzymatic 
activity was initiated by adding H2O2, 3 mM, 
and evaluated at 650 nm at 37◦C during 3 
min. MPO standards were used and the 
results were expressed U/g of protein. 
 
Paraquat quantification  
Quantification of PQ in plasma, urine, lung 
tissue and feces was performed following a 
previously described method (Moreira et al., 
2012). Briefly, an aliquot of 0.5mL of each 
aqueous supernatant, 1.5 mL of phosphate 
buffered saline solution (pH 8.0) and 20 μL of 
the internal standard [ethyl paraquat (EPQ) 
solution (100µg/mL)] were pipetted into a 
15mL glass tubes. Ten milligrams of NaBH4 
were added to the mixture in order to reduce 
PQ and the EPQ to the hydrogenated 
derivatives (HPQ and HEPQ) accordingly to 
the method described (Draffan et al., 1977). 
The reduction was left to occur at 60°C for 10 
min and the mixture was then kept in cold 
water for 2 min. SPE was performed using 
Bond Elut® C18 cartridges installed on a 
vacuum manifold. The cartridges were 
preconditioned with 2mL of methanol and 2mL 
phosphate buffer (pH 8). The sample was 
transferred to the SPE column, which was 
washed with 2mL of deionized water. 
Afterwards, PQ was eluted under vacuum, at 
a flow/rate of 1.5 mL/min with 2mL of 
methanol. The eluate was evaporated at room 
temperature under a gentle stream of 
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nitrogen. The residue was reconstituted in 100 
μL of methanol and 2μL was injected in the 
GC-IT/MS system (Moreira et al., 2012). GC‐
IT/MS analyses were performed using a 
Varian CP‐3800 GC (USA) gas 
chromatographer equipped with a Varian 
Saturn 4000 ion trap mass detector (USA) 
and a Saturn GC/MS workstation software 
version 6.8. The GC was equipped with a VF‐
5ms (30m×0.25mm×0.25 μm film thickness) 
from Varian. The carrier gas was Helium C‐60 
(from Gasin, Portugal) at a constant flow rate 
of 1 mL/min. The temperature of the injector 
port was 250°C and it operated in split mode 
1:10. The initial column temperature was 
maintained at 80°C for 1 min; programmed at 
10°C/min to 200°C and 20°C/min to 270°C 
with a hold at 270°C for 5 min. All mass 
spectra were acquired by electron impact (EI, 
70 eV) in full‐scan mode. The ion‐trap 
detector was set as follows: the transfer line, 
manifold and trap temperatures were 280, 50 
and 180°C, respectively. The mass range was 
50–600 m/z, with a scan rate of 6 scan/s. The 
emission current was 50 μA, and the electron 
multiplier was set in relative mode to autotune 
procedure. The maximum ionization time was 
25000 μs, with an ionization storage level of 
35 m/z. Chromatographic peaks (for retention 
time evaluation) and ions for HPQ qualitative 
and quantitative analysis were initially 
selected from the analysis of pure standards 
(i.e. without matrix). Confirmation of the ions 
was done by the analysis of spiked blank 
samples with a known PQ concentration in a 
full scan chromatogram (FSC) mode. Ions 
with significant abundance were vectored as 
either target or qualifier ions for the selected 
ion monitoring analysis. The designated ions 
were m/z 96, 148, 192 (HPQ) and 110, 162 
and 220 (HEPQ). 
 
Tissue processing for structural analysis 
Cubic pieces from the right upper lobe, right 
middle lobe and right lower lobe of the lung 
were fixed [4% (vol/vol) buffered 
paraformaldehyde] by diffusion, during 24 h, 
and subsequently dehydrated with graded 
ethanol and included in paraffin blocks. 
Xylene was used in the transition between 
dehydration and impregnation. Serial sections 
(5 µm of thickness) of paraffin blocks were cut 
by a microtome and mounted on silane-
coated slides. The semiquantitative 
histopathological evaluation of acute lung 
damage was performed according to a 
previously described procedure (Dinis-Oliveira 
et al., 2006a; Dinis-Oliveira et al., 2006b). The 
following parameters were analyzed for each 
group: (i) tissue disorganization, (ii) 
inflammatory reaction, (iii) necrotic zones, and 
(iv) interstitial fibrosis. The severity of tissue 
disorganization was scored according to the 
percentage of the affected tissue: score 0 = 
normal structure; score 1 = less than one-third 
of tissue; score 2 = greater than one-third and 
less than two-thirds; score 3 = greater than 
two-thirds of tissue. The severity of 
inflammatory reaction was scored as follows: 
grade 0 = no cellular infiltration; grade 1 = 
mild leukocyte infiltration (1 to 3 cells by visual 
field); grade 2 = moderate infiltration (4 to 6 
leukocytes by visual field); and grade 3 = 
heavy infiltration by neutrophils. The severity 
of necrosis was scored as follows: grade 0 = 
no necrosis; grade 1 = dispersed necrotic foci; 
grade 2 = confluence necrotic areas; grade 3 
= massive necrosis. The interstitial fibrosis 
was scored from 0 (normal lung) to 8 (total 
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fibrosis) according to the following criteria: 
grade = 0 normal lung; grade 1 = minimal 
fibrous thickening of alveolar or bronchial 
walls; grades 2–3 = moderate thickening of 
walls without obvious damage of lung 
architecture; grades 4–5 = increased fibrosis 
with definite damage to lung architecture and 
formation of fibrous bands or small fibrous 
mass; grades 6–7 = severe distortion of 
structure and large fibrous areas; “honeycomb 
lung” was placed in this category; grade 8 = 
total fibrotic obliteration of the field (Dinis-
Oliveira et al., 2007b). 
 
Staining procedures 
The slides were dewaxed in xylene and 
hydrated through graded alcohols finishing in 
phosphate-buffered saline (10mM PBS, pH 
7.2). Deparaffinised sections were stained 
with haematoxylin-eosin, and others were 
prepared for immunohistochemistry NF-κB 
analysis, accordingly to the previous 
described study (Dinis-Oliveira et al., 2009b). 
Briefly, the haematoxylin-eosin staining was 
performed by immersion slides in Mayer’s 
haematoxylin solution for 3–4 min followed by 
immersion in 1% eosin solution for 7 min, 
dehydration with graded alcohols through 
xylene, and mounting with DPX. To perform 
the NF-κB immunohistochemistry detection, 
after deparaffinization and rehydration of the 
slides, endogenous peroxidase activity was 
blocked with 3% H2O2 in Tris-buffered saline 
(TBS) and methanol for 15 min, followed by 
2×5 min washes with 0.1% TBS with Tween 
20 (TTBS). To reduce nonspecific binding, 
slides were incubated with blocking solution 
(3% BSA in TTBS) for 1h30. Next, sections 
were incubated for 3h with the primary 
antibody directed to NF-κB (NFκB p50 rabbit 
polyclonal antibody; 1:50, sc-114; Santa Cruz 
Biotechnology). Sections were then washed 
2×5 min with TTBS and incubated with 
secondary antibody (goat anti-rabbit IgG-
horseradish peroxidase; 1:100, ab6721; 
abcam) for 2 h at room temperature. 3, 3´-
Diaminobenzidina was used as the 
precipitating substrate for the localization of 
peroxidase activity (DAB Substrate Kit 
ab64238; 1min incubation RT). 
 
Statistical analysis 
All statistical calculations were performed with 
the GraphPad Prism version 5.00 for 
Windows (GraphPad Software, San Diego 
California, USA). The Shapiro-Wilk test was 
performed to check normality of the data. 
Statistical comparisons among groups were 
estimated using the one-way ANOVA (in case 
of normal distribution) followed by the Student 
Newman Keuls post hoc test or Kruskal-Wallis 
(in case of distribution is not normal). Data 
from light microscopy analysis were 
expressed as median and interquartile range 
and the statistical comparisons were 
performed using Kruskal-Wallis. 
In all cases, p values lower than 0.05 were 
considered as statistically significant. All data 
obtained from the results of the biochemical 
assays and PQ quantifications were 
expressed as mean±SD (standard deviation) 
 
Results 
Determination of the acute oral toxicity by 
the up-and-down (UDP) procedure 
The progression of the toxicological signs 
after dosing was notoriously different between 
PQ and PQ+LAS groups. The dose 
progression is shown in Table 1 and 2. The 
estimated LD50 values were calculated by the 
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AOT software and were 34.86 mg/kg (95% CI 
40–125 mg/kg) and 187.5 mg/kg (95% CI 
125–400 mg/kg), respectively. The animals 
that received 125 mg/kg of PQ+LAS did not 
show any signs of toxicity and fully survived 
more than 14 days. On the other hand, 
animals intoxicated with PQ 125 mg/kg were 
prostrated after dosing and 24h later they 
showed other signs of toxicity such as 
epistaxis, piloerection, cyanosis and 
respiratory distress. All the animals from this 
group died in a period between 3 to 14 days 
post dosing probably due to respiratory 
failure. 
 
Table 1. Dose progression given with short-term (48 h) and long-term (14 days) fates of individual female 
Wistar rats dosed orally with Gramoxone® 
Test animal Gender Dose mg/kg Short term 
(48h) 
Long term 
(14 days) 
1 female 40 O O 
2 female 125 O X 
3 female 400 X X 
4 female 125 O X 
5 female 400 X X 
6 female 125 O X 
7 female 400 X X 
X = Died, O = Survived 
 
 
Table 2. Dose progression given with short-term (48 h) and long-term (14 days) fates of individual female 
Wistar rats dosed orally with the new formulation PQ+LAS 
Test animal Gender Dose mg/kg Short term 
(48h) 
Long term 
(14 days) 
1 female 40 O O 
2 female 125 O X 
3 female 400 X X 
4 female 125 O X 
5 female 400 X X 
6 female 125 O X 
7 female 400 X X 
X = Died, O = Survived 
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Acute toxicity at the end points 24h and 
48h 
Rats exposed to PQ formulation showed 
histological and biochemical changes in blood 
and lungs. The protection of LAS was more 
pronounced at the end point 48h. Noteworthy, 
for the PQ 48h were necessary 7 animals, 
since 2 rats from this group died before the 
48h. Rats intoxicated with the new formulation 
survived until the end point of the protocol. 
 
Biochemical analysis in plasma and urine 
As shown in Fig. 1, animals from PQ 24h 
group exhibited a significant increase of NAG 
levels in urine compared to control group 
(18.42±2.42 vs 9.23±5.08, p < 0.05). On the 
other hand, this parameter was kept near to 
control levels in the PQ+LAS group 
(10.80±3.07). Analogous results were 
obtained for protein content, while for the 
clearance of creatinine it was observed the 
inverse effects, in accordance with the NAG 
levels (Fig. 1). Plasma biochemistry quantified 
24h after intoxication only showed slight 
variations (Table S1). On the other hand, 
several plasma biochemical parameters 
evaluated 48h after administration varied 
significantly, as shown in Table 3. Conjugated 
bilirubin, glucose, cholesterol, LDL, GGT, and 
CK levels were significantly increased in the 
PQ group, while this effect was reverted in the 
PQ+LAS group. On the other hand, creatinine, 
ALP, CK-MB, α-1-antitrypsin and calcium 
levels were increased in PQ and PQ+LAS 
groups. Conversely, the animals exposed to 
PQ, PQ+LAS and LAS had lower levels of 
HDL compared to the control group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Biomarkers of kidney injury after 24h. A) Urinary N-acetyl-β-D-glucosaminidase (NAG) activity in the 
control, lysine acetylsalicylate (LAS), paraquat (PQ), and paraquat plus lysine acetylsalicylate (PQ + LAS) 
groups. B) Total proteins in the control, LAS, PQ, and PQ+LAS groups. C) Clearance of creatinine in the 
control, LAS, PQ, and PQ+LAS groups. Values are given as mean±S.D. (n = 5). *p< 0.05, **p< 0.01 and ***p< 
0.001 vs. control; #p< 0.05, ##p< 0.01 vs. LAS; ƚp< 0.05 vs. PQ+LAS. 
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Pulmonary oxidative stress and 
inflammatory biomarkers 
In view of the fact that PQ produces ROS 
during the redox cycling, several pulmonary 
oxidative stress and inflammatory biomarkers 
were also evaluated. The lung GSH and 
TBARS levels did not change 24h after 
intoxication among groups (data not shown). 
However, 48h after intoxication there was a 
significant depletion of lung GSH levels in the 
PQ groups that correspond to a depletion of 
approximately 40% compared to control 
(Fig.2A). In accordance, a significant increase 
of approximately 85% was observed in the 
GSSG levels of the PQ-treated group (Fig. 
2B). In accordance, the GSH/GSSG ratio 
suffered a significant reduction in the PQ 
group compared to the control group (Fig. 
2C). In both cases, LAS attenuated the 
induction of oxidative stress shown by the 
normalization of GSH and GSSG levels. 
Likewise, pulmonary lipid peroxidation was 
exacerbated in PQ group (Fig 2D) and a 
significant decrease in TBARS levels to 
normal was observed in the lung of animals 
from PQ+LAS group. Concerning MPO, it was 
observed that this inflammatory parameter 
increased at 24h in the PQ group, but the 
presence of LAS did not modify this trend. On 
the other hand, at 48h, the differences among 
groups were no longer apparent (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. GSH (nmol GSH/mg of protein), GSSG (nmol GSSG/mg of protein), GSH/GSSG ratio and 
malondialdehyde (MDA nmol/mf of protein) in the control, PQ, LAS, PQ, and PQ+LAS groups. Values are 
given as means±S.D (n=5). *p< 0.05, **p< 0.01 vs. control; #p< 0.05, ##p< 0.01 vs. LAS; ƚp< 0.05 vs. PQ+LAS. 
 
 Study III: Lysine acetylsalicylate improves the safety of paraquat 
113 
  
*
#
*
#
Table 3. Plasma biochemistry following 48h of intoxication. 
Values are given as mean±S.D. (n = 5); * p < 0.05 vs. Control; # p < 0.05 vs. LAS; ƚ p < 0.05 vs. PQ+LAS  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Lung mieloperoxidase (MPO activity (U/mg of protein) of the control, LAS, PQ, PQ+LAS groups. 
Values are given as means±S.D (n=5). *p < 0.05 vs. control; #p< 0.05 vs. LAS. 
Evaluated parameter Control LAS PQ PQ+LAS 
Albumin (g/L) 45.91 ± 4.52 36.01 ± 10.44 42.23 ± 4.88 57.30 ± 31.23 
Total proteins (g/L) 74.21 ± 3.55 54.56 ± 2.85 59.25 ± 6.33 57.20 ± 1.66 
Total Bilirubin (mg/dL) 0.08 ± 0.01 0.12 ± 0.04ƚ 0.13 ± 0.07ƚ 0.04 ± 0.02 
Direct Bilirubin (mg/dL) 0.18 ± 0.03 0.09 ± 0.07 0.046 ± 0.03 0.02 ± 0.03** 
Glucose (mg/dL) 100.32 ± 24.73 114.16 ± 17.58 360.64 ± 51. 98 ƚ ƚ ƚ ***### 223.70 ± 34.74###*** 
Creatinine (mg/dL) 0.36 ± 0.06 0.68 ± 0.63 0.60 ± 00* 0.72 ± 0.39* 
Urea (mg/dL) 27.15 ± 5.93 28.80 ± 15.23 50.96 ± 19.52 29.64 ± 7.49 
Amylase (U/L) 358.80 ± 28.36 314.28 ± 41.78 405.00 ± 91.12 426.32 ± 49.98# 
LDH (U/L) 332.30 ± 86.21 485.76 ± 349.68 666.68 ± 263.92 731.32 ± 263.92 
Cholesterol (mg/dL) 49.52 ± 9.87 53.56 ± 9.93 82.24±16.53**## ƚ 64.16 ± 6.10 
LDL (md/dL) 25.06 ± 6.69 38.78 ± 9.91 60.38 ±19.45**# 45.88 ± 5.70* 
HDL (mg/dL) 17.24 ± 3.77 8.32 ± 4.16** 13.20 ± 1.54*# 11.36 ± 1.28*# 
Uric acid (mg/dL) 0.52 ± 0.18 0.76 ± 0.43 0.92 ± 0.52 0.80 ± 0.37 
TG  (mg/dL) 36.12 ± 4.85 32.28 ± 22.86 43.28 ± 13.86 34.60 ± 8.56 
ALAT (U/L) 26.40 ± 7.47 26.05 ± 13.95 16.65 ± 8.82 14.28 ± 5.31 
ASAT (U/L) 77.08±9.04 102.60±26.41 112.40±69.95 154.30±49.99 
GGT (U/L) 0.28 ± 0.15 0.64 ± 0.92 1.72 ± 3.57*#ƚ 0.16 ± 0.15 
ALP (U/L) 60.40 ± 5.90 95.6 ± 38.26 131.20 ± 19.10** 113.60 ± 30.63* 
Lactate (mg/dL) 22.79 ± 6.62 22.84 ± 7.74 33.04 ± 6.99 24.15 ± 6.80 
α-1-Anti-tripsyn (g/L) 0.07 ± 0.00 0.07 ± 0.04 0.07 ± 0.03 0.09 ± 0.01* 
CRP (mg/L) 0.004 ± 0.009 0.042 ± 0.034 0.084 ± 0.188 0.027 ± 0.038 
CK (U/L) 562.54±111.34 440.95 ± 259.82 956.10±307.49*#ƚƚ 458.50 ± 64.61 
CK-MB (U/L) 308.40±76.90 444.55 ± 142.16 677.91 ± 60. 95**# 552.76 ± 109.71* 
Potassium (mmol/mL) 4.17 ± 0.33 6.61 ± 1.04** 4.50 ± 0.66### 4.99 ± 0.29## 
Calcium (mg/dL) 9.85 ± 2.00 14.00 ± 0.66 14.71 ± 0.85* 15.03 ± 1.53* 
Sodium (mmol/mL) 129.76 ± 12.27 180.20 ± 11.56*** 165.76 ± 11.19 173.08 ± 8.61 
CHAPTER IV   
114 
 
 
*
*
 
Paraquat quantification 
The plasma concentration of PQ in the PQ 
24h group was 8.14±4.90 µg/mL. Animals 
treated with PQ+LAS formulation evidenced a 
significant decrease in plasma PQ 
concentration, down to 2.80±0.29 µg/mL 
(p<0.05; Fig. 4). Although not significant, a 
trend for an increase of urinary PQ elimination 
was registered in the PQ+LAS group. On the 
other hand, PQ fecal excretion was 
significantly increased in rats exposed to 
PQ+LAS compared to the group only exposed 
to PQ, from 122.45±13.79 µg/mL to 
605.25±414.76 µg/mL (p<0.01; Fig. 4). No PQ 
was detected in lung tissue in both groups 
after 24h. After 48h, the concentration of PQ 
in lungs of the PQ+LAS-treated group was 
lower than the PQ-treated group, 0.41±0.07 
µg/mL and 1.83±1.03 µg/mL (p<0.05), 
respectively (Fig. 5). In addition, rats treated 
with PQ+LAS and sacrificed 48h later also 
had significantly lower levels of PQ in plasma 
than PQ-treated group (for PQ 1.83±1.03 vs. 
0.41±0.06 for PQ+LAS, p<0.05). Urine and 
feces concentration of PQ was unaltered after 
48h.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Paraquat (PQ) concentration in the plasma, urine, and feces of PQ 24h and paraquat+lysine 
acetylsalicylate (PQ+LAS 24h) groups. Values are given as means±S.D (n=5). *p<0.05 vs. PQ. 
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Figure 5. Paraquat (PQ) concentration in the plasma, lung, feces, and urine of PQ 48h and paraquat+lysine 
acetylsalicylate (PQ+LAS 48h) groups. Values are given as means±S.D (n=5). *p<0.05 vs. PQ 
 
 
Histology 
The major histological findings and 
respective semi-quantitative analysis is 
shown in Table 4. Animals from the control 
and LAS group presented a normal and 
preserved pulmonary architecture, without 
evidences of alveolar collapse or cellular 
infiltrations at 24 and 48h (Fig.6 and 7). 
Lungs from PQ only exposed rats showed 
marked fibrin deposition in the alveolar 
space, diffuse alveolar collapse, strong 
vascular congestion and infiltrative cells 
within the alveolar space (Fig.6). These 
histopathological alterations became more 
exuberant at 48h after PQ exposure, with an 
extension of interstitial areas occupied by 
fibrin and trapped erythrocytes, dispersed 
necrotic foci and inflammatory cells (Fig. 7). 
Noteworthy, in the PQ+LAS 24 and 48h 
groups, compared to the PQ-only exposed 
animals, the incidence of the above referred 
alterations was drastically attenuated, 
particularly the macrophage-like cells 
infiltration, fibrin deposition and the alveolar 
collapse.  
 The immunohistochemistry for the evaluation 
of the lung activation of the inflammatory 
transcriptional factor, NF-κB in response to 
PQ and PQ+LAS insult is depicted in Figure 
8. Both lungs from PQ 24 and 48h group 
showed a strong positive staining for 
activated NF-κB in the macrophage-like cells. 
On the other hand, in the PQ+LAS 24 and 
48h groups the activation of NF-κB was 
dramatically attenuated. Noteworthy, 
activated macrophages-like cells were not 
found.  
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Table 4. Semi-quantitative histological analysis of the control, lysine acetylsalicylate (LAS), paraquat (PQ) and 
paraquat plus lysine acetylsalicylate (PQ+LAS) groups. 
Group 
Evaluated morphological parameter 
Interstitial 
inflammatory cell 
infiltration 
Tissue 
Desorganization 
Fibrine deposition 
24h 
Control 0.0ƚƚ 0.0ƚƚ 0.0ƚ 
LAS 0.0ƚƚ 0.0ƚƚ 0.0ƚ 
PQ 2.0 (2-3) 1.0 (1-2) 1.0 (1-2) 
PQ+LAS 1.0 (0.5-1)ƚ 0.5 (0.25-0.75) 0.5 (0.25-0.75) 
48h 
Control 0.0ƚƚ 0.0ƚƚ 0.0ƚƚ 
LAS 0.0ƚƚ 0.0ƚƚ 0.0ƚƚ 
PQ 2.0 (2.0-2.5) 1.0 (1.0-1.5) 1.0 (1.0-1.5) 
PQ+LAS 0.25 (0.0-0.625)ƚ 0.0ƚƚ 0.0 (0.0-0.5)ƚ 
  Values are given as median and interquartile range (n = 3).  ƚ   p < 0.05 vs. PQ group;   ƚƚ p < 0.01 vs. PQ 
group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Representative light micrographs of lungs from animals of control 24h, LAS 24h, PQ 24h and 
PQ+LAS 24h groups. The infiltrative cells (green arrows) along with extensive fibrin deposition (*) and trapped 
erythrocytes (yellow arrows) within the alveolar space can be observed. It can also be noted few necrotic 
areas (#) shown by the presence of cellular debris. 
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Figure 7. Representative light micrographs of lungs from animals of control 48h, LAS 48h, PQ 48h and 
PQ+LAS 48h groups. The infiltrative macrophages (blue arrows) adherent to endothelium and other 
inflammatory cells (green arrows) within the vases can be observed. It can also be observed capillaries filled 
with erythrocytes, suggestive of vascular stasis (yellow arrows) and extended interstitial areas filled with fibrin 
(*) and dispersed necrotic foci (#). 
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Figure 8. Light micrographs of lung NF-κB immunohistochemistry from animals belonging to the control, LAS, 
PQ and PQ+LAS groups, sacrificed 24 and 48 h after the administrations. NF-κB activation is evident in 
macrophage-like cells (red arrows). 
 
 
Discussion 
The present study provides unequivocal 
evidence that the addition of LAS to the PQ 
commercial formulation (Gramoxone®) 
ameliorates the signs of PQ induced-toxicity in 
Wistar rats. The current findings corroborate 
previous results that demonstrated the 
improvement of the safety profile of this new 
formulation, as shown by the full survival of 
male Wistar rats (Baltazar et al., 2013a). 
Accordingly, it was now shown that the 
PQ+LAS formulation has a much higher LD50 
than the LD50 of Gramoxone® (34.86 mg/kg 
vs. 187.5 mg/kg). 
In the past few decades, a considerable 
amount of research was performed in order to 
discover new therapeutic solutions for the 
burden associated with PQ poisonings (Dinis-
Oliveira et al., 2008b). Measures to alter the 
toxicokinetics of PQ were the first to appear. 
PQ is known to be very rapidly absorbed, 
apparently associated with the carrier-
mediated transport system for choline on the 
brush-border membrane (Nagao et al., 1993). 
PQ distribution follows a three-compartment 
model where the third compartment is the 
lung, especially the pneumocytes type I and II 
and Clara cells, in which exchanges with the 
central compartment (blood) are slow 
(Hawksworth et al., 1981). Peak 
concentrations of PQ in the lung are reached 
5-7 h after ingestion and lethal concentrations 
may be achieved within 6h of ingestion of 35 
mg/kg (Houze et al., 1990). Since patients are 
Control 48h
LAS 48h
PQ 24h PQ 48h
PQ+LAS 48hPQ+LAS 24h
 
 
 
 
 
 
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rarely hospitalized within this time, the 
extracorporeal elimination techniques will be 
effective in lowering PQ plasma levels but 
with low effectiveness in improving the 
survival rate. The reason is that when these 
techniques of elimination are initiated, 
potentially lethal concentrations of PQ have 
already been reached in the highly vascular 
tissues of vital organs and in pneumocytes 
(Bismuth et al., 1987). Administration of other 
drugs aiming to control the damage caused by 
PQ, such as dexamethasone, 
cyclophosphamide and N-acetylcysteine also 
tend to fail to improve the survival rate for the 
same reason, since most of the damage is 
already irreversible by the time of the 
treatment (Eddleston et al., 2003). Heylings 
and colleagues initiated the first attempts to 
make the product safer, whether the 
poisoning occurs accidentally or intentionally. 
The new formulation developed by this group 
contained an alginate that has the unique 
property that it gels on contact with gastric 
acid, decreasing the dispersion and delivery 
of the toxic chemical to its site of absorption in 
the small intestine (Heylings et al., 2007). 
However, as already mentioned, this 
formulation had a negligible impact in the 
survival rate. Our attempt to make 
Gramoxone® safer was to include LAS in the 
original formulation that, immediately after 
ingestion, would protect the gastrointestinal 
tract and counteract the toxicity of the 
absorbed PQ (Baltazar et al., 2013a). This 
measure, that does not influence the 
herbicidal effect (Baltazar et al., 2013a),  has 
the potential to overcome the critical period 
between poisoning and hospital treatment by 
preventing lethal concentrations to reach the 
lung and even supposing that lethal 
concentrations accumulate in this organ, LAS 
would immediately exert its cytoprotection.  
The 24h results have shown that LAS alters 
the toxicokinetics of PQ by increasing the PQ 
elimination in urine and feces, decreasing 
plasma concentration. The results suggest 
that the alteration might be related to the 
improvement of the renal function, as 
sustained by the restoration of the clearance 
of creatinine and the levels of the lysosomal 
enzyme NAG, a tubular nephrotoxicity marker. 
Besides lung, kidney injuries are major 
causes of PQ morbidity, since it is mainly 
excreted unchanged by the kidney (Kim et al., 
2011; Kim et al., 2009; Roberts et al., 2011). 
Renal dysfunction leads, in turn, to decreased 
renal PQ clearance, which promotes greater 
toxicity in other organs. After 48h of 
intoxication, the results were similar for the 
PQ plasmatic concentrations, and PQ was 
already detectable in the lung but at a lower 
extent in the PQ+LAS group. In acute PQ 
poisoning, creatinine peaks around five days 
post-ingestion and resolves within three 
weeks in survivors (Kim et al., 2009). This fact 
may explain in part the reason why in the 
present study a rise of creatinine is not 
observed in the PQ group at the end of 24 
and 48h. A recent preclinical model explored 
a variety of urinary and plasma biomarkers 
and their possible roles in the prediction of 
acute kidney injury following administration of 
sub-lethal PQ doses (Wunnapuk et al., 2013). 
The authors found that urinary kidney injury 
molecule-1, urinary albumin and urinary 
Cystatin-C elevations outperformed plasma 
creatinine in predicting histological changes at 
8–24 h. Other explanation for the reduced 
levels of lung PQ in the group PQ+LAS 48h 
might arise from a direct interference with the 
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mechanism of PQ uptake by the cells. The 
substrates of the polyamine uptake system 
require specific structural characteristics such 
as: (i) two or more positively charged nitrogen 
atoms, (ii) maximum positivity of charge 
surrounding these nitrogens, (iii) a nonpolar 
group between these charges, and (iv) a 
minimum of steric hindrance (Ross and 
Krieger, 1981). Evidences suggest that LAS 
metabolite, salicylic acid (SA), forms 
crystalline charge-transfer complexes with PQ 
dichloride (Dinis-Oliveira et al., 2008a). 
Therefore, it could be hypothesized that the 
portion of PQ complexed with LAS would not 
be recognized by the polyamine uptake 
system, thus limiting its internalization.  
The pharmacokinetic studies have shown that 
apart from the lung, the muscle is the other 
main reservoir of PQ (Smith, 1988) and for 
that reason muscle toxicity is expected. 
Postmortem analysis have shown that heart 
muscle and the diaphragm presented cellular 
degeneration, including changes of cross 
striation, vascular congestion, interstitial 
edema, localized hemorrhagic infiltration and 
numerous marginalized leukocytes within 
capillaries (Dinis-Oliveira et al., 2009b). 
Several authors reported elevated plasma CK 
levels (1147 -1796 U/L), increased PQ muscle 
concentration, and damage (Rose et al., 
1976; Sharp et al., 1972) four or five days 
after admission (Tabata et al., 1999; Van de 
Vyver et al., 1985). Accordingly, our data 
revealed that the plasma CK values were 
elevated after 24h and 48h of administration 
of PQ (1383 and 956 U/L, respectively). On 
the other hand, LAS administration exerted a 
beneficial effect since the levels of CK were 
significantly lower after 48h (956.10±307.49 
vs. 458.50±64.61 U/L, respectively). 
PQ acute fulminant toxicity is characterized by 
an elevation of the pancreatic enzymes 
(Bismuth et al., 1982) and mild acute 
pancreatitis was observed at autopsy of PQ-
poisoned patients (Soontornniyomkij and 
Bunyaratvej, 1992). Accordingly, in our 
experimental model it was observed an 
increase of the pancreatic enzyme, amylase 
in both groups PQ 24h and PQ+LAS 24h, 
while at 48h the increase was only statistical 
significant for the group PQ+LAS 48h. Early 
animal experiments have shown that PQ 
increases blood glucose and decreases 
plasma insulin (Giri et al., 1979). The 
mechanism underlying PQ induced-
hyperglycemia might be related to the 
inhibition of the activities of 
phosphatidylinositol 3´-OH kinase (PI 3-
kinase) bound to insulin receptor substrates 
and phosphorylation of Akt (Shibata et al., 
2010). This kinase has been shown to play an 
essential role in insulin dependent 
translocation of GLUT4 to the plasma 
membrane, leading to the impairment of 
glucose uptake by adipocytes (Kimura et al., 
2010; Shibata et al., 2010). The 
hyperglycemic effect observed in PQ-treated 
rats was attenuated by LAS only in the 
PQ+LAS 48h, probably due to a direct effect 
of LAS in lowering glucose levels rather that 
an amelioration of the pancreas toxicity since 
the amylase levels were unchanged. In fact, 
case reports suggested that high-dose NaSAL 
could diminish glycosuria in diabetic patients 
and plasmatic glucose concentrations (Reid et 
al., 1957; Williamson, 1901). The transcription 
factor nuclear factor kappa B (NF-κB) is 
activated in response to several oxidant and 
inflammatory stimuli and promotes the 
activation of downstream effectors not only 
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involved in the inflammatory response but 
also promoting insulin resistance (Shoelson et 
al., 2003; Tanti and Jager, 2009). The 
salicylates mediated-reversal of 
hyperglycemia, hyperinsulinemia, and 
dyslipidemia is associated with the ability of 
salicylates to inhibit IKK-β and NF-κB (Kopp 
and Ghosh, 1994; Yin et al., 1998) and 
therefore ameliorate insulin resistance and 
improve glucose tolerance (Cai et al., 2005; 
Hundal et al., 2002; Yuan et al., 2001). 
The main target organ for PQ toxicity is the 
lung as a consequence of its accumulation, 
against a concentration gradient, through the 
highly developed polyamine uptake system. 
Once inside the cells, PQ2+ is reduced to the 
PQ monocation free radical (PQ•+), which is 
rapidly reoxidised by O2 to PQ2+, initiating a 
series of reactions leading to production of 
superoxide anion (O2•−). As expected, the 
oxidative stress biomarkers were markedly 
increased in PQ-treated groups namely 
GSSG and lipid peroxidation. The protection 
conferred by salicylates against PQ toxicity 
has been postulated to be, at least in part, 
due to their antioxidant properties (Baltazar et 
al., 2011). PQ leads to the generation of O2.- 
that when dismutated originates hydrogen 
peroxide (H2O2) which in turn, in the presence 
of Fe (II) is reduced to HO., a far more 
damaging ROS (Dinis-Oliveira et al., 2008b). 
Acetylsalicylic acid and mainly its SA 
metabolite strongly scavenge HO. and chelate 
transition metals such as Fe (III) and Cu (II), 
thus inhibiting the Fenton reaction (Grootveld 
and Halliwell, 1986). Additionally, 
acetylsalicylic acid has unique biological 
functions namely the induction of ferritin and 
of 15-epi-lipoxin A4 synthesis, NO up-
regulation, hemoxygenase-1 expression and 
inhibition of NAD(P)H oxidase activity 
(Baltazar et al., 2011).  
As mentioned above, an important target is 
the nuclear factor NF-κB, a pivotal 
transcription factor involved in the regulation 
of the expression of proinflammatory genes 
encoding various cytokines, chemokines, 
enzymes (e.g., iNOS, COX-2), and adhesion 
molecules. PQ-induced oxidative stress 
strongly activates NF-κB in the lung cells of 
rats intoxicated with PQ (Dinis-Oliveira et al., 
2007b). As expected, lung NF- κB was 
strongly activated in both PQ groups and the 
incorporation of LAS to the formulation 
markedly suppressed the PQ-induced lung 
NF-κB activation. These results are in 
accordance with previous studies reporting 
that SA and acetylsalicylic acid inhibit the 
activation of NF-κB after inflammatory insults 
such as LPS (Kopp and Ghosh, 1994), or 
after PQ intoxication (Dinis-Oliveira et al., 
2007b). During the inflammatory process, 
platelets undergo chemotaxis, release 
proinflammatory cytokines and adhesive 
proteins, and recruit of neutrophils and 
macrophages (Manning et al., 1995; Wagner 
and Burger, 2003). The histological findings 
also show that LAS inhibited the chemotaxis 
of inflammatory cells that might be explained 
either by the inhibition of the adhesion 
molecule P-selectin or due to the antiplatelet 
beneficial effects of LAS (O'Sullivan and 
Michelson, 2006).  
The present study shows that the PQ+LAS 
formulation has the potential to reduce the 
risks associated with PQ intoxication in 
mammals, as demonstrated by the 
amelioration of the overall pathophysiology of 
PQ poisoning. It is important to focus that the 
improvement in the survival rate previously 
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reported (Baltazar et al., 2013a), together with 
the current findings, support the use LAS in 
the PQ formulation, as the PQ herbicidal 
effect is maintained (Baltazar et al., 2013a) 
and the environmental impact is also 
attenuated (Baltazar et al., 2013b). 
Noteworthy, these results were obtained upon 
the administration of one single dose without 
other supportive measures. It might be 
supposed that repetitive LAS therapy could 
result in survival or at least to extend the 
survival time enough to allow lung 
transplantation in the PQ-poisoned patients in 
worst case approaches. 
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Supplementary Table 
 
Table S1. Plasmatic biochemical parameters after 24h of intoxication 
 
Values are given as mean±S.D. (n = 5). n.d: not detectable. * p < 0.05 vs. control; # p < 0.05 vs. LAS;  
ƚ p < 0.05 vs. PQ+LAS. 
Evaluated parameter Control LAS PQ PQ+LAS 
Albumin (g/L) 42.65 ± 1.37 39.55 ± 13.13 43.23 ± 4.71 46.15 ± 3.74 
Total proteins (g/L) 56.50 ± 4.42 64.98 ± 9.45 59.55 ± 6.96 66.43 ± 6.01 
Total Bilirubin (mg/dL) 0.060 ± 0.000 0.040 ± 0.028 0.044 ± 0.017 0.027 ± 0.012 
Direct Bilirubin (mg/dL) 0.068 ± 0.011 0.064 ± 0.017 0.072 ± 0.027 0.047 ± 0.012 
Glucose (mg/dL) 144.20 ± 31.43 121.70 ± 42.71 247.80 ± 80.50*#  257.20 ± 73.91*# 
Creatinine (mg/dL) 0.48 ± 0.11 0.52 ± 0.11 0.60 ± 00ƚ 0.40 ± 0.00 
Urea (mg/dL) 34.92 ± 4.24 32.32 ± 10.34 31.20 ± 5.34 35.35 ± 7.52 
Amylase (U/L) 367.70 ± 38.86 358.40 ± 45.27 425.90 ± 78.80ƚ 565.30 ± 243.20*# 
LDH (U/L) 468.90 ± 303.10 512.90 ± 277.90 1065.00 ± 903.40 1512.00 ± 443.40 
Cholesterol (mg/dL) 44.40 ± 8.57 45.08 ± 3.89 63.12±15.66**# 46.84 ± 9.37 
LDL (md/dL) 27.28 ± 5.54 30.85 ± 3.53 48.99 ±14.57*ƚ# 27.39 ± 9.65 
HDL (mg/dL) 9.05 ± 1.69  8.66 ± 1.98 13.78 ± 2.67*# 10.48 ± 2.86 
Uric acid (mg/dL) 1.28 ± 0.50 2.36 ± 0.97 2.64 ± 1.04 3.80 ± 1.69* 
Triglycerides  (mg/dL) 23.88 ± 4.90 27.84 ± 6.83 20.88 ± 12.65 31.70 ± 17.87 
ALAT (U/L) 22.24 ± 4.06 29.36 ± 9.38 30.48 ± 4.86 34.20 ± 14.01 
ASAT (U/L) 77.08 ± 10.10 102.60 ± 29.52 112.40 ± 78.20 154.30 ± 57.72 
GGT (U/L) 0.10 ± 0.00 n.d. 0.70 ± 0.00 0.30 ± 0.00 
ALP (U/L) 12.00 ± 6.16 10.80 ± 1.92 7.60 ± 2.88 9.75 ± 2.06 
Lactate (mg/dL) 22.79 ± 6.62 26.13 ± 6.63 33.98 ± 11.66 37.64 ± 4.43* 
α-1-Anti-tripsyn (g/L) 0.032 ± 0.011 0.060 ± 0.020 0.044 ± 0.022 0.064 ± 0.026 
Reactive C protein (mg/L) 0.072 ± 0.058 0.024 ± 0.022   0.068 ± 0.059 0.025 ± 0.030 
CK (U/L) 381.70±184.60 673.40 ± 336.00 1383.00 ±1182.00   1340.00 ± 810.70 
CK-MB (U/L) 361.10 ± 135.40 380.40 ± 158.00 1071.00 ± 894. 00 1058.00 ± 604.60 
Sodium (mmol/mL) 109.90 ± 4.43 100.40 ± 44.17 101.80 ± 8.53 100.80 ± 7.98 
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PQ is among the most widely used herbicides for weed control management. Its adverse 
health effects are well recognized, and industrialized countries such as USA, Canada and 
Australia that allow PQ use, classify it as of "restricted use," which means that it can be 
used only by people who are licensed applicators. Personal Protective Equipment 
requirements for those applying paraquat include a long-sleeved shirt and long pants, 
chemical-resistant gloves, shoes and socks. On the other hand, in developing countries 
these conditions cannot be guaranteed and despite occupational exposure is not believed 
to pose a considerable risk, unintentional fatalities still occur (Garnier et al., 1994; 
Wesseling et al., 1993; Wesseling et al., 1997; Zhou et al., 2013). When it was first 
marketed, the reddish-brown color led to PQ products being mistaken for beverages such 
as coffee and coke (prior to 1988), particularly when decanted to other containers – a 
common practice in developing countries. However, since 1988 the manufacturer 
Syngenta has changed the color to blue, added an emetic, and a stenching agent to 
prevent the accidental and intentional ingestions from occurring. U.S. Poison Control 
Center data, showed a decline of almost 50% when comparing the proportion of all 
pesticide intoxication cases due to paraquat ingestion for the four years pre- and post-
1988 (Wesseling et al., 2001). Although not all the brands marketed have these 
safeguards added, in USA only formulations with these agents are permitted.  
Following the global controversial regarding PQ use, the ban in Europe (explained in 
commentary I, from the theoretical background chapter of this dissertation) campaigns 
towards its complete phase-out in developing countries by the Berne Declaration, 
Pesticide Action Network Asia Pacific, Pesticide Action Network UK and the Swedish 
Society for Nature Conservation, Syngenta has made some efforts to improve again the 
safety of PQ (Heylings et al., 2007; Wilks et al., 2008; Wilks et al., 2011). Syngenta has 
increased the concentration of the emetic, added a purgative (magnesium sulphate), and 
included an alginate designed to cause gel formation of ingested product and thus delay 
absorption, namely by giving emetic enough time to work. Blood levels of PQ are 
indicative of outcome, but many patients have levels over 100 times the estimated lethal 
concentration, making treatment extremely difficult. In these patients, death may occur 
within a few hours from multi-organ failure, so measures to reduce PQ absorption seem a 
rightful choice. Nevertheless, there was some inconsistency in the approaches used to 
alter the formulation, in that gastric emptying was intended to be delayed by the use of an 
alginate that would gel in gastric acid. However, since emetics work predominantly after 
passive absorption from the small bowel, their absorption is necessarily coincident with 
the active uptake of the PQ in the small bowel. The alginate will thereby limit the 
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absorption of the emetic—hence the overall approach seems a little confused (Bateman, 
2008). 
The general aim of this thesis was to develop a safer PQ formulation with the 
incorporation of LAS as the antidote and preserving the herbicide effectiveness. Our 
research group has been exploring the effect of salicylates as antidotes for PQ 
poisonings. Previously it was clearly shown that NaSAL (200 mg/Kg i.p.) and LAS (200 
mg/Kg i.p.) led to full survival of PQ intoxicated rats (Dinis-Oliveira et al., 2009; Dinis-
Oliveira et al., 2007b). The major difference between NaSAL and LAS is the presence of 
an acetyl group attached to the phenol ring as in Aspirin® (ASA). In contrast to Aspirin®, 
LAS is a salt compound and therefore it is possible to dissolve LAS in the aqueous 
solution of PQ formulation. In humans, the plasma half-life of LAS is about 15 min, 
whereas for SAL it is between 2 and 30h, depending on the ingested dose. Because of 
the much longer half-life and an anti-inflammatory potency comparable to Aspirin®, it is 
probably salicylate that causes most, if not all, of the analgesic, antipyretic, anti-
inflammatory, and antiproliferative actions of Aspirin® (as extensively explained in the 
review I in the theoretical background chapter). An exception is the antiplatelet effect that 
is specific for ASA and other targets that depend on the acetylation (Schrör, 2009a). For 
that reason, LAS constitutes an advantage since there are two bioactive components in 
one molecule. Although the mixing of PQ with an antidote appears to be a logical 
approach, there was no data so far showing that LAS or PQ would maintain its properties 
in a mixture. Besides this lack of data, as SAL forms a soluble crystalline charge-transfer 
complex with PQ (Dinis-Oliveira et al., 2008a), it was also important to verify the stability 
of the formulation concerning the herbicidal effectiviness and toxic effects. In Study I the 
safety of the formulation was evaluated using Wistar rats as a mammalian model. Diluted 
Gramoxone® (125 mg/kg) was mixed with increasing concentrations of LAS [half-molar 
(79mg/kg); equimolar (158mg/kg); and double-molar (316mg/kg) doses, relatively to PQ] 
and, for the first time, both compounds were administered by gavage. The mixture of PQ 
with LAS (125 mg/kg+316 mg/kg) proved to be safe, granting 100% of survival in 
comparison to only 40% observed in the PQ group.  Noteworthy, in addition to the 
experiments with fresh solutions, experiments with two- and six- months-old formulations 
were also performed, and full survival was also achieved. Due to the commercial interest 
of this novel formulation, the herbicidal effect was also assessed against grass species 
belonging to the Poaceae family. Simultaneous foliar application of PQ and LAS provided 
similar efficacy to PQ alone when the solutions were freshly prepared. In the experiments 
carried out with two- and six-month-old formulations, the herbicidal activity was 
maintained, but the efficacy showed a time-dependent decrease. As mentioned above, 
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LAS is rapidly deacetylated to SAL in neutral or basic aqueous solutions which mean that 
after 2 or 6 months the formulation will mostly contain SAL and PQ. In view of the fact that 
SAL forms a soluble crystalline charge-transfer complex with PQ (Dinis-Oliveira et al., 
2008a) it can be assumed that the decrease of the herbicidal efficacy is due to the 
formation of the complex PQ:SAL. Further work is necessary to assess the formulation 
stability, the full scale-up costs and the development of a technology able to prevent LAS 
hydrolysis within the formulation. In terms of the herbicidal effect the complexation is an 
inconvenience but regarding the mammalian toxicity it constitutes an advantage. Since 
50% of LAS is immediately hydrolyzed in the gastrointestinal mucosa, and the remaining 
50% is hydrolyzed within 15 min in plasma, PQ is either complexed before absorption 
(limiting the uptake by intestinal cells) or complexed with SAL after absorption within the 
plasma or cells. This putative mechanism of complexation with PQ in vivo might also 
contribute to the safer profile of LAS observed across all the studies of the thesis. 
Concerning the human toxicity, assuming a formulation containing PQ (200 g/L)+LAS (510 
g/L), an ingestion of 30 mL would mean ingestion of 15 g of LAS. Acute life-threatening 
salicylates intoxication in adults occurs at doses of about 12–15 g and 3 g in children but 
under optimum conditions, mortality of severe intoxications amounts to less than 5% 
(Chyka et al., 2007). The treatment of salicylates poisoning include gastric lavage, 
administration of activated charcoal, and in cases of metabolic acidosis the administration 
of sodium bicarbonate (Schrör, 2009b). Given that the present formulation contains an 
emetic and that the measures mentioned for salicylates intoxication are also employed in 
cases of PQ poisoning, the concentration of both compounds will thereby be reduced. 
Besides, the PQ:SAL complexation should not be disregarded as it represents a valid 
pathway to reduce of the toxicity of both compounds. More importantly, the incorporation 
of LAS in PQ formulation will overcome the disadvantage of the critical time between 
intoxication and treatment, with an expected increase in survival rate and decrease in 
morbidity. 
Nowadays, pesticides are widely used and may enter the aquatic ecosystems from 
agricultural runoff or leaching. The adverse effects of these pollutants on nontarget plants 
are particularly of concern due to the increasing worldwide use of these chemicals. Algae 
play an important role in the equilibrium of aquatic ecosystems, being the first level of the 
trophic chain to produce organics and oxygen. Accordingly, the subsequent objective of 
this thesis was to provide valuable information regarding the ecotoxicity of this new 
formulation using the microalga Chlorella vulgaris as a testing model. Our results 
corroborated previous studies showing that PQ significantly reduces the growth rate of 
microalgae cultures (Study II). Noteworthy, in the presence of LAS, the growth of C. 
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vulgaris is stimulated and is even higher than the control. Moreover, when PQ and LAS 
were added simultaneously, LAS exerted a beneficial effect. Indeed, LAS conferred 
protection against PQ toxicity of approximately 1.8 fold when the formulation was added in 
the proportion 1:8 in molarity.  
The question remained: how is it possible to explain that this combination is non-toxic for 
C. vulgaris and at the same time still being effective against weeds? PQ herbicidal activity 
and algae toxicity is strongly associated with the inhibition of photosynthesis and the 
irreversible damage through the generation of ROS in a light-dependent manner. Despite 
higher plants and algae have the same target sites in photosynthesis, the differences rely 
on the formulation applied and its stability. In Study I we observed that LAS in the 
proportions 1:2 did not inhibit the herbicidal effect of PQ. Noteworthy, the solution was 
freshly prepared before application, but when the same study was performed with the 2 
and 6 months-old a slight decrease in the efficacy was observed. Due to the neutral pH of 
the algae media, after 48h, almost all the LAS was hydrolyzed to SAL. Previous studies 
have shown that pre-treatment of seedlings with 0.5 mM SA for 24h before exposure to 10 
µM PQ reduces PQ-induced chlorophyll losses, H2O2 production, LPO, electrolyte 
leakage, and completely blocked the inhibitory effect of the herbicide on photosynthesis 
(Ananieva et al., 2004). It seems that the rapid removal of SA by C. vulgaris plays an 
important role in the bioremoval and biotransformation of this compound since after 48h 
SAL was almost completely removed from the media.  
Therefore, there are two possible mechanisms involved: 1) the SAL formed from the 
hydrolysis of LAS could complex with PQ thus preventing the inhibitory effect on 
photosynthesis, and 2) the antioxidant properties of LAS and SAL. In conclusion, in order 
to avoid the interference of SAL with the herbicidal effect of PQ, the formulation has to be 
applied immediately after preparation to overcome the instability problem with LAS. At the 
same time, the hydrolysis of LAS in the aquatic medium is advantageous to the 
environment as seen by the stimulation of algal growth in the presence of SA. Although 
the optimal effects were obtained at the ratio 1:8 (PQ:LAS), it is noteworthy that LAS, at 
the proposed ratio for the herbicide formulation of 1:2, was already protective for the 
toxicity mediated by PQ in the microalga C. vulgaris.  
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Figure 1. Metabolism of lysine acetylsalicylate (LAS) in the aqueous media and removal by 
Chlorella vulgaris.  
 
Considering that the incorporation of LAS in the commercial formulation of PQ, 
Gramoxone®, was shown to significantly increase the survival of intoxicated mammals, 
while maintaining the herbicidal effect (Study I), the aim of the Study III was to clarify the 
mechanisms involved in the protective effect of LAS in a rodent model, through monitoring 
PQ levels and the histological and biochemical biomarkers of toxicity. The results clearly 
showed that LAS improves the safety of PQ formulation as shown by the much higher 
LD50 of the PQ+LAS formulation than the LD50 of Gramoxone® (34.86 mg/kg vs. 187.5 
mg/kg, respectively). More specifically, LAS altered the toxicokinetics of PQ by increasing 
the PQ elimination in urine and feces, and decreasing plasma concentration. The results 
suggest that the alteration might be related to the improvement of the renal function, as 
sustained by the restoration of the clearance of creatinine and the levels of the lysosomal 
enzyme NAG, a tubular nephrotoxicity marker. LAS prevented the biochemical and 
histological alterations in lung induced by PQ at the end of 24h and 48h, showed by 
significant reduction in PQ-induced activation of NF-κB, reduction of infiltrative cells and 
preservation of the alveolar structure. This was evidenced by a significant reduction in 
LPO, the maintenance of GSH levels and decreased levels of GSSG in the lung. One may 
consider that the dose of LAS used in this study is quite high, yet the animals receiving 
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only LAS did not present any signs of toxicity. In mild to moderate salicylates poisoning, 
side effects such as nausea, vomiting, tinnitus, hyperventilation, respiratory alkalosis, 
tachypnea loss of coordination, and restlessness, can take place. Nevertheless, PQ 
poisoning is a serious life-threatening situation without an effective treatment and 
therefore the ratio benefit/risk will most probably tend to the benefits from the inclusion of 
LAS in the formulation of PQ. Though this new formulation has yet to prove to be less 
neurotoxic, because exposure to PQ may also be an etiological factor of PD and other 
neurodegenerative diseases (as extensively explained in the review II in the theoretical 
background chapter). Of note, only a single dose of LAS was given concomitantly with PQ 
to the animals. In hospital emergency rooms, first line therapy with fuller´s earth or 
activated charcoal, antioxidants and immunosuppressant agents are currently the 
measures adopted and the continuous infusion or repeated administrations of LAS are 
feasible, which could lead to a decrease of the subsequent doses of LAS. 
In conclusion, the results obtained in the ambit of this thesis suggest that the new 
formulation developed is safer to mammalian and algae species with an effective 
herbicidal activity.  
. 
 
 
 
 
 
 
 
 
 
 
Figure 2. The evolution of paraquat formulations since its introduction in the market in 1962 until 
the present day. 
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I. The administration of a new formulation containing PQ (125 mg/kg per os) and 
LAS (316 mg/kg per os) resulted in full survival of the animals (extended for more 
than 30 days) in comparison with the 40% of survival rate in animals exposed only 
to PQ. 
 
II. The LD50 of the PQ+LAS formulation is higher than the LD50 of Gramoxone® 
(34.86 mg/kg vs. 187.5 mg/kg, respectively). 
 
III. The foliar application of the new formulation containing PQ (2 g/L) and LAS (5.1 
g/L) has a similar efficacy to PQ alone. 
 
IV. There is a slight decline of the herbicidal activity of the formulations with 2- and 6-
months of shelf storage.  
 
V. Full survival was also recorded in animals treated with the formulations with 2- and 
6-months old. 
 
VI. C. vulgaris growth was almost completely inhibited by increasing concentrations of 
PQ. The values of EC50 and EC75 for PQ obtained were 525.5 µg/L and 1158.5 
µg/L. The % of inhibition of growth was reduced in both groups PQ+LAS 1:1 and 
PQ+LAS 1:2 but the maximal effect was obtained for the proportion 1:8. In the end 
of the 96h, approximately 50% of the added LAS was depleted in the medium. The 
depletion of LAS was mainly due to its spontaneous hydrolysis into SAL in 
aqueous medium. 
 
VII. SAL is, to some extent, biotransformed by C. vulgaris after 48 h and is not 
detected after 96h in the culture medium. The protection observed is mainly 
mediated by SAL. 
 
VIII. PQ elimination in urine and feces was higher in animals treated with PQ+LAS than 
PQ only, at least 24h after exposure. After 48h, lung PQ concentration was lower 
in the group PQ+LAS than in PQ. The improvements of the elimination of PQ were 
accompanied by the restoration of the normal values of urinary creatinine, 
proteins, and NAG. 
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IX. The addition of LAS counteracted the PQ-induced ROS production and LPO in 
lung. MPO elevated values were not prevented by LAS but it was able to prevent 
the activation of NF-κB in lung. 
 
X. LAS prevented muscle toxicity, as shown by the normalization of the CK values. 
The hyperglycemic effect observed in PQ-treated rats was attenuated by LAS only 
in the PQ+LAS 48h group, probably due to a direct effect of LAS in lowering 
glucose levels rather that an amelioration of the pancreas toxicity since the 
amylase levels were unchanged. 
 
XI. The overall aim of this thesis was accomplished since it was developed a safer 
formulation of PQ. 
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If PQ use is to continue, and we believe it will in many countries for the foreseeable future, 
then prospect projects are required to continue with pre-clinical studies in order to find the 
ideal combination of antidotes with the formulation. Due to the multiple mechanisms of PQ 
toxicity, salicylates seem to be the most complete antidote discovered so far, since they 
can block several signalling pathways involved in PQ toxicity. However, clinical data will 
be essential to assess the efficacy of salicylates towards PQ poisoning. Additionally, other 
pathways might also be important to be explored as the modulation of PQ toxicokinetics 
through the discovery of potent inducers/activators of P-glycoprotein or inhibitors of the 
uptake of PQ in the intestinal brush border and lung. Due to the differences of PQ levels 
found in the biological samples, the mechanisms underlying the influence of LAS in the 
uptake of PQ should be verified. These molecules together with antioxidants and anti-
inflammatory drugs appear to be the right direction. 
 In relation to the formulation developed, further work is necessary to assess the 
formulation stability, the full scale-up costs and the development of a technology able to 
prevent LAS hydrolysis within the formulation. Additionally the effects of this new 
formulation on birds, fish, frogs, Daphnia magna, and other aquatic species should also 
be assessed. Future studies are necessary to verify the efficacy of this formulation on 
broadleaf weeds and in larger fields.  
The sublethal effects such as respiratory symptoms, central nervous system disorders, 
dermal and inhalation toxicity of the new formulation should also be tested. Due to the 
global concern with the association of PQ exposure with neurodegenerative diseases 
such as PD, studies focusing in the evaluation of the protective effects of LAS or other 
drugs to the nigrostriatal system are also important.  
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